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Abstract:
This work concerns the preparation of novel [2.2]paracyclophane derivatives intended for use
as

asymmetric ligands

and investigations

into surface

coatings

prepared from

[2.2]paracylophanes. This begins with a general introduction to enantioselective synthesis,
followed by a review of relevant reported ligands based on the [2.2]paracyclophane
framework and their applications.
Next is described the preparation of novel ligands based on the [2.2]paracyclophane structure.
Starting with the preparation of a range of mono and disubstituted [2.2]paracyclophanes,
including several novel analogues, this moves on to investigating resolution procedures
where a novel method for the preparation of enantiopure 4-bromo[2.2]paracyclophane is
described.

The

coupling

of

prepared

phenyl

oxazoline

analogues

with

the

[2.2]paracyclophane moiety via the Buchwald-Hartwig amination is used to prepare several
novel ligands and characterisation, along with a detailed investigation in the optimisation of
their synthesis is presented.

The focus of the work then moves to the analogous

octafluoro[2.2]paracyclophane and several routes towards its preparation are investigated.
The structure was functionalised and attempts at preparing analogous fluorinated ligands to
those already detailed are discussed.
Protective surface coatings prepared from [2.2]paracyclophanes are known as parylenes and
herein is presented methods for improved surface adhesion of these coatings. This was
accomplished through the use of sol-gel coating pre-treatments. The pre-treatment
formulations presented were characterised and ultimately proved superior to the current
industrial benchmark. A number of fluorinated sol-gel additives were also prepared and
characterised, two of which are novel, along with a brief study on the incorporation of
organic dyes into sol-gel coatings.

ii

The Synthesis and Applications of [2.2]Paracyclophane Derivatives

Craig Hicks

The work concludes with a discussion of the outcomes and suggestions for future work. The
most significant issue is the improvement of the synthesis of the new ligands which it is
suggested may be enhanced by either the application of microwave synthesis or altering the
coupling partners. Once this has been achieved the next steps would be examining the crystal
structure of an isolated ligand-metal complex and then the application of this complex in
model asymmetric transformations.
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AcOH

Acetic acid

AF4

Octafluoro[2.2]paracyclophane

AIBN

Azobisisobutyronitrile

BCl3

Boron trichloride

BF3

Boron trifluoride

BINAP

2,2’bis(diphenylphosphino)-1,1’-binaphthyl

BTF

Trifluorotoluene

CCl4

Carbon tetrachloride

CF3

Trifluoromethyl

CIP

Cahn-Ingold-Prelog

Cl2

Chlorine gas

COSY

Correlation spectroscopy

CsF

Caesium fluoride

CTAB

Cetyl trimethylammonium bromide

CVD

Chemical vapour deposition

DAST

Diethylaminosulfur trifluoride

DCM

Dichloromethane

DiPAMP

(R,R)-1,2-Bis[(2-methoxyphenyl)(phenylphosphino)]ethane

DMA

Dimethylacetamide

DMF

Dimethylformamide

DMSO

Dimethylsulfoxide

DPPF

1,1’-bis(diphenylphosphino)ferrocene
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EDX

Energy dispersive X-ray spectroscopy

EtOH

Ethanol

FeBr3

Iron (III) bromide

HBr

Hydrogen bromide

HCl

Hydrogen chloride

HF

Hydrogen fluoride

HNO3

Nitric acid

HOOH

Hydrogen peroxide

H2SO4

Sulfuric acid

i-PrNEt

Ethyldiisopropylamine

IR

Infrared

KI

Potassium iodide

KOtBu

Potassium tert-butoxide

MAAH

Methacrylic acid

MAPTMS

3-Methacryloxypropyltrimethoxysilane

mCPBA

m-Chloroperoxybenzoic acid

MeCN

Acetonitrile

MeOH

Methanol

MPS

Mesoporous silicates

N2

Nitrogen gas

NaBH4

Sodium borohydride

n-BuLi

n-Butyllithium

NMR

Nuclear magnetic resonance
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NOESY

Nuclear Overhauser effect spectroscopy

NO2BF4

Nitronium tetrafluoroborate

OPc

Octafluoro[2.2]paracyclophane

Pc

[2.2]Paracyclophane

PCl5

Phosphorus pentachloride

Pd(dba)2

Bis(dibenzylideneacetone)palladium(0)

PFOTS

1H,1H,2H,2H-Perfluorooctyltriethoxysilane

Phanephos

(RP)-4,12-bis-diphenylphosphino[2.2]paracyclophane

pOPc

Perfluoro[2.2]paracyclophane

PPh3

Triphenylphosphine

rpm

Rotations per minute

SEM

Scanning electron microscopy

SF4

Sulfur tetrafluoride gas

SNAr

Type of nucleophilic aromatic substitution

SRN1

Radical nucleophilic aromatic substitution

SO2

Sulfur dioxide gas

SOCl2

Thionyl chloride

SO2Cl2

Sulfuryl chloride

TB

Trypan blue

TBAB

Tetrabutylammonium bromide

t-Bu

tert-Butyl

t-BuLi

tert-Butyllithium

TES

Transmission electron microscopy
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TEOS

Tetraethyl orthosilicate

THF

Tetrahydrofuran

TiCl4

Titanium (IV) tetrachloride

TLC

Thin layer chromatography

TMS

Tetramethylsilane

Tol

Toluene

TsOH

p-Toluenesulfonic acid

UV-Vis

Ultraviolet-Visible

ZnCl2

Zinc chloride

ZPO

Zirconium (IV) propoxide
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Introduction to Enantioselective Synthesis

1.1

Introduction

The first documented observation of stereochemistry was made by Louis Pasteur in 1849
when he observed that the salts of tartaric acid could rotate plane polarised light. Then in
1874, Jacobus Henricus van't Hoff and Joseph Le Bel attributed this optical activity to the
tetrahedral arrangement of atoms about a carbon centre1 (Figure 1.1).

Figure 1.1: Both enantiomers of a simple chiral molecule.
Molecules of this nature are referred to as chiral, as it is not possible to superimpose the
molecule onto its mirror image. These mirror images are called enantiomers. A simple natural
analogy for this is the comparison between the right and left hand. In fact, nature
demonstrates a consistent asymmetry with the vast majority of naturally occurring amino
acids having an L configuration.2 Enantiomers demonstrate identical physical and chemical
properties in an achiral environment except in the direction that they rotate plane polarised
light. The properties of enantiomers differ when they interact with other chiral molecules,
receptors or enzymes within the body for example, which may result in different biological
responses. This can be seen with simple compounds such as (S)-limonene which smells like
lemons and (R)-limonene which smells like oranges. Another example is (S, S)-aspartame
which is used as an artificial sweetener while (R, R)-aspartame has a bitter taste (Figure 1.2).
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Figure 1.2: The structure of simple enantiomer pairs which affect the body differently.
Perhaps the most famous example and the one which highlighted the importance of chirality
and enantiopure substances is thalidomide, a compound prescribed to treat morning sickness
in the 1960’s. (R)-Thalidomide does indeed treat morning sickness however the (S)enantiomer was found to be teratogenic leading to foetal abnormalities (Figure 1.3). It was
later found that thalidomide racemises in vivo meaning that even an enantiopure form would
not have averted this tragedy.3

Figure 1.3: The enantiomers of thalidomide.
Currently, European and U.S. law dictates that all pharmaceutical products must be fully
evaluated and for chiral compounds this includes testing both enantiomers.4 This means there
is a need for effective enantioselective synthesis, which involves the preparation of chiral
products with a specific preference for a single enantiomer. The compounds shown in Figure
1.4 are used to treat a variety of illnesses and have accounted for billions of dollars in sales.
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This illustrates the possible commercial applications of improved enantioselective synthetic
methods.

Figure 1.4: The structure of three successful chiral drug compounds.
1.2

Synthesis of enantiopure compounds

The methods for producing enantiopure compounds may be categorised under three broad
headings which are the chiral pool strategy, resolution of racemic mixtures and asymmetric
synthesis (Figure 1.5).

Figure 1.5: The methods for preparing enantiopure compounds.
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Chiral pool strategy

The term chiral pool refers to readily available, naturally occurring enantiopure compounds
such as amino acids, sugars, alkaloids and terpenoids. These may be used as starting
materials to synthesise the desired enantiopure product by providing basic chiral centres
which can be built upon. This may be an attractive approach if the desired product is
structurally similar to the starting material so as to have a short synthetic sequence. However
care must be taken to preserve the chirality of the starting material. This method has been
used in the synthesis of prostaglandin F2α5and chiraphos (Scheme 1.1).6

Scheme 1.1: Chiral pool synthesis of prostaglandin F2α and chiraphos.
1.2.2

Resolution

Resolution is the process by which a racemic mixture is separated into its two enantiomers. It
is the most widely used industrial method for obtaining enantiopure compounds. The
disadvantage of this method is that the highest obtainable yield by definition is 50%.
Resolution may be categorised under four headings which are classical resolution, kinetic
resolution, enzymatic resolution and chromatographic resolution.
1.2.2.1

Classical resolution

Classical resolution involves derivatising a racemic mixture with an enantiopure reagent to
yield a diastereomer. Diastereomers, unlike enantiomers, have different physical and
4
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chemical properties which allow them to be separated by conventional techniques. The
resolving agent is then removed to yield the desired material in an enantiopure form. This
approach is applied extensively in industry such as the resolution of Naproxen (Scheme 1.2).
This particular example is noteworthy as the unwanted (R)-enantiomer 1 can be efficiently
racemised and recycled to give yields for (S)-Naproxen 2 above 95% along with over 98%
recovery of the resolving agent N-propylglucosamine 3.7

Scheme 1.2: The resolution of (S)-Naproxen.
1.2.2.2

Kinetic resolution

Kinetic resolution relies on the different rates of reaction of a pair of enantiomers with a
chiral reagent or catalyst. Ideally, one enantiomer reacts while the other does not, making
them readily separable. As with classical resolution, the unwanted enantiomer must be
racemised and resolved to increase the yield. If these processes can occur concurrently the
5
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process is referred to as dynamic kinetic resolution. Noyori et al. reported the preparation of
(R)-1-phenylethanol using kinetic resolution facilitated by a ruthenium catalyst (Scheme
1.3).8

Scheme 1.3: The kinetic resolution of (R)-1-phenylethanol.
1.2.2.3

Chromatographic resolution

Chromatographic resolution relies on the different affinities of enantiomers between a chiral
stationary phase and a mobile phase. This is an attractive method as it does not involve
additional steps to derivatise enantiomers, separate them and then regenerate the desired
compound. As an example, Li et al. reported the efficient resolution of a range of α,α’dihydroxybiaryls using a modified silica prepared from readily available amino acid
derivatives (Figure 1.6).9

Figure 1.6: The structure of three successfully resolved biaryl compounds.
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Enzymatic resolution

Enzymes may also be used for the resolution of enantiomers. In the example shown in
Scheme 1.4, resolution is achieved using the enzyme Pseudomonas Stutzeri lipase TL. A
racmate of cis-5’-hydroxythalidomide 4 is selectively acylated to give enantiopure 5 while
leaving the other enantiomer unchanged. These compounds can then be separated by
conventional means and the initial compound regenerated using TsOH in MeOH.10

Scheme 1.4: Enzymatic resolution of a thalidomide derivative.
1.2.3

Asymmetric synthesis

Asymmetric synthesis may be defined as a synthesis in which an achiral unit in a substrate
molecule is converted to a chiral unit such that the possible stereoisomers are formed in
unequal amounts.7 There are various ways this may be achieved and the approaches make use
of chiral reagents, chiral auxiliaries or chiral catalysts to introduce the chirality into the
substrate molecule.
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Chiral reagents

This approach involves the conversion of an achiral substrate to a chiral substrate with the
use of an appropriate chiral reagent which controls the asymmetry introduced. Chiral
allylboranes are common reagents for this methodology (Scheme 1.5). For example,
Hoffmann et al. developed allylboronate 6 for the preparation of a range of homoallylic
alcohols 7.11 Brown et al. prepared a range of chiral lactones 8 using allylboronate 9.12,13 The
obvious limitation of this methodology is the requirement for stoichiometric quantities of
potentially expensive or difficult to prepare chiral reagent.

Scheme 1.5: The stereoselective allylation of carbonyl compounds using chiral
allylboronates.
1.2.3.2

Chiral auxiliaries

A chiral auxiliary is a reagent incorporated into the substrate molecule to influence the
stereoselectivity of one or more subsequent reactions. The diastereomers produced are
separated and the auxiliary is then removed from the products and, in ideal cases, recycled.
Examples are shown in Figure 1.7 and include pseudoephedrine 10 used to produce
enantiomerically pure carboxylic acids, alcohols, aldehydes and ketones.14 Other frequently
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used chiral auxiliaries are the valine 11 and norephedrine 12 derived oxazolidinones
developed by Evans.15,16

Figure 1.7: Common chiral auxiliaries.
1.2.3.3

Chiral catalysts

The third approach to asymmetric synthesis is the use of a chiral catalyst to facilitate an
asymmetric transformation. This method is attractive because it does not require
stoichiometric quantities of the chiral material which is one of the biggest disadvantages of
using chiral reagents or chiral auxiliaries. Chiral catalysts may be categorised under four
headings which are enzymes, catalytic antibodies, organocatalysts and metal catalysts.
1.2.3.3.1

Enzymes

Enzymes as catalysts are efficient, fast acting and usually give high levels of
enantioselectivity. A successful use of an enzyme as a stereoselective catalyst is shown in
Scheme 1.6 which is the synthesis of (S)-norcoclaurine 13. Tyrosine 14 is first
decarboxylated and the subsequent aldehyde 15 coupled with dopamine 16 in the presence of
the enzyme (S)-norcoclaurine synthase (NCS) to furnish the product.17 The limitations of
enzymes are their pH sensitivity and limited solubility in organic solvents. They may also be
less stable in these solvents than in aqueous solutions. Enzymes are natural materials
designed to facilitate specific transformations so they tend to be substrate specific and not
applicable as a general method.
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Scheme 1.6: The synthesis of (S)-norcoclaurine.
1.2.3.3.2

Catalytic antibodies

Antibodies are used by the immune system to neutralise foreign objects such as bacteria and
viruses. Like enzymes, they are proteins and operate in a similar fashion to enzymes in that
they have an active site that will respond to a specific substrate. In recent years it has been
shown that antibodies can be utilised as asymmetric catalysts. The example in Scheme 1.7
shows the conversion of the ketone 17 to the (S)-enantiomer of the Wieland-Miescher ketone
18 via the Robinson annulation using the antibody Ab38C2.18

Scheme 1.7: The synthesis of enantiopure Wieland-Miescher ketone.
1.2.3.3.3

Organocatalysts

An organocatalyst as the name suggests, is an organic molecule which does not contain a
metal but which catalyses a chemical transformation. This is currently a major area of
research and the advantages these materials offer are that they are easily accessible and
robust, usually being stable towards moisture and oxygen. They also avoid the use of metals
which makes them more environmentally friendly and cheaper to produce. Examples include
10
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L-Proline 1919, thioureas such as 2020 and alkaloids such as 2121,which have all been used as
organocatalysts for a variety of asymmetric transformations (Figure 1.8).

Figure 1.8: Three compounds used as organocatalysts.
1.2.3.3.4

Metal catalysts

Metal catalysts are the largest and most active area in asymmetric synthesis. These systems
operate with a reactive metal centre coordinated to a chiral ligand. As such these ligands
typically have donor atoms such as nitrogen, oxygen, phosphorus or sulfur. The metal
activates the reagents allowing the reaction to proceed and the chirality of the products is
translated from the chiral ligands around the metal centre. Figure 1.9 shows ligands which
have been used in this methodology and these may possess axial chirality (BINAP 22)22,
central chirality (DiPAMP 23)23 or planar chirality (Phanephos 24).24

Figure 1.9: Three different chiral ligands used in asymmetric metal catalysis.
Phanephos is an example of a [2.2]paracyclophane and since it was shown to be an effective
compound for use in asymmetric catalysis, there has been a dramatic increase in research
concerning [2.2]paracylophanes.
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Conclusion

This chapter has provided an introduction to enantioselective synthesis and will be followed
by a review of relevant reported ligands based on the [2.2]paracyclophane framework and
their applications in Chapter 2. Chapter 3 will describe the preparation of a novel class of
asymmetric [2.2]paracyclophane ligands from commercially available starting materials.
Chapter

4

contains

a

comprehensive

review

of

the

closely

related

octafluoro[2.2]paracyclophane. This is followed by Chapter 5 which is a description of
progress towards the preparation of an analogous class of fluorinated [2.2]paracylophane
ligands to complement those prepared in Chapter 3. Chapter 6 details protective surface
coatings prepared from [2.2]paracyclophanes which are known as parylenes and here are
presented methods for improved surface adhesion of these coatings. This was accomplished
through the use of sol-gel pre-treatments on aluminium substrates, sol-gels themselves being
another frequently used class of surface coatings. Chapter 7 discusses the preparation of a
number of fluorinated sol-gel additives, along with a brief study on the incorporation of
organic dyes into sol-gel coatings. Finally, Chapter 8 contains a brief conclusion along with
suggestions for future work.
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2.1

Introduction

The first report of [2.2]paracyclophane 1 was in 1949 with its isolation from a mixture of
hydrocarbon polymers.1 The beginning of [2.2]paracyclophane (Pc) chemistry as a field of
research however, is likely best credited to Cram and co-workers for their work commencing
in 1951.2 Widespread industrial use of this compound and its derivatives are owed to Gorham
for the development of a chemical vapour deposition (CVD) process to produce polymeric
surface coatings3, commonly known as parylenes. The use of 1 and derivatives in this regard
will be discussed in more detail in Chapter 7. The Pc framework has also been utilised in
ligands for asymmetric catalysis. The advent of this area can be attributed to the preparation
of enantiopure (RP)-4,12-bis-diphenylphosphino[2.2]paracyclophane 2 by Pye and Rossen in
1997 (Scheme 2.1), used for rhodium catalysed asymmetric hydrogenations.4

Scheme 2.1: The synthesis of (RP)-4,12-bis-diphenylphosphino[2.2]paracyclophane.

15

Review of [2.2]Paracyclophane Ligands: Preparation and Application
2.2

Chapter 2

Preparation of [2.2]paracyclophane

1 and certain derivatives may be prepared via the Winberg dimerisation.5,6 This reaction
proceeds through the formation of the 1,4-quinodimethane intermediate 3. An optimised
Winberg dimerisation is shown in Scheme 2.2 and can be used to prepare some useful halide
derivatives.7

Scheme 2.2: The preparation of [2.2]paracyclophane and simple derivatives.
2.3

Assignment

and

stereochemical

notation

of

[2.2]paracyclophane

derivatives
Substituted Pc derivatives may possess no asymmetric carbon centres yet they may still be
chiral molecules and this is because they exhibit planar chirality. This occurs due to two noncoplanar rings which are not symmetrical and rotation being restricted by the bonds
connecting them, ethyl bridges in the case of Pc derivatives. Therefore, substituted Pc may
exist as two enantiomers RP and SP, where subscript P denotes planar chirality. A numbering
scheme must be introduced which can be used to assign the various positions of the molecule
and this is shown in Figure 2.1.8
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Figure 2.1: Numbering and assigning [2.2]paracyclophane derivatives.
The plane with the highest level of substitution is considered the chiral plane. Position 1 is
labelled as the closest out of plane atom to the chiral plane. This will be one of the ethyl
bridge carbons in the case of Pc derivatives and the one chosen should lead to the lowest
numbering for the highest priority substituent as per the Cahn-Ingold-Prelog (CIP) system.9,10
The adjacent atoms a, b and c will then show either a clockwise (RP) or counter clockwise
(SP) orientation which provides a stereochemical assignment. When substituents are on the
same ring this is readily assigned, when the substituents are on opposing rings the chiral
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plane is determined based on the highest priority substituent. To assign the tri-substituted
enantiomers of 4-hydroxy-5-methyl-16-bromo[2.2]paracyclophane 4, the bromo substituent
has the highest priority according to the CIP system however it does not reside on the chiral
plane, as this has been defined as the most heavily substituted plane. Therefore the hydroxy
substituent takes priority and is used as the basis to assign the stereochemistry. The
development of more complex Pc structures has led to some ambiguity with nomenclature11
but the rules that have been presented here will be sufficient to assign all compounds
described in this work.
The most commonly reported Pc regioisomers are shown in Figure 2.2. Bridge substituted
analogues are quite rare but have been reported.

Figure 2.2: Common regioisomers of disubstituted [2.2]paracyclophane.
2.4

Resolution of [2.2]paracyclophane derivatives

Effective resolution protocols are a necessity if asymmetric ligands based on the Pc
framework are to gain more attention. Various methods have been developed in classical
resolution, kinetic resolution and enzymatic resolution, and examples are presented for key
monosubstituted derivatives in Table 2.1. The chromatographic resolution approach is less
common.12
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Table 2.1: Resolution protocols for key [2.2]paracyclophane derivatives.

R

Resolution procedure

NH2

Crystallisation of diastereomeric salts of (1S)-(+)-10-camphorsulfonic acid.13

OH

Enzymatic kinetic

resolution

of OAc derivatives

and subsequent

hydrolysis,14,15,16,17 crystallisation of diastereomeric esters of (1S)-(-)camphanic

acid

and

subsequent

hydrolysis,18

crystallisation

of

diastereomeric imines of methylbenzylamine and subsequent Dakin
oxidation.19
CHO

Crystallisation of diastereomeric imines of methylbenzylamine and
subsequent hydrolysis19,20 and enzymatic kinetic resolution.21

COCH3

Crystallisation of diastereomeric SAMP-hydrazones followed by reduction
with NaBH4.22

CO2H

Crystallisation of diastereomeric Brucine salts23 and crystallisation of
diastereomeric salts of α-methyl-4-nitrobenzylamine.24

Other notable resolutions of monosusbtituted Pc include that of phosphine derivatives via
diastereomeric phosphine-palladacycle complexes25 and 4-bromo[2.2]paracyclophane via
kinetic resolution using a Buchwald-Hartwig amination.26 Some success in the resolution of
more heavily substituted derivatives has been reported with pertinent examples being the bisphosphine oxide 5,4 the bis-phenol 6,27 the bis-bromide 728 and a tetra-substituted derivative
829 (Figure 2.3).
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Figure 2.3: The structures of resolved substituted [2.2]paracyclophanes.
Any endeavour in preparing enantiomerically pure Pc derivatives will likely require the use
of one of these key intermediates presented in Table 2.1 or the development of an entirely
new resolution protocol. Recent developments in the area have been focused on a single
resolution protocol that could be used to prepare a range of Pc derivatives in enantiomerically
pure form. The sulfoxide methodology is at present the most promising approach.
Sulfoxide derivatives of Pc were first prepared using Anderson reagent 9 and it was found
that the resulting diastereomers could be separated via column chromatography (Scheme
2.3).30 Sulfoxides garnered from the thiosulfinate 1031 were also found to be separable. The
reaction proceeds with inversion of the sulfur centre but is stereospecific, the resulting
diastereomers differ only in planar chirality. Both the toluene (Tol) and tert-butyl (t-Bu)
moieties allow resolution however the different groups significantly alter the subsequent
chemistry that can be carried out on the Pc framework.

Scheme 2.3: The resolution of diastereomeric sulfoxide derivatives.
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Sulfoxide-metal exchange on the Tol derivative 11 using n-butyl lithium (n-BuLi) generates
the 4-lithio[2.2]paracyclophane intermediate 12 and subsequent treatment with the
appropriate electrophile yields a range of enantiopure monosubstituted Pc derivatives
(Scheme 2.4).32,33

Scheme 2.4: The preparation of enantiopure [2.2]paracyclophane derivatives.
Bromination of 11 may allow access to enantiopure pseudo-geminal derivatives 13, but thus
far selective substitution of the bromo group has proven problematic. Sulfide 14 and sulfone
15 analogues were also examined with mixed results (Scheme 2.5).33

Scheme 2.5: The preparation of sulfide and sulfone analogues.
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The sulfoxide methodology has been applied to pseudo-ortho derivatives allowing an
alternative resolution approach to the phosphine oxide precursor of Phanephos 5 (Scheme
2.6).34

Scheme 2.6: The resolution of disubstituted sulfoxide derivatives.
The use of the t-Bu derivative 16 allows selective ortho-lithiation of the Pc framework rather
than substitution of the sulfoxide moiety. This is permissible only if the diastereomer has the
t-Bu group orientated away from the ring as in Scheme 2.7.35

Scheme 2.7: Ortho-lithiation and derivatisation of sulfoxide derivatives.
If the t-Bu group is orientated in towards the ring then lateral substitution of the C2
methylene carbon may occur as is the case in Scheme 2.8.36
22
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Scheme 2.8: Bridge functionalisation of sulfoxide derivatives.
The t-Bu derivative 16 is not amenable to psuedo-geminal substitution and its resistance to
sulfoxide-metal exchange makes selective removal of the sulfoxide substituent problematic.
The t-Bu sulfoxide may be converted to the thiol 17 if desirable via the pathway shown in
Scheme 2.9.37,38

Scheme 2.9: The synthesis of thiol derivatives.
The examples presented in this section provide an overview of the established resolution
methodologies concerning Pc derivatives and the recent advances. This account is not
exhaustive and there are other examples of resolutions of Pc derivatives presented in the
literature. For further discussion of this area see reviews by Hopf39, Gibson8 and Rowlands.36
2.5

Oxazoline containing [2.2]paracyclophane derivatives

Oxazoline containing Pc derivatives have allowed the preparation of a versatile group of
bidentate ligands. Examples to date encompass P,N, N,O, N,N, S,N and Se,N ligands and
these have been applied to various asymmetric transformations.
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As ligands in transition metal catalysis

The most common approach to preparing these derivatives is to begin with the carboxylic
acid 18 and generate the corresponding amide 19 from an amino alcohol (Scheme 2.10). The
oxazoline 20 is then formed via the Appel reaction. The stereochemistry and substitution of
the oxazoline moiety is tuned by selecting the appropriate amino alcohol, so this method is
widely applicable. In the example presented here by Hou et al., direct ortho-lithiation of 20
and

treatment

with

diphenyl

disulfide

or

diphenyl

diselenide

yielded

three

chromatographically separable stereoisomers 21a-c and 22a-c. The bridge substituted
analogues 21c and 22c were not expected. The fact that only one bridge substituted
diastereomer was detected indicates a steric effect from the oxazoline isopropyl group.40

Scheme 2.10: The preparation of N,S and N,Se ligands.
These ligands were applied in a palladium catalysed allylic alkylation (Table 2.2). It was
found that the selenium derivatives 22a-c were slightly more selective than sulfur derivatives
24
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21a-c and the bridge substituted derivatives 21c and 22c were more efficacious than their aryl
substituted counterparts. The stereochemistry of the products appears to be controlled by the
planar chirality of the ligand in the case of the aryl analogues 21a-b and 22a-b. Both
diastereomers of the bridge substituted derivatives were not prepared so it is not clear if this
is the case with that substitution pattern.
Table 2.2: Asymmetric allylic alkylations of 1,3-diphenylallyl acetate.40

Ligand

Solvent

Salt

Time (h)

Yield (%)

ee (%)

Configuration

(SPS)-21a

Tol

LiOAc

40

98

54

R

(SPS)-21a

DCM

LiOAc

24

98

50

R

(SPS)-21a

DCM

KOAc

36

98

53

R

(SPS)-21a

MeCN

KOAc

32

98

54

R

(RPS)-21b

MeCN

KOAc

21.5

98

63

S

(SPRS)-21c

MeCN

KOAc

1.5

98

94

S

(SPS)-22a

MeCN

KOAc

20

98

57

R

(RPS)-22b

MeCN

KOAc

30

98

73

S

(SPRS)-22c

MeCN

KOAc

2

98

93

S

Another report published at the same time detailed the preparation of a number of oxazoline
containing pseudo-geminal derivatives. Standard bromination of amide 23 yielded 24
exclusively. The oxazoline 25 was furnished from 24 using the Appel reaction and this
derivative gave access to useful analogues 26 and 27 (Scheme 2.11). None of these
derivatives were prepared in optically pure form in this case.41
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Scheme 2.11: The preparation of oxazoline containing disubstituted derivatives.
Hou et al. then used an analogous method to that presented in Scheme 2.14, to prepare a
series of pseudo-geminal precursors 28a-d and 29a-d which could be separated via column
chromatography (Scheme 2.12). From these precursors was derived a series of ligands with
varied groups on both the oxazoline moiety 30a-d, 31a-d and the phosphorus centre 32a-d.42
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Scheme 2.12: The preparation of P,N ligands.
These ligands were also applied in a palladium catalysed allylic alkylation (Table 2.3).
Contrary to the results presented in Table 2.2, in this case the central chirality of the
oxazoline determined the configuration of the product. Altering the aryl substituents on the
phosphorus centre had mixed results. The 4-methoxy derivative 32c showed a marked
increase in selectivity and was the best reported ligand overall, while the 2-methyl derivative
32a showed very little selectivity and was the worst in the series.
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Table 2.3: Asymmetric allylic alkylations of 1,3-diphenylallyl acetate.42

Ligand

Time (min)

Yield (%)

ee (%)

Configuration

(RPS)-30a

20

98

37

S

(SPS)-31a

15

98

6

S

(RPS)-30a

10

98

49

S

(RPS)-30a

90

98

62

S

(RPS)-30b

210

98

11

S

(SPS)-31b

90

98

41

S

(RPS)-30c

60

98

42

S

(SPS)-31c

60

98

29

S

(RPR)-30d

60

98

73

R

(SPR)-31d

90

98

54

R

(RPR)-32a

180

98

6

R

(RPR)-32b

60

98

69

R

(RPR)-32c

20

98

90

R

(RPR)-32d

240

98

49

R

Hou et al. subsequently prepared a series of N,O ligands again utilising the precursors 28a-d
and 29a-d. Bromo-lithium exchange and treatment with benzophenone furnished ligands
33a-d and 34a-d (Scheme 2.13).43
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Scheme 2.13: The preparation of N,O ligands.
These ligands were applied in the addition of diethyl zinc to a variety of aldehydes (Table
2.4). It was found that matched planar and central chirality was optimal for appreciable
selectivity. The benzyl ligand 33c proved to be particularly efficacious over a range of
substrates.
Table 2.4: Asymmetric addition of diethyl zinc to benzaldehyde.43

Ar

Ligand

Time (h)

Yield (%)

ee (%)

Configuration

Ph

(SPS)-33a

9

96

93

R

Ph

(RPS)-34a

24

35

5

S

Ph

(SPS)-33b

24

37

32

R

Ph

(RPS)-34b

24

13

7

S

Ph

(SPS)-33c

7

93

93

R
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Ph

(RPS)-34c

24

12

7

S

Ph

(SPR)-33d

24

12

5

S

Ph

(RPR)-34d

18

85

87

S

p-ClC6H4

(SPS)-33c

8

96

94

R

p-BrC6H4

(SPS)-33c

9

95

93

R

p-MeOC6H4

(SPS)-33c

24

86

82

R

o-MeOC6H4

(SPS)-33c

4

94

81

R

α-naphtyl

(SPS)-33c

20

87

86

R

β-naphtyl

(SPS)-33c

9

95

95

R

The final report from Hou et al. also examined N,O ligands with a series which varied in
steric bulk about the hydroxyl substituent. 33a-c and 34a-c were examined previously and
were now compared to ligands with less steric bulk. 35a-c and 36a-c represent the least
hindered hydroxyl group and then an intermediate series in 37a-b and 38 (Figure 2.4).44
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Figure 2.4: The preparation of N,O ligands.
These ligands were also applied in the addition of diethyl zinc to aromatic aldehydes (Table
2.5). The less hindered ligands 35a-c and 36a-c gave improved or comparable yields and
selectivity in all cases compared to 33a-c and 34a-c. Again the results showed that matched
planar and central chirality was optimal. The methylated derivative 37b was shown to be
slightly more selective than its phenyl counterpart 33c over a range of substrates.
Table 2.5: Asymmetric addition of diethyl zinc to benzaldehyde.44

Ar

Ligand

Time (h)

Yield (%)

ee (%)

Config.

Ph

(SPS)-35a[(SPS)-33a]

5 (9)

94 (96)

91 (93)

R (R)
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Ph

(RPS)-36a[(RPS)-34a]

24 (24)

49 (35)

25 (5)

S (S)

Ph

(SPS)-35b[(SPS)-33b]

7 (24)

93 (37)

94 (32)

R (R)

Ph

(RPS)-36b[(RPS)-34b]

24 (24)

46 (13)

36 (7)

S (S)

Ph

(SPS)-35c[(SPS)-33c]

5 (7)

94 (93)

91 (93)

R(R)

Ph

(RPS)-36c[(RPS)-34c]

24 (24)

51 (12)

45 (7)

S (S)

Ph

(SPS)-37a

3.5

93

97.9

R

Ph

(SPS)-37b

1.5

95

98.4

R

Ph

(RPS)-38

48

<5

-

-

p-ClC6H4

(SPS)-37b[(SPS)-33c]

2 (8)

96 (96)

97.6 (94)

R (R)

p-BrC6H4

(SPS)-37b [(SPS)-33c]

2 (9)

95 (95)

96.8 (93)

R (R)

p-MeOC6H4

(SPS)-37b [(SPS)-33c]

3.5 (24)

94 (86)

96 (82)

R (R)

o-MeOC6H4

(SPS)-37b [(SPS)-33c]

1 (4)

96 (94)

96 (81)

R (R)

Using a ligand with an achiral oxazoline moiety 39a-b afforded excellent yields and
selectivity, comparable to 37a and 37b which also possessed central chirality (Scheme 2.14).
This clearly demonstrates that the planar chirality is crucial in the selectivity of the ligand. It
is of note that 38, which possessed opposing planar and central chirality was an ineffective
ligand.
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Scheme 2.14: The synthesis and application of N,O ligands in the addition of diethyl zinc.44
These ligands were also utilised in the nickel catalysed asymmetric addition of diethyl zinc to
a range of chalcones (Table 2.6). The reaction yields were uniformly excellent and the
selectivity was moderate to high. The configurations were not assigned for the majority of
cases but for those that were the product matched the configuration of the planar chirality of
the catalysts. Again mismatched planar and central chirality was observed to reduce
selectivity.
Table 2.6: Asymmetric addition of diethyl zinc to chalcones.44

Ar1

Ar2

Ligand

Ligand

ee (%)

Config.

(mol%)
Ph

Ph

33-34

10

0

-

Ph

Ph

(SPS)-37a

10

8

S (-)

Ph

Ph

(SPS)-35a [(RPS)-36a]

10

52 (0)

S (-)

Ph

Ph

(SPS)-35b [(RPS)-36b]

10

63 (0)

S (R)
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Ph

Ph

(SPS)-35c [(RPS)-36c]

10

53 (4)

S

Ph

Ph

(SPS)-35b

20

75

-

p-MeC6H4

Ph

(SPS)-35b

20

63

-

p-BrC6H4

Ph

(SPS)-35b

20

71

-

p-ClC6H4

Ph

(SPS)-35b

20

72

-

Ph

p-BrC6H4

(SPS)-35b

20

61

-

Ph

p-MeOC6H4

(SPS)-35b

20

83

-

The majority of the ligands presented thus far have been pseudo-geminal structures however
Bolm et al. have reported pseudo-ortho ligands. The precursor series 40 was functionalised
with varying imidazole groups. The subsequent ligands 41a-d and 42b,d were used to
prepare catalytic iridium carbene complexes 43a-c and 44b (Scheme 2.15).45

34

Review of [2.2]Paracyclophane Ligands: Preparation and Application

Chapter 2

Scheme 2.15: The preparation of iridium carbene complexes.
These iridium complexes were then applied to the asymmetric hydrogenation of a variety of
alkenes 45a-e. Substrates 45a and 45b were tested at both 25 °C and 50 °C (Table 2.7). The
higher temperature afforded higher yields but generally reduced selectivity. 43c which
possessed only planar chirality was found to be the best performing ligand and was extended
to substrates 45c-e. Yields were uniformly excellent except when using only 1 bar of H2. The
configuration of the products when using catalyst 43b and 44b were the same indicating that
in this case central chirality may be more dominant than planar chirality.
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Table 2.7: Asymmetric hydrogenation of alkenes.45

Substrate

Catalyst

Time

Temp

(h)

(°C)

H2(bar)

Yield

ee (%)

Config.

(%)

45a

(SP)-43a

6-24

25/50

50

-/40

-/0

-

45a

(SPS)-43b

6-24

25/50

50

17/61

12/4

R

45a

(RPS)-44b

6-24

25/50

50

15/59

11/10

R

45a

(SP)-43c

6-24

25/50

50

35/76

28/15

R

45b

(SP)-43c

6-24

25/50

50

25/100

11/4

-

45c

(SP)-43c

2

25

50

100

9

R

45c

(SP)-43c

6-24

25

10

100

13

R

45c

(SP)-43c

48

25

1

46

46

R

45d

(SP)-43c

6-24

25

50

99

38

R

45e

(SP)-43c

6-24

25

50

100

21

R

Bolm et al. produced a later report detailing a series of N,O ligands. A variety of
regioisomers were prepared including pseudo-geminal 46-47, pseudo-ortho 48-49 and ortho
50-51 derivatives (Figure 2.5).46
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Figure 2.5: The preparation of N,O ligands.
These ligands were applied in the addition of diethyl zinc to benzaldehyde (Table 2.8).
Pseudo-geminal ligands 46a-b demonstrated the highest selectivity while 47 showed the
lowest. Opposing planar and central chirality was optimal and an increase in steric bulk on
the oxazoline as with 46b increased yield and selectivity. The planar chirality seems to
determine the configuration of products with pseudo-geminal ligands 46-47 and ortho ligands
50-51. In the case of pseudo-ortho ligands 48-49 however the central chirality appears to be
the deciding factor.
Table 2.8: Asymmetric addition of diethyl zinc to benzaldehyde.46

Ligand

Time

Yield (%)

ee(%)

Configuration

(RPS)-46a

2

78

78

R

(SPS)-47

24

93

11

S
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(SPS)-48

4

96

51

S

(RPS)-49

24

74

35

S

(RPS)-50

48

72

44

R

(SPS)-51

24

79

62

S

(RPS)-46b

4

93

87

R

The final report from Bolm et al. details the preparation of a series of P,N ligands. Again
pseudo-geminal 52-53, pseudo-ortho 54-55 and ortho derivatives 56-57 were prepared. There
was also variation around the phosphorus centre and the oxazoline moiety 54a-c and 55a-c
(Figure 2.6).47

Figure 2.6: The preparation of N,P ligands.
These ligands were applied in a palladium catalysed allylic alkylation (Table 2.9). The
pseudo-geminal ligands 52-53 with matched planar and central chirality provided the
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optimum selectivity and the central chirality appears to determine the configuration of the
product. This is also the case for the ortho ligands 56-57. The pseudo-ortho ligands 54a and
55a in contrast perform best with mismatched planar and central chirality and the product
configuration appears to be determined by the planar chirality. Replacing the phenyl groups
on the phosphorus centre with Tol groups increased selectivity, markedly so in the (SPS)
derivative 54b. Interestingly, changing the oxazoline substituent from an isopropyl to a
phenyl group reversed the situation and the mismatched analogue 54c outperforms the
matched analogue 55c.
Table 2.9: Asymmetric allylic alkylation of 1,3-diphenylallyl acetate.47

Ligand

Time (h)

Yield (%)

ee (%)

Configuration

(RPS)-52

8

96

30

S

(SPS)-53

6

>98

56

S

(SPS)-54a

10

>98

28

R

(RPS)-55a

10

>98

82

S

(RPS)-56

8

>98

23

S

(SPS)-57

7

>98

47

S

(SPS)-54b

20

>98

63

R

(RPS)-55b

5

>98

89

S

(SPR)-54c

5

>98

89

R

(RPR)-55c

20

>98

62

S

39

Review of [2.2]Paracyclophane Ligands: Preparation and Application
2.5.2

Chapter 2

As organocatalysts

The last report discussing oxazoline containing Pc ligands is more unusual as a rather
different approach has been taken in the preparation of the target compound. Firstly the
unusual aza derivative 58 has been utilised as a precursor.48 The oxazolines 59a-d were
prepared from the cyano moiety of 58 via the Witte Seeliger reaction. This is in contrast to
previous examples which all relied on some variation of amide formation followed by
cyclisation via the Appel reaction. The final step to yield organocatalysts 60a-d is treatment
with the oxidant mCPBA (Scheme 2.16).49

Scheme 2.16: The preparation of N-oxide organocatalysts.
The catalysts were applied in the allylation of 4-methoxybenzaldehyde (Table 2.10). The
choice of solvent and base had a significant impact on the yield and selectivity of the
reaction. MeCN and i-Pr2NEt were found to be the optimal solvent and base respectively. The
configuration of the product appears to be controlled by the planar rather than central
chirality. The t-Bu derivative 60a provided the highest ee of 90%.
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Table 2.10: Asymmetric allylation of 4-methoxybenzaldehyde.49

Catalyst

Base

Solvent

Yield (%)

ee (%)

Configuration

(RPS)-60a

i-Pr2NEt

THF

83

47

S

(RPS)-60a

i-Pr2NEt

Toluene

61

48

S

(RPS)-60a

i-Pr2NEt

DCM

82

86

S

(RPS)-60a

i-Pr2NEt

MeCN

91

90

S

(RPS)-60a

Et3N

MeCN

67

38

S

(RPS)-60b

i-Pr2NEt

MeCN

83

75

S

(RPR)-60c

i-Pr2NEt

MeCN

92

37

S

(RPR)-60d

i-Pr2NEt

MeCN

85

43

S

The catalysts were then applied to a variety of aromatic aldehydes using the optimised
conditions (Table 2.11). This series further confirmed that the planar chirality was the
determining factor in the configuration of the products. 60a was again found to be the most
selective catalyst across all substrates with the exception of 4-nitrobenzaldehyde where it was
slightly outperformed by 60b.
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Table 2.11: Asymmetric allylation of aromatic aldehydes.49

Ar

Catalyst

Yield (%)

ee (%)

Configuration

Ph

(RPS)-60a

95

93

S

Ph

(RPS)-60b

90

87

S

Ph

(RPR)-60c

93

47

S

Ph

(RPR)-60d

89

53

S

4-CH3C6H4

(RPS)-60a

87

88

S

4-CH3C6H4

(RPS)-60b

91

67

S

4-CH3C6H4

(RPR)-60c

84

36

S

2-CH3C6H4

(RPR)-60d

85

41

S

2-CH3C6H4

(RPS)-60a

88

85

S

2-CH3C6H4

(RPR)-60c

86

31

S

3,4-(OCH3)2C6H3

(RPS)-60a

93

96

S

3,4-(OCH3)2C6H3

(RPR)-60c

90

12

S

4-ClC6H4

(RPS)-60a

91

91

S

4-ClC6H4

(RPS)-60b

90

82

S

4-ClC6H4

(RPR)-60c

88

27

S

4-ClC6H4

(RPR)-60d

-

-

-

2-ClC6H4

(RPS)-60a

89

93

S

2-ClC6H4

(RPS)-60b

92

83

S

4-N2OC6H4

(RPS)-60a

96

87

S
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4-N2OC6H4

(RPS)-60b

89

91

S

4-CF3C6H4

(RPS)-60a

91

96

S

4-CF3C6H4

(RPS)-60b

88

74

S

2-naphtyl

(RPS)-60a

92

87

S

2-naphtyl

(RPS)-60b

84

71

S

2-furan

(RPS)-60a

73

72

S

2-furan

(RPS)-60b

73

51

S

Conclusion

This review introduces [2.2]paracyclophane beginning with its discovery and details the
advent of its application in asymmetric catalysis. The methods of assigning stereochemical
configuration to planar chiral Pc structures have been detailed along with the established
protocols and current research trends in the resolution of this class of compounds. Oxazoline
containing Pc derivatives have been discussed in detail, both their preparation and application
in asymmetric catalysis. Although these ligands have proved versatile in their own right, they
represent only a subset of Pc ligands which have been investigated. For a broader discussion
of the area see reviews by Hopf39, Gibson8, Paradies50,51, David52 and Rowlands.53

43

Review of [2.2]Paracyclophane Ligands: Preparation and Application
2.7

Chapter 2

References

(1)

Brown, C. J.; Farthing, A. C. Nature 1949, 164, 915.

(2)

Cram, D. J.; Steinberg, H. J. Am. Chem. Soc. 1951, 73, 5691.

(3)

Gorham, W. F. J. Polym. Sci. Part A-1 1966, 4, 3027.

(4)

Pye, P. J.; Rossen, K.; Reamer, R. A.; Tsou, N. N.; Volante, R. P.; Reider, P. J. J. Am.
Chem. Soc. 1997, 119, 6207.

(5)

Winberg, H. E.; Fawcett, F. S.; Mochel, W. E.; Theobald, C. W. J. Am. Chem. Soc.
1960, 82, 1428.

(6)

Longone, D. T.; Reetz, M. T. Chem. Commun. 1967, 46.

(7)

Chow, H. F.; Low, K. H.; Wong, K. Y. Synlett 2005, 2130.

(8)

Gibson, S. E.; Knight, J. D. Org. Biomol. Chem. 2003, 1, 1256.

(9)

Cahn, R. S.; Ingold, C. K.; Prelog, V. Angew. Chem. Int. Ed. Engl. 1966, 5, 385.

(10)

Prelog, V.; Helmchen, G. Angew. Chem. Int. Ed. Engl. 1982, 21, 567.

(11)

Pye, P. J.; Rossen, K. Tetrahedron Asymmetry 1998, 9, 539.

(12)

Meyer-eppler, G.; Sure, R.; Schneider, A.; Schnakenburg, G.; Grimme, S.; Lu, A. J.
Org. Chem. 2014, 79, 6679.

(13)

Cipiciani, A.; Fringuelli, F.; Mancini, V.; Piermatti, O. J. Org. Chem. 1997, 4, 3744.

(14)

Cipiciani, A.; Fringuelli, F.; Mancini, V.; Piermatti, O.; Scappini, A. M. Tetrahedron
1997, 53, 11853.

(15)

Pamperin, D.; Schulz, C.; Hopf, H.; Syldatk, C.; Pietzsch, M. European J. Org. Chem.
44

Review of [2.2]Paracyclophane Ligands: Preparation and Application

Chapter 2

1998, 1441.
(16)

Pamperin, D.; Ohse, B.; Hopf, H.; Pietzsch, M. J. Mol. Catal. - B Enzym. 1998, 5, 317.

(17)

Cipiciani, A.; Bellezza, F.; Fringuelli, F.; Silvestrini, M. G. Tetrahedron Asymmetry
2001, 12, 2277.

(18)

Rozenberg, V.; Danilova, T.; Sergeeva, E.; Vorontsov, E.; Starikova, Z.; Korlyukov,
A.; Hopf, H. European J. Org. Chem. 2002, 468.

(19)

Friedmann, C. J.; Ay, S.; Brase, S. J. Org. Chem. 2010, 75, 4612.

(20)

Banfi, S.; Manfredi, A.; Montanari, F.; Pozzi, G.; Quici, S. J. Mol. Catal. A Chem.
1996, 113, 77.

(21)

Pamperin, D.; Hopf, H.; Syldatk, C.; Pietzsch, M. Tetrahedron Asymmetry 1997, 8,
319.

(22)

Minuti, L.; Taticchi, A.; Marrocchi, A. Tetrahedron Asymmetry 2000, 11, 4221.

(23)

Cram, D. J.; Allinger, N. L. J. Am. Chem. Soc. 1955, 77, 6289.

(24)

Rozenberg, V.; Dubrovina, N.; Sergeeva, E.; Antonov, D.; Belokon, Y. Tetrahedron
Asymmetry 1998, 9, 653.

(25)

Zhang, T. Z.; Dai, L. X.; Hou, X. L. Tetrahedron Asymmetry 2007, 18, 251.

(26)

Kreis, M.; Friedmann, C. J.; Brӓse, S. Chem. - A Eur. J. 2005, 11, 7387.

(27)

Braddock, C. D.; MacGilp, I. D.; Perry, B. G. J. Org. Chem. 2002, 67, 8679.

(28)

Rossen, K.; Pye, P. J.; Maliakal, A.; Volante, R. P.; Liebigs, H. J.; Chem, A. J. Org.
Chem. 1997, 62, 6462.

45

Review of [2.2]Paracyclophane Ligands: Preparation and Application
(29)

Chapter 2

Morisaki, Y.; Gon, M.; Sasamori, T.; Tokitoh, N.; Chujo, Y. J. Am. Chem. Soc. 2014,
136, 3350.

(30)

Reich, H. J.; Yelm, K. E. J. Org. Chem. 1991, 56, 5672.

(31)

Weix, D. J.; Ellman, J. a. Org. Lett. 2003, 5, 1317.

(32)

Hitchcock, P. B.; Rowlands, G. J.; Parmar, R. Chem. Commun. 2005, 4219.

(33)

Parmar, R.; Coles, M. P.; Hitchcock, P. B.; Rowlands, G. J. Synthesis (Stuttg). 2010,
4177.

(34)

Morisaki, Y.; Hifumi, R.; Lin, L.; Inoshita, K.; Chujo, Y. Chem. Lett. 2012, 41, 990.

(35)

Hitchcock, P. B.; Rowlands, G. J.; Seacome, R. J. Org. Biomol. Chem. 2005, 3, 3873.

(36)

Rowlands, G. J. Org. Biomol. Chem. 2008, 6, 1527.

(37)

Stuhr-Hansen, N. Synth. Commun. 2003, 33, 641.

(38)

Rowlands, G. J.; Seacome, R. J. Beilstein J. Org. Chem. 2009, 5 (9).

(39)

Hopf, H.; Gleiter, R. Modern Cyclophane Chemistry; Gleiter, R., Hopf, H., Eds.;
Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, FRG, 2004.

(40)

Hou, X.-L.; Wu, X.-W.; Dai, L.-X.; Cao, B.-X.; Sun, J. Chem. Commun. 2000, 1195.

(41)

Marchand, A.; Maxwell, A.; Mootoo, B.; Pelter, A.; Reid, A. Tetrahedron 2000, 56,
7331.

(42)

Wu, X.; Yuan, K.; Sun, W.; Zhang, M.; Hou, X. Tetrahedron Asymmetry 2003, 14,
107.

(43)

Wu, X.; Hou, X.; Dai, L.; Tao, J.; Cao, B.; Sun, J. Tetrahedron Asymmetry 2001, 12,

46

Review of [2.2]Paracyclophane Ligands: Preparation and Application

Chapter 2

529.
(44)

Wu, X. W.; Zhang, T. Z.; Yuan, K.; Hou, X. L. Tetrahedron Asymmetry 2004, 15,
2357.

(45)

Bolm, C.; Focken, T.; Raabe, G. Tetrahedron Asymmetry 2003, 14, 1733.

(46)

Bolm, C.; Whelligan, D. K. Adv. Synth. Catal. 2006, 348, 2093.

(47)

Whelligan, D. K.; Bolm, C. J. Org. Chem. 2006, 71, 4609.

(48)

Wörsdörfer, U.; Vögtle, F.; Nieger, M.; Waletzke, M.; Grimme, S.; Glorius, F.; Pfaltz,
A. Synthesis (Stuttg). 1999, 597.

(49)

Chai, Q.; Song, C.; Sun, Z.; Ma, Y.; Ma, C.; Dai, Y.; Andrus, M. B. Tetrahedron Lett.
2006, 47, 8611.

(50)

Paradies, J. Synthesis (Stuttg). 2011, No. 23, 3749.

(51)

Schneider, J. F.; Fröhlich, R.; Paradies, J. Isr. J. Chem. 2012, 52, 76.

(52)

David, O. R. P. Tetrahedron 2012, 68, 8977.

(53)

Rowlands, G. J. Isr. J. Chem. 2012, 52, 60.

47

Preparation of Asymmetric Ligands Based on [2.2]Paracyclophane

Chapter 3

3.0

Preparation of Asymmetric Ligands Based on [2.2]Paracyclophane

3.1

Introduction

This chapter describes the synthetic work carried out towards the preparation of novel Pc
ligands. This begins with the preparation of a variety of mono and disubstituted derivatives of
[2.2]paracyclophane 1. A selection of these derivatives were then utilised in preparing novel
oxazoline containing derivatives of 1 via the Buchwald-Hartwig amination. Various
conditions and substrates were examined for these amination reactions and these are
discussed in detail.
The general design and structure of these Pc ligands is shown in Scheme 3.1. This specific
design was chosen for a number of reasons. Firstly, no ligands have been reported with this
type of arrangement. The structurally closest examples are discussed in Chapter 2. Secondly,
it was envisaged that the ligand would act as a bidentate N,N ligand forming a six membered
system with a metal centre. Finally, it was proposed that a high level of stereo control could
be obtained due to having two separate chiral moieties on the ligand, planar chirality from the
Pc group and central chirality from the oxazoline substituent.

Scheme 3.1: A general outline for the preparation of novel oxazoline containing
[2.2]paracyclophane ligands and the proposed binding of a metal atom.
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Synthesis of monosubstituted [2.2]paracyclophane derivatives

A range of monosubstituted Pc derivatives were prepared from the precursor 1 using various
methodologies (Scheme 3.2).

Scheme 3.2: The preparation of monosubstituted [2.2]paracyclophanes.
3.2.1

Synthesis of 4-bromo[2.2]paracyclophane

4-bromo[2.2]paracyclophane 2 is synthesised directly from 1 using a combination of bromine
and iron in DCM.1 The reaction was heated at reflux for 20 hours and 2 may be isolated by a
standard aqueous workup in 96% yield (Scheme 3.3). No further purification is required.

Scheme 3.3: The synthesis of 4-bromo[2.2]paracyclophane.
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The proposed mechanism shown in Scheme 3.4, is an electrophilic aromatic substitution with
the iron (III) bromide (FeBr3) catalyst formed in situ from elemental bromine and iron. This
catalyst facilitates the electrophilic addition of bromine which forms a resonance stabilised
carbocation. Aromaticity is restored by the abstraction of a proton to give the product,
hydrogen bromide (HBr) and regenerate the catalyst.

Scheme 3.4: The proposed mechanism for the formation of 4-bromo[2.2]paracyclophane.
3.2.2

Synthesis of 4-formyl[2.2]paracyclophane

4-Formyl[2.2]paracyclophane 3 may be synthesised directly from 1 by Rieche formylation2 in
reported quantitative yield.3,4 It may also be produced from the corresponding sulfoxides.5
Here 3 was prepared by the Rieche formylation but it was found the reported conditions were
not optimal. Using the reported conditions which involved a reaction time of 6 hours and
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isolation by standard aqueous workup4, it was found that the resulting product was not pure
and contained significant amounts of 1. Using an extended reaction time of 20 hours and
purifying the product using flash column chromatography pure product was isolated in a 63%
yield (Scheme 3.5).

Scheme 3.5: The synthesis of 4-formyl[2.2]paracyclophane.
The proposed mechanism shown in Scheme 3.6 begins with the generation of the electrophile
from dichloromethoxymethane and titanium tetrachloride (TiCl4). This electrophile attacks
the aromatic ring and forms a resonance stabilised carbocation. The proton is abstracted to
form HCl and regenerates the catalyst. Finally, treatment with water results in the loss of the
chloro and methyl groups as HCl and MeOH respectively, yielding the product.
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Scheme 3.6: The proposed mechanism for the formation of 4-formyl[2.2]paracyclophane.
3.2.3

Synthesis of 4-hydroxy[2.2]paracyclophane

4-Hydroxy[2.2]paracyclophane 4 is most readily prepared from 3 via an acid catalysed Dakin
oxidation.4 Alternatively it may be synthesised from the bromo derivative 2 using a three step
protocol beginning with lithiation, transmetallation onto boron and subsequent hydrolysis of
the borate ester to yield the title compound.6 Here the Dakin oxidation was utilised to give 4
in 55% yield (Scheme 3.7).
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Scheme 3.7: The synthesis of 4-hydroxy[2.2]paracyclophane.
The proposed mechanism shown in Scheme 3.8 begins with the formation of a resonance
stabilised oxonium ion by protonation with H2SO4. Hydrogen peroxide (HOOH) then attacks
the carbocation resulting in another oxonium species. There is a hydrogen transfer and a loss
of water, forming a carbonyl oxonium ion. The carbonyl carbon is attacked by MeOH
followed by another hydrogen transfer. This yields the desired product, regenerates the
catalyst and produces methyl formate as a by-product.
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Scheme 3.8: The proposed mechanism for the formation of 4-hydroxy[2.2]paracyclophane.
3.2.4

Synthesis of 4-nitro[2.2]paracyclophane

4-Nitro[2.2]paracylophane 5 was originally synthesised from 1 by nitration using a mixture
of AcOH and HNO3 yielding 5 in yields of 33%.7 A more recent report detailed a modified
procedure which gave an improved yield of 5 at 48%.8 The low yields are attributed to the
oxidation sensitivity of 1 which, under these conditions, leads to the formation of tars. Yields
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above 95% have been achieved using an acidic ion exchange resin called Nafion.9 Using a
modified version of the procedure reported by Paradies et al.8, 5 was prepared in quantities
above 5 g in 27% yield (Scheme 3.9). The time this reaction is allowed to proceed for is
crucial and it was found that 30-60 seconds was optimal. If the reaction was allowed to
proceed any longer yields were significantly reduced.

Scheme 3.9: The synthesis of 4-nitro[2.2]paracyclophane.
The proposed mechanism shown in Scheme 3.10, begins with the electrophilic addition of the
nitronium ion to the aromatic ring. The resulting carbocation is resonance stabilised and
aromaticity is restored by loss of an aromatic proton.
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Scheme 3.10: The proposed mechanism for the formation of 4-nitro[2.2]paracyclophane.
3.2.5

Synthesis of 4-amino[2.2]paracyclophane

4-Amino[2.2]paracyclophane 6 was initially synthesised via the reduction of 5 using MeOH
and Platinum oxide in 89% yield.7 A later report utilises a similar procedure with hydrogen
gas as the hydrogen source instead of methanol.10 6 was also prepared using a phase transfer
catalysis procedure which furnished the compound in 95% yield.9 A two-step procedure
beginning with metalation and subsequent amination of bromo derivative 2 has also been
reported.11 Here, 6 was prepared from 5 using HCl with iron as a catalyst in yields of up to
83% (Scheme 3.11). Although a standard procedure for the reduction of nitro compounds, this
method does not appear to have been applied to 5. This compares well to the other reported
procedures and has the benefit of avoiding expensive materials such as platinum and crown
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ethers. Furthermore, the product may be isolated by standard aqueous workup and requires no
further purification.

Scheme 3.11: The synthesis of 4-amino[2.2]paracyclophane.
The proposed mechanism shown in Scheme 3.12 is facilitated by acid and electrons from the
iron catalyst. First the nitro group is reduced to a hydroxylamine which is reduced again to
yield the amine.

Scheme 3.12: The proposed mechanism for the reduction of 4-nitro[2.2]paracyclophane.
3.3

Synthesis of disubstituted [2.2]paracyclophane derivatives

A range of disubstituted [2.2]paracyclophane analogues were also prepared (Scheme 3.13).
Analysis of these analogues required a close examination of the 1H NMR spectra to elucidate
at which position substitution had occurred and this will be discussed in detail.
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Scheme 3.13: The preparation of disubstituted [2.2]paracyclophanes.
3.3.1

Synthesis of 4-bromo-13-nitro[2.2]paracyclophane

4-Bromo-13-nitro[2.2]paracyclophane 7 is prepared from 5 using bromine and iron in
reported yields of up to 70%.8,12,13 Here, 7 was isolated in yields up to 28% (Scheme 3.14).

Scheme 3.14: The synthesis of 4-bromo-13-nitro[2.2]paracyclophane.
The mechanism for this reaction is proposed to be similar to that shown in Scheme 3.4,
however the regioselectivity is explained by the formation of a complex between the nitro
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group and the hydrogen atom at the 4’ position as shown in Scheme 3.15. This effect has also
been documented to occur with methyl ester, methyl ketone and carboxy Pc derivatives and is
termed the pseudo-geminal effect.14

Scheme 3.15: The proposed mechanism for the bromination of 4-nitro[2.2]paracyclophane.
The low yield for the desired product is attributed to the formation of two distinct
trisubstituted by-products which were isolated here. Surprisingly no mention of this issue
appears in the literature. The by-products can be readily identified as trisubstituted by having
only five aromatic protons in their 1H NMR spectra (Figure 3.1). They therefore must differ
in the addition of two bromine atoms from the starting material 5. They also share the same
splitting pattern of 2 singlets, 2 doublets and a doublet of doublets (dd). The two doublets and
the dd indicate a monosubstituted ring with the doublet displaying the small coupling
constant being ortho to the substituent, in this case a nitro group. The dd is then in the para
position and the other doublet, with the larger coupling constant, being in the meta position.
The opposing ring is responsible for the two singlets and these indicate disubstitution in a
para orientation.
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Figure 3.1: A segment of the 1H NMR spectra of trisubstituted by-products.
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It would be likely for the two bromo substituents to be on the opposing ring to the nitro
substituent. The initial investigation into directing effects by Cram et al13 would support this
inference as they have not identified any homo-annular bromination of 5. Although it is
reported that the vast majority of product (70%) is the pseudo-geminal configuration, pseudometa is the next most abundant isomer (8%). On this basis and in consideration of the
splitting

pattern

only

two

structures

are

possible

which

are

4,7-dibromo-13-

nitro[2.2]paracyclophane 8 and 4,7-dibromo-12-nitro[2.2]paracyclophane 9. These are
presented in Figure 3.2 and it is suggested both have been isolated here. However with the
available information it is not possible to definitively assign which one is which.

Figure 3.2: The structures of the by-products in the Bromination of 4nitro[2.2]paracyclophane.
3.3.2

Synthesis of 4-bromo-13-amino[2.2]paracyclophane

4-Bromo-13-amino[2.2]paracyclophane 10 has been prepared by reduction using hydrogen
and platinum15,16 and with HCl and Iron8 in yields up to 91%. The latter approach was carried
out here to give 10 in 68% yield (Scheme 3.16). The mechanism for this reaction is proposed
to be analogous with that shown in Scheme 3.12. The 1H NMR data for this compound is in
agreement with the published values for this regioisomer.
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Scheme 3.16: The synthesis of 4-bromo-13-amino[2.2]paracyclophane.
3.3.3

Synthesis of 4-nitro-13-formyl[2.2]paracyclophane

This compound has not been previously reported. The Reich formylation was extended to 5
to garner 4-nitro-13-formyl[2.2]paracyclophane 11 in 18% yield (Scheme 3.17). The
mechanism for this reaction is analogous with that proposed in Scheme 3.6 but again with the
pseudo-geminal effect responsible for the regioselectivity.

Scheme 3.17: The synthesis of 4-nitro-13-formyl[2.2]paracyclophane.
The 1H NMR spectrum shows the characteristic formyl proton at 9.94 ppm along with the
presence of six aromatic protons. This confirms that 5 has been substituted with the formyl
moiety. Furthermore it can be readily elucidated that the substitution pattern is hetero-annular
due to the splitting pattern of the aromatic protons shown in Figure 3.3. The two doublets
with small coupling constants are the ortho protons, the 2 dds are the para protons and the
remaining two doublets are the meta protons, relative to each functional group.
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Figure 3.3: A segment of the 1H NMR spectrum of 4-nitro-13-formyl[2.2]paracyclophane.
At this point the structure could be assigned as a pseudo-geminal, pseudo-ortho, pseudo-meta
or pseudo-para regioisomer. The nitro and formyl functional groups cause the closest alkyl
proton to be shifted downfield so it would be expected to observe two alkyl protons clearly
separated from the remaining six. This is what is observed and the COSY spectrum shows
coupling between these two indicating they are on positon 1’ and 2’ or the same side of the
system (Figure 3.4).
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Figure 3.4: A segment of the COSY spectrum of 4-nitro-13-formyl[2.2]paracyclophane.
This then eliminates the pseudo-ortho and pseudo-para configurations. The remaining
possibilities are then the pseudo-geminal and pseudo-meta isomers and as stated previously
the pseudo-geminal effect of the nitro group should lead to specificity. However the COSY
spectrum does not allow assignment of these two alkyl protons as cis or trans to one another.
This required examination of through-space coupling by nuclear Overhauser effect
spectroscopy (NOESY) analysis. Coupling between these protons would confirm the product
as the pseudo-geminal isomer while no interaction would indicate the pseudo-meta isomer.
This was attempted but a clear spectrum could not be obtained. It is on the basis of the
pseudo-geminal effect that the product is tentatively assigned as the pseudo-geminal isomer
however the spectroscopic evidence presented here is not sufficient for unambiguous
assignment.
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Synthesis of 4-amino-7-formyl[2.2]paracyclophane

This compound has not been previously reported. Initially reduction of 11 was attempted
using HCl and iron to prepare 12 however it was found that the starting material degraded
and no product was detected (Scheme 3.18). Reaction times as short as 15 minutes and lower
temperatures still resulted in degradation.

Scheme 3.18: The unsuccessful synthesis of 4-amino-13-formyl[2.2]paracyclophane.
In light of this it was then attempted to extend the Reiche formylation to 6. It was expected
that in this case homo-annular substitution would be observed due to the activating effect of
the amino substituent. This was found to be the case and the para isomer 4-amino-7formyl[2.2]paracyclophane 13 was isolated in 26% yield (Scheme 3.19). It was expected that
the ortho isomer may be produced but likely in lower quantities as this position is not as
sterically favourable however no such material was isolated.

Scheme 3.19: The synthesis of 4-amino-7-formyl[2.2]paracyclophane.
Homo-annular analogues prove much simpler to assign than hetero-annular analogues. Firstly
the presence of the formyl moiety is confirmed by a singlet at 9.76 ppm in the 1H NMR
spectrum. The aromatic splitting shows 4 dd’s which correspond to an unsubstituted ring
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(Figure 3.5). The two singlets indicate a para orientation. The ortho isomer would present
two doublets as would the meta isomer however these would be readily distinguishable by the
coupling constant.

Figure 3.5: A segment of the 1H NMR spectrum of 4-amino-7-formyl[2.2]paracyclophane.
3.4

Resolution of [2.2]paracyclophane derivatives

3.4.1

Resolution of 4-amino[2.2]paracyclophane

(RP)-4-amino[2.2]paracyclophane 6 was resolved using a previously reported procedure.11
Resolution was achieved by recrystallisation of diastereomeric salts formed from (1S)-(+)-10camphorsulfonic acid. Yields of 24% were reported however only yields up to 6% were
achieved here (Scheme 3.20).
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Scheme 3.20: The resolution of 4-amino[2.2]paracyclophane.
3.4.2

Resolution of 4-bromo[2.2]paracyclophane

Resolution of [2.2]paracyclophane derivatives via the use of diastereomeric sulfoxides has
been discussed in detail in Section 2.4. The method was utilised here and proceeded as
reported garnering both the 14-(RPS) and 14-(SPS) derivatives in 25% and 26% yield
respectively (Scheme 3.21).5,17

Scheme 3.21: The resolution of 4-(4-Tolylsulfinyl)-[2.2]paracyclophanes.
From these resolved sulfoxides Rowlands et al. prepared an impressive variety of useful
enantiopure derivatives. However they were not successful in preparing any halide
derivatives. Attempts to do so using electrophiles such as bromine and iodine resulted in
protonation of the intermediate lithio species yielding only the parent compound 1. In this
work, bromobenzene was added to the lithio species generated in-situ with the aim of a
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bromo-lithio exchange occurring. This proved to be the case and 2-(SP) was isolated in 35%
yield (Scheme 3.22). This represents a novel method for the preparation of both enantiomers
of 2.

Scheme 3.22: The resolution of 4-bromo[2.2]paracyclophane.
3.5

Synthesis of phenyl-oxazoline derivatives

As mentioned in Section 2.5, oxazolines are usually prepared from the cyclisation of the
appropriate amino alcohol and carboxylic acid. The carboxylic acid is normally activated by
generating the corresponding acid chloride via thionyl chloride (SOCl2) or a modification of
the Appel reaction which uses triphenylphosphine (PPh3). Oxazolines are also readily
prepared using the Witte Seeliger reaction.18 This is the cyclisation of nitriles and amino
alcohols using zinc chloride (ZnCl2) as a catalyst.19,20 This procedure was utilised here to
prepare a range of compounds, two of which have not been previously reported (Table 3.1).
A mechanism for this reaction has not been reported.
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Table 3.1: The preparation of phenyl-oxazoline derivatives via the Witte Seeliger reaction.

R1

R2

R3

R4

R5

Yield

Reported
yield

NH2

H

H

H

H

24%

72%21

NH2

H

H

iPr

H

82%

72%21

NH2

H

H

Bn

H

58%

65%21

NH2

H

H

tBu

H

40%

77%21

NH2

OMe

OMe

iPr

H

45%

----

Br

H

H

iPr

H

42%

78%21

I

H

H

iPr

H

48%

----

3.6

Synthesis of phenyl-oxazoline [2.2]paracyclophane ligands

It was envisaged that the prepared phenyl-oxazolines could be linked to the Pc moiety using
the Buchwald-Hartwig amination. This reaction forms a carbon-nitrogen bond via the
palladium catalysed cross-coupling of an amine and a halide. To begin, 2 and the oxazoline
15 were selected. Along with these components Buchwald-Hartwig reactions also require an
appropriate ligand and base to proceed. Hence a series of conditions were examined to
determine the optimum reagents for the synthesis. This included different palladium sources
and

bases

and

three

ligands

which

2,2’bis(diphenylphosphino)-1,1’-binaphthyl

were

triphenylphosphine

(BINAP)
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bis(diphenylphosphino)ferrocene (DPPF). The results of these experiments are given in Table
3.2.
Table 3.2: Buchwald-Hartwig reaction of 4-bromo[2.2]paracyclophane with (S)-2-(4isopropyl-4,5-dihydrooxazol-2-yl)aniline.[a,b]

Entry

Pd source

Base

Ligand

Time (days)

Yield

1

Pd(OAc)2

CsCO3

PPh3

5

----

2

Pd(OAc)2

CsCO3

BINAP

5

12%

3

Pd(OAc)2

CsCO3

DPPF

5

----

4

Pd(OAc)2

tBuOK

PPh3

5

----

5

Pd(OAc)2

tBuOK

BINAP

5

13%

6

Pd(OAc)2

tBuOK

DPPF

5

----

7

Pd(dba)2

CsCO3

PPh3

5

----

8

Pd(dba)2

CsCO3

BINAP

5

13%

9

Pd(dba)2

CsCO3

DPPF

5

---

10

Pd(dba)2

tBuOK

PPh3

5

----

11

Pd(dba)2

tBuOK

BINAP

5

14%

12

Pd(dba)2

tBuOK

DPPF

5

----

13

Pd(dba)2

tBuOK

BINAP

5

19%[c]

14

Pd(dba)2

tBuOK

BINAP

7

20%[c]
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[a] 0.5 mmol 15, 1.2 eq. 2, 5% Pd, 10% ligand, 2 eq. base, 10 ml toluene at 120 °C. [b]
Yields based on isolated mixture of diastereomers 16 [c] 10% Pd, 20% ligand.
Based on the results of this series of reactions several conclusions can be drawn. The
selection of palladium source and base do not appear to significantly impact the reaction. The
choice of ligand is essential and no product was observed when DPPF or PPh3 was used.
Higher loadings of palladium and BINAP increased the yield by approximately 5% (Entry
13) while longer reaction times had little effect (Entry 14). Even after 7 days significant
amounts of starting material remain in the mixture and it was found that 45-50% of the
starting material could be retrieved.
The 1H NMR spectra of the isolated mixture shows two peaks at approximately 10.21 and
10.33 ppm. These have been identified as the NH peaks for the diastereomers 16-(RPS) and
16-(SPS) respectively, based on a crystal structure obtained of 16-(SPS). This region of the
spectra is generally clean so it provides a convenient way of assessing the diastereomeric
ratio (d.r.) of the products. In all cases here there was no excess and an equal distribution of
diastereomers was observed. However on lowering the reaction temperature to 70 °C a
change in the product distribution is observed, with 16-(RPS) produced in 62:38 d.r. (Figure
3.6).
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Figure 3.6: A segment of the1H NMR spectrum of the diastereomeric mixture.
Using the established conditions but changing the solvent to benzene gave 16-(RPS) in 90:10
d.r. which is a very significant increase in selectivity and surprising given the only change is
the solvent. Unfortunately this diastereomer could not be recrystallised to purify the material
further.
It was found that using the appropriate solvent system 16-(SPS) and 16-(RPS) had small
differences in their Rf values and could be separated by careful flash column
chromatography. The products were not completely pure after separation and required
recrystallisation. This was successful with the 16-(SPS) diastereomer which was isolated as
white crystals. Again the 16-(RPS) diastereomer could not be recrystallised. Further,
attempting to recrystallize from a 1:1 mixture of diastereomers could not be achieved and
enriching the 16-(SPS) isomer by column chromatography first was necessary. Crystals of the
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16-(SPS) isomer suitable for X-ray crystallography were obtained and the structure is
presented in Figure 3.7.

Figure 3.7: The crystal structure of (SPS)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)[2.2]paracyclophane-4-amine.
Full details of the crystallographic data including bond lengths and bond angles are presented
in Appendix 106. This compound is expected to act as a bidentate N,N ligand that will bond
to a metal centre. A hypothetical model of 16-(RPS) bonded to a zinc atom has been prepared
and this is shown in Figure 3.8.
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Figure 3.8: Molecular model of a proposed ligand-zinc complex with minimised energy from
different perspectives.
Using this purification protocol the preparation of other derivatives was attempted (Table
3.3). The isopropyl derivative was ultimately prepared in only 6% yield while the benzyl
derivative was prepared in 7% yield. The t-Bu derivative was detected in the reaction mixture
however ultimately none could be isolated. While the yields are poor it is important to note
that this method represents a one pot synthesis and resolution procedure. This is significant as
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resolving [2.2]paracyclophane precursors is arguably the most laborious aspect of dealing
with this class of ligands.
Table 3.3: The synthesis of phenyl-oxazoline-[2.2]paracyclophane ligands using the
Buchwald-Hartwig amination.[a]

Entry

R

Yield

1

iPr

6%

2

Bn

7%

3

tBu

----

[a] 1 mmol oxazoline, 1.2 eq. 2, 10% Pd, 20% ligand, 2 eq. base, 20 ml toluene at 120 °C, 5
days.
3.7

Attempted optimisation of ligand synthesis

Although a procedure for the preparation and resolution of novel ligands had been
demonstrated the yields were extremely poor. The limits of catalyst and ligand loadings as
well as reaction time and temperature were at the practical limits so it was decided to
investigate changes to the synthetic routes (Table 3.4). Switching to an amino Pc and a bromo
oxazoline (Entry 1) showed no increase in the yield at 18% as 19% was achieved under these
conditions with the initial reagents. Using an iodo oxazoline (Entry 2) there was a marked
increase in yield to 29%.
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Furthermore, an oxazoline derivative containing aryl methoxy groups was examined (Entry
3). It was hoped this electron rich system would couple more readily however it was found to
perform less effectively than the original system garnering only 10% product. Furthermore
the resulting diastereomers could not be separated chromatographically as was the case with
the original ligands.
Table 3.4: Attempted optimisation of phenyl-oxazoline-[2.2]paracyclophane synthesis.[a]

Entry

X1

X2

X3

X4

Yield

1

NH2

Br

H

H

18%

2

NH2

I

H

H

29%

3

Br

NH2

OCH3

OCH3

10%

[a] 1 mmol oxazoline, 1.2 eq. cyclophane, 10% Pd, 20% ligand, 2 eq. base, 20 ml toluene at
120 °C, 5 days.
A linear synthetic sequence was also considered where the aryl nitrile is coupled to the Pc
moiety and the subsequent product utilised in the Witte Seeliger reaction to give the final
ligands (Table 3.5). Using the bromo Pc and an amino nitrile no product was detected (Entry
1). Switching the functionalities, using amino Pc and halo nitriles yielded no detectable
product either (Entry 2 and 3). It is suggested that the deactivating nitrile in the ortho position
is the cause for this lack of reactivity. Using the more electron rich dimethoxy derivative, the
resulting

product

2-(4-amino-[2.2]paracyclophane)-4,5-dimethoxybenzonitrile

isolated in 32% yield (Entry 4).
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Table 3.5: Buchwald-Hartwig reaction of substituted [2.2]paracyclophanes with aryl
nitriles.[a]

Entry

R1

R2

R3

R4

Yield

1

Br

NH2

H

H

----

2

NH2

Br

H

H

----

3

NH2

I

H

H

----

4

Br

NH2

OCH3

OCH3

32%[b]

[a] 1 mmol nitrile, 1.2 eq. Pc, 10% Pd, 20% ligand, 2 eq. base, 20 ml toluene at 120 °C, 5
days [b] 2 days.
17 was then used in the Witte Seeliger reaction where it proceeded in only 16% yield
(Scheme 3.23). This result indicates that the linear synthetic approach is not superior to the
initial convergent synthesis.

Scheme 3.23: The synthesis of (SPS)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)4,5dimethoxy-phenyl)-[2.2]paracyclophane-4-amine.
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Conclusion

A series of monosubstituted Pc were prepared including bromo, formyl, hydroxy, nitro and
amino derivatives. Using a number of these compounds, additional functionality was added to
prepare a range of disubstituted derivatives including two novel materials. The resolution of
two Pc derivatives was investigated and a novel procedure for preparing enantiopure 4bromo[2.2]paracyclophane was reported. Following this, a series of phenyl-oxazolines were
prepared via the Witte Seeliger reaction, including two novel derivatives, for use in
Buchwald-Hartwig aminations intended to prepare novel asymmetric ligands. Initial studies
were aimed at optimising conditions and two novel asymmetric ligands were isolated in
enantiopure form and characterised. The yields however were under 10% so further work was
aimed at an alternative synthetic route that would be more efficacious. Attempts at different
combinations of amines and halides provided a mild improvement in the case of iodides. A
more electron rich phenyl-oxazoline system prepared by introducing aryl methoxides failed
to improve the coupling efficiency. Finally a linear synthetic sequence was investigated but
again this did not provide a more effective route over the initial preparation. Further work is
needed to optimise this synthesis and the most likely avenues will be the use of microwave
synthesis or some redesign of the oxazoline component to make it more amenable to
Buchwald-Hartwig coupling.

78

Preparation of Asymmetric Ligands Based on [2.2]Paracyclophane
3.9

Chapter 3

References

(1)

Cram, D. J.; Day, A. C. J. Org. Chem. 1966, 31, 1227.

(2)

Rieche, A.; Gross, H.; Hoft, E. Chem. Ber. 1960, 93, 88.

(3)

Hopf, H.; Raulfs, F. W. Isr. J. Chem. 1985, 25, 210.

(4)

Friedmann, C. J.; Ay, S.; Brase, S. J. Org. Chem. 2010, 75, 4612.

(5)

Hitchcock, P. B.; Rowlands, G. J.; Parmar, R. Chem. Commun. 2005, 4219.

(6)

Kane, V. V; Gerdes, A.; Grahn, W.; Ernst, L.; Dix, I.; Jones, P. G. Tetrahederon Lett.
2001, 42, 373.

(7)

Cram, D. J.; Allinger, N. L. J. Am. Chem. Soc. 1955, 77, 6289.

(8)

Schneider, J.; Fröhlich, R.; Paradies, J. Synthesis (Stuttg). 2010, 2010, 3486.

(9)

Lahann, J.; Höcker, H.; Langer, R. Angew. Chem. Int. Ed. Engl. 2001, 40, 726.

(10)

Yanada, R.; Higashikawa, M.; Miwa, Y.; Taga, T.; Yoneda, F. Tetrahedron
Asymmetry 1992, 3, 1387.

(11)

Cipiciani, A.; Fringuelli, F.; Mancini, V.; Piermatti, O. J. Org. Chem. 1997, 4, 3744.

(12)

Reich, H. J.; Cram, D. J. J. Am. Chem. Soc. 1969, 91, 3505.

(13)

Reich, H. J.; Cram, D. J. J. Am. Chem. Soc. 1968, 90, 1365.

(14)

Hopf, H.; Gleiter, R. Modern Cyclophane Chemistry; Gleiter, R., Hopf, H., Eds.;
Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, FRG, 2004.

(15)

Allgeier, H.; Siegel, M. G.; Helgeson, R. C.; Schmidt, E.; Cram, D. J. J. Am. Chem.
Soc. 1975, 97, 3782.
79

Preparation of Asymmetric Ligands Based on [2.2]Paracyclophane

Chapter 3

(16)

Duan, W.; Ma, Y.; Xia, H.; Liu, X.; Ma, Q.; Sun, J. J. Org. Chem. 2008, 73, 4330.

(17)

Parmar, R.; Coles, M. P.; Hitchcock, P. B.; Rowlands, G. J. Synthesis (Stuttg). 2010,
4177.

(18)

Witte, H.; Seeliger, W. Angew. Chem. Int. Ed. Engl. 1972, 11, 287.

(19)

Hargaden, G.; O’Sullivan, T.; Guiry, P. Org. Biomol. Chem. 2008, 6, 562.

(20)

Mckeon, S.; Müller-Bunz, H.; Guiry, P. European J. Org. Chem. 2009, 4833.

(21)

Hargaden, G. Applications of Oxazoline-Containing Ligands in Asymmetric Catalysis,
University College Dublin, 2007.

80

Review of the Synthesis and Modification of Octafluoro[2.2]paracyclophane
4.0

Review

of

the

Synthesis

and

Chapter 4

Modification

of

Octafluoro[2.2]paracyclophane
4.1

Introduction

Octafluoro[2.2]paracyclophane (OPc) 1, commonly referred to industrially as AF4, is a
fluorinated analogue of [2.2]paracyclophane with the alkyl hydrogen atoms replaced by
fluorine (Figure 4.1). This compound finds widespread application in industry for preparing
surface coatings. These coatings offer superior thermal and UV stability, a low dielectric
constant and excellent barrier properties in comparison to their hydrocarbon counterparts.1,2
However a facile and high yielding synthesis of 1 has proven difficult and the following
details the advances to date in its preparation and modification.

Figure 4.1: The structure of octafluoro[2.2]paracyclophane.
4.2

Preparation of octafluoro[2.2]paracyclophane

The initial procedures for the preparation of 1 were developed in the early 1960’s when a
number of 1,4-bis-alkylsulfonyls 2 were pyrolysed at high temperatures (600-800 °C) to yield
1.3 Around the same time, a similar high temperature procedure in the presence of copper was
developed using 1,4-bis-alkylhalo analogues 3 and 4 from derivative 5 (Scheme 4.1).4 These
methods did not exclusively yield 1 and a variety of cyclic and linear oligomers were also
formed contributing to a yield of approximately 30% by either method. Subsequent research
focused on pathways which would lead exclusively to 1.5
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Scheme 4.1: The synthesis of 1,4-bis-alkylsulfonyl and 1,4-bis-alkylhalo precursors for the
high temperature synthesis of octafluoro[2.2]paracyclophane.
The high temperature synthesis optimised by Wheelright et al.5 remained the only route to
produce 1 for almost 30 years. It was not until the early 1990’s that a new method was
presented. Dolbier et al. attempted to extend the Hoffman elimination of an amino
tetrafluorborate salt 6 to yield 1, based on a previous synthesis of the parent hydrocarbon
paracyclophane (Scheme 4.2).6 This proved unsuccessful as did an attempt to use a carboxylic
acid salt 7. It was found that treatment of compound 4 with a combination of titanium
tetrachloride and lithium aluminium hydride afforded 1 in a 32% yield.7

Scheme 4.2: Development of a low temperature preparation of
octafluoro[2.2]paracyclophane.
Although this work removed the necessity for high temperatures, it presented a new issue. An
appreciable yield was only obtained when the reaction was carried out under highly dilute
conditions, 1.5L of solvent yielded 1.7g of 1 (32%) and extremely slow addition of reactants
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was necessary. This limitation is explained by consideration of the reaction mechanism which
proceeds via formation of the reactive tetrafluoro-p-xylylene 8, as evidenced by a small
amount of the trimer 9 in the reaction mixture (Scheme 4.3). There is an increase in the
concentration of 8 as the dilution factor is decreased so it must be maintained to limit the
collisions with the di-radical intermediate 10. This dilution also provides the optimal kinetic
environment to minimise the bimolecular oligomerisation of the extended conformer 11.

Scheme 4.3: The possible reaction pathways of the intermediate tetrafluoro-p-xylylene.
Dolbier et al. reported an improved method several years later which obviated the need for
high dilution. Based on a study into Diels-Alder reactions by Mori et al.,8,9 it was found that a
combination of trimethylsilyl tributyltin and caesium fluoride (CsF) could affect the required
debromination of 4 to yield 1 in 40% yield (Scheme 4.4). It was found that a solvent system
of 4:1 THF:DMSO was crucial for this to proceed. A mechanistic reasoning explains the need
for this and the formation of 8. CsF has limited solubility in this solvent system so it impedes
the rate of formation of the necessary intermediate such that at any one time its concentration
is low. This essentially presents the same favourable kinetic environment that high dilution
facilitates, but without the increased solvent volume.10
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Scheme 4.4: A tin catalysed debromination to prepare octafluoro[2.2]paracyclophane.
This synthesis allowed production of 1, did not require high dilution technology and was
industrially feasible to produce the material on a kilogram scale, but some issues remained.
The reaction was still low yielding at 40%, there is significant cost associated with the
reagents, and the use of stochiometric quantities of an organostannane is undesirable.
In a subsequent report by Dolbier et al., it was shown that 1 could be produced in a 60% yield
without the use of stannanes. Treating the chloro analogue 3 with zinc dust in
dimethylacetamide (DMA) yielded the product without needing high dilution conditions
(Scheme 4.5). The mechanism is not fully understood but it is believed that the coupling
occurs on the metal surface. Not requiring high dilution would imply that the pathway does
not involve generation of free intermediate 8.11

Scheme 4.5: The zinc catalysed coupling of 1,4-bis-chlorodifluoromethylbenzene to prepare
octafluoro[2.2]paracyclophane..
A year following this report, Uneyama et al. presented a new carbon-fluorine bond cleavage
route to 1 from the inexpensive starting material 1,4-bis-trifluoromethyl benzene 12 (Scheme
4.6). A magnesium-promoted defluorinative silylation of one of the trifluoromethyl (CF3)
groups was used to yield the corresponding trimethylsilyl compound 13. This was then heated
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at reflux in anisole in the presence of catalytic amounts of CsF and Pd2(dba)3 providing 1 in
yields of 53%.12

Scheme 4.6: The preparation of octafluoro[2.2]paracyclophane via the formation of an
organosilane and a subsequent Pd/CsF catalysed coupling.
This procedure, along with the previously mentioned zinc catalysed method, represent the
current leading technology for the synthesis of 1. The yields of both procedures are
comparable so when deciding which route is best it would be prudent to consider the
precursor compounds required. While 12 is inexpensive and readily available in bulk
commercially, 3 is not commercially available and its preparation from an inexpensive
precursor could prove laborious.
There are two pathways presented in the literature to this end and these will now be
considered. The first is described in a patent from the mid 1990s13 and is summarised in
Scheme 4.7. Terephthalaldehyde 14 is fluorinated using sulfur tetrafluoride (SF4) to yield 1,4bis-difluoromethyl benzene 514 and this is subsequently chlorinated (or brominated if desired)
by a photo halogenation process to yield the desired precursor 3. SF4 is a highly corrosive gas
which liberates HF on contact with moisture. Such a material is undesirable industrially.
However, the use of this material can be circumvented in two steps, by chlorinating 14 with
boron trichloride (BCl3) to yield 1,4-bis-dichloromethyl benzene 1515, and a subsequent solid
state halogen exchange process with CsF to give 516 or the use of phase transfer agents.17
Thionyl chloride (SOCl2) may be utilised in place of BCl3 to yield 15.18 The second approach
to this precursor was published in 2007 by Dolbier et al. and describes its production from
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1,4-bis-trichloromethyl benzene 16 (readily produced itself via photochlorination of pxylene) using anhydrous HF with reported yields of 79% for 3.16

Scheme 4.7: Two chemical pathways to the precursor 1,4-bis-chlorodifluoromethylbenzene.
4.3

Preparation of substituted octafluoro[2.2]paracyclophane derivatives

There have been numerous reports to date examining analogues of 1 and they range from the
preparation of commercially useful substituted analogues to studies of chiral diparacyclophanes which are of academic interest. Pc systems have elicited much academic
interest due to their unique chemical behaviours such as unusual reactivities, trans-annular
communication and spectroscopic abnormalities1. It is worth noting that the reports discussed
in the following were all carried out by Dolbier’s group. Work published in 1999 details
procedures for the electrophilic aromatic substitution of 1. Methods were developed to
introduce an impressive variety of functionalities, beginning with nitration using nitronium
tetrafluoroborate (NO2BF4) in sulfolane (Scheme 4.8).19 This work is particularly relevant
because these additional groups can act as linkers for the attachment of other chemical
entities to the precursors or the subsequent coating they generate.
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Scheme 4.8: The preparation of a variety of monosubstituted octafluoro[2.2]paracyclophane
derivatives.19
It was subsequently shown that utilising harsher nitrating conditions could yield a di-nitro
analogue of 1 in 81% yield, again using NO2BF4 in sulfolane but at a higher temperature. The
product was found to be an equivalent mixture of three hetero-annularly substituted isomers
which were pseudo-ortho 17, pseudo-meta 18 and pseudo-para 19 (Scheme 4.9). No pseudogeminal or homo-annular substitution was detected. Interestingly the pseudo-ortho isomer
could be readily separated by column chromatography (along with any mono-nitrated or
starting material). These isomers could all be reduced to the corresponding amines and
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converted to bromo or chloro derivatives by substitution. Attempts at the reduction of a single
nitro group were achieved but were found to be low yielding at 11%.20

Scheme 4.9: The preparation of di-nitro derivatives of octfluoro[2.2]paracyclophane and
their subsequent reduction and halogention.
Direct bromination was also carried out on 1 using N-bromosuccinimide and H2SO4 and gave
an unexpected result. The reaction proceeded in 55% yield and the product was exclusively a
homo-annular p-dibromide which is unusual given the deactivating nature of halo
substituents.20 This provides a method for the synthesis of novel homo-annularly and heteroannularly disubstituted analogues of 1. Such compounds may prove superior to their
hydrocarbon counterparts as ligands for asymmetric synthesis because they show a
significantly higher resistance to thermal isomerisation.20,21
As shown previously, the CF3 derivative of 1 could be produced in 5 steps (Scheme 4.8).
Attempts were made to extend Sawada’s free radical trifluoromethylation procedure to 1
which utilises decomposition of trifluoroacetyl peroxide in DCM.22 Although the CF3 radical
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added to one of the rings, no rearomatisation was observed. Instead the resulting
cyclohexadienyl radical 20 proved stable enough to dimerise to one of the isomers 21 or 22
(Scheme 4.10). The value of these isomers is in the generation of CF3 radicals.23 Usually
these are generated using trifluoroacetyl peroxide which is thermally unstable even at room
temperature or by the use of Scherer’s radical which is considered an excellent clean
source.24 The isomers shown here are stable crystalline compounds which produce CF3
radicals at temperatures above 150 °C with the only by product being the essentially
chemically inert 1.

Scheme 4.10: The preparation of trifluoromethyl substituted bisoctafluoro[2.2]paracyclophane analogues.
Following this was the first report of a di-octafluoro[2.2]paracyclophane produced via the
palladium catalysed reductive homo-coupling of the iodo analogue 23 (Scheme 4.11). The
result was again an isomeric mixture of 24 and 25. Low temperature

19

F NMR studies

showed that the meso compound 25 is a rotamer. The introduction of a CF3 group as in 26
yielded only the meso compound 27 by a similar procedure.25
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Scheme 4.11: The preparation of di-octafluoro[2.2] paracyclophanes and trifluoromethyl
derivatives.
Facile access to the iodo analogue 23 also allowed an investigation into the use of Suzuki
cross couplings (Scheme 4.12). The reactions proved very effective when using non-hindered
boronic acids and pinacol esters. A method was also developed for the production of boronic
acid derivative 28. This novel material showed comparable yields under the same conditions
when coupled with non-hindered aryl iodides.26

90

Review of the Synthesis and Modification of Octafluoro[2.2]paracyclophane

Chapter 4

Scheme 4.12: Suzuki cross couplings of octafluoro[2.2]paracyclophane derivatives.
It was found that phenyl spacer groups could be introduced between the OPc units under
appropriate conditions to yield novel compounds 29 and 30 (Scheme 4.13).

Scheme 4.13: The preparation of di-cyclophane derivatives using Suzuki cross couplings.
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An examination of the SRN1 reactivity of 23 showed that it reacts with certain aryl thiolates
and stabilised enolates (Scheme 4.14). This result was promising because it indicated that
many novel OPc derivatives may be produced from SRN1 nucleophiles. These reactions did
however require photochemical initiation and did not proceed via thermal methods alone.27

Scheme 4.14: The preparation of substituted octafluoro[2.2]paracyclophane derivatives by
an SRN1 pathway.
An unusual product of nucleophilic attack of the nitro analogue 31 led to the discovery of a
novel ring cleaving reaction of OPc (Scheme 4.15).28 Although there were reports of opening
the [2.2]paracyclophane system with the parent hydrocarbon,29,30 this occurred via the alkyl
bridge carbons whereas in this case the cleavage occurs at the alkyl-aryl bond. It is suggested
that this occurs via an SNAr pathway.
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Scheme 4.15: The ring cleaving reaction of nitro OPc with a nucleophile.
4.4

Preparation of substituted octafluoro[2.2]paracyclophane analogues by

Diels-Alder reactions
Arynes (or benzynes) are a highly reactive intermediary species that are known to readily
take part in Diels-Alder reactions. It was shown in a report from 2002 that benzynes 32 and
33 can be produced from mono and di-iodo substituted analogues of 1 (Figure 4.2).31,32

Figure 4.2: The structure of 4,5-dehydrooctafluoro[2.2]paracyclophane and 4,5,15,16-bisdehydrooctafluoro[2.2]paracyclophane.
Prior to this report in 1969, Longone et al. had used [2.2]paracyclophane in the presence of
anthracene to produce the Diels-Alder adduct, however the yield was only 15%.33 In the same
year Cram et al. also reported a bis Diels-Alder product via the dehalogenation of 4,5,15,16
tetrabromo[2.2]paracyclophane.34 Longone generated the necessary aryne using KOtBu a
method normally avoided since its original reporting.35 This is because arynes typically react
with the nucleophilic t-Bu ion leading to significant amounts of by-product. In the case of
arynes generated from 1 however this method is ideal giving excellent yields with virtually
none of this by-product detected. As an example, Scheme 4.16 shows the Diels-Alder
products produced from iodo analogues of 1 (which occur via the formation of the
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corresponding arynes 32 and 33) with anthracene as a substrate which gave excellent yields.
Other substrates employed were benzene, naphthalene, t-butylbenzene, furan and
[2.2]paracyclophane, each of which demonstrated comparable yields with anthracene.

Scheme 4.16: Diels-Alder cycloaddition reactions yielding substituted
octafluoro[2.2]paracyclophane derivatives.
As a continuation of this synthesis it was found that the Diels-Alder adduct 34, amongst
others, could be used to prepare novel OPc derivatives such as the anthraceno analogue 35
(Scheme 4.17). This compound is of note because it was found to form a dimer when exposed
to UV light. The structure is unusual in that the anthracene ring directly involved in the OPc
system breaks aromaticity to form a cyclobutane ring.36
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Scheme 4.17: The preparation of 1,4-anthraceno-octafluoro[2.2]paracyclophane and its
dimerisation.
The approach used thus far in this area was the Cram methodology but Diels-Alder adducts
may also be produced using the Cadogan method.37 This method generates the aryne by
reaction of an N-nitroacetanilide, produced in-situ by the reaction of acetanilide 36 and 4chlorobenzoyl nitrite 37, which proceeds to react with the desired arynophile. This method is
typically low yielding with the reaction of acetanilide and anthracene for example, yielding
only 16% of the Diels-Alder adduct. When extended to the acetanilide derivative 38 the yield
was 90% (Scheme 4.18). The increased efficiency of the reaction is ascribed to the bridge
fluorine atoms because they increase the ring hydrogen acidity and produce a more electron
deficient aryne.
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Scheme 4.18: The preparation of the anthracene Diels-Alder adduct of
octafluoro[2.2]paracyclophane.
The Cadogan methodology was also found to be very effective for reactions with alkenes. For
example, the reaction with oct-1-ene yielded 91% of the ene product 39 (Scheme 4.19).
Interestingly, the same reaction under Cram conditions yielded no product, only reduction of
the aryl iodide. No alkene utilised was shown to produce any ene product under Cram
conditions.
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Scheme 4.19: Ene reactivity of octafluoro[2.2]paracyclophane derivatives under Cadogan
and Cram conditions.
The final report relating to this area details a sequential ene reaction followed by a DielsAlder reaction with cyclohepta-1,3,5-triene. The ene adduct 40 produced via the Cadogan
method reacts further with an additional aryne to yield a Diels-Alder adduct (Scheme 4.20).
The product was synthesised as a diastereomeric 2:1 mixture 41 and 42 in a yield of 25%. It
was possible to fully characterise the mixture solely by NMR.38
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Scheme 4.20: Sequential ene and Diels-Alder reaction of OPc-acetamide and cyclohepta1,3,5-triene.
4.5
A

Preparation and modification of perfluoro[2.2]paracyclophane
logical

progression

from

the

preparation

of

1

was

the

synthesis

of

perfluoro[2.2]paracyclophane (pOPc) 43 (Scheme 4.21). The initial preparation of this
compound detailed two synthetic routes; a five step procedure beginning with 2,3,5,6tetrachloroterphthalonitrile 44, and a second refined pathway beginning with 1,2,4,5tetrachlorobenzene 45. Although a zinc-catalysed homo-coupling is again utilised to produce
pOPc, the presence of aromatic fluorine instead of hydrogen meant a different approach was
required to make the necessary precursor 46. It was determined that ultimately 43 may be
produced in a 39% yield when the coupling is carried out in MeCN at 100 °C for 38 hours.39
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Scheme 4.21: Two synthetic pathways for the synthesis of perfluoro[2.2]paracyclophanes.
Following the preparation of 43, an investigation was carried out to examine the reactivity of
this compound to nucleophilic aromatic substitution.40 It was found that 43 could indeed be
modified in this manner and several examples were reported using both mono and bi-dentate
nucleophiles. The presence of such significant amounts of fluorine produces an extremely
electron deficient aromatic system which is then quite reactive to nucleophiles (Scheme 4.22).
No disubstitution is observed in the phenol derivative 47 and this is likely due to the strongly
electron donating ability of the phenoxide. It is noteworthy that this effect is transmitted to
the other ring of the system. This then explains why the more weakly donating methoxy
derivative 48 shows some disubstitution exclusively in the form of the pseudo-para isomer
49. The reaction of 43 with sodium thiophenoxide yielded no monosubstituted product but
gave a para isomer 50, indicating that this group had an activating effect. This is in
agreement with a previous study of the reaction of sodium thiophenoxide and 2,3,5,6tetrafluorobenzene.41 The most successful bi-dentate ligand class were found to be catechols
followed closely by bis-amines. In a reaction with ethylene glycol no cyclisation product was
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observed. Competition experiments showed that 43 was in fact much more reactive than
hexafluorobenzene under these conditions. It was determined that the most likely mechanistic
pathway for these reactions is an SNAr mechanism.

Scheme 4.22: Nucleophilic substitution reactions of perfluoro[2.2]paracyclophane.
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Mono-substituted analogues of 43 constitute a break in the symmetry and this allowed a
detailed study of the spectral and conformational properties of these new analogues.
Examination of the

19

F coupling constants, particularly long range four and five bond

couplings, allowed a detailed characterisation of the system and any disubstituted products
could be differentiated. It was found that substitution skews the geometry of the system such
that the unsubstituted ring may be drawn toward or away from the new substituent (Figure
4.3). The results showed that this was not just due to the size of the substituent but is likely to
be heavily dependent on the electronic environment of the aromatic rings. The experimental
data was found to be in good agreement with computational models.42

Figure 4.3: Possible conformations of the perfluoro[2.2]paracyclophane system with respect
to the new substituent.
The most recent report concerning 43 is the atropoisomerism of the acetoacetic ester
produced by the reaction of 43 and ethyl acetoacetate.43 Atropisomers are stereoisomers
resulting from restricted rotation about a single bond where the barrier of rotation is
sufficiently high that both isomers can be isolated. In this case the isomers were produced as
a mixture 51 and 52 (Scheme 4.23) in the form of a crystalline solid and it was determined
that the compound exists purely in the enol form with no keto tautomer detected by 1H NMR.
In solution the energy barrier to rotation was found to be 23.5 Kcal mol -1 and it is suggested
this is due to interference from the close fluorinated methylene bridge. The ester was then
cyclised under basic conditions to a furan product 53.
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Scheme 4.23: The preparation of the acetoacetic ester derivative of
perfluoro[2.2]paracyclophane and its subsequent cyclisation under basic conditions.
4.6

Conclusion

This review has discussed the history and development of OPc and subsequent investigations
into its chemistry. The development of facile synthetic pathways to the compound and the
subsequent functionalisation of its structure have demonstrated that it is amenable to a broad
variety of chemistry. Its unusual electronic properties, ascribed to the highly fluorinated
structure, have led to it being surprisingly efficacious under a range of conditions. At present
it is a highly desirable material in industry for protective coatings. Research to date has
demonstrated that it would be an ideal precursor to a new generation of multifunctional
coatings as it can be readily modified. The chirality of the substituted Pc framework, along
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with its unique electronic properties, means that it could have applications as a scaffold in
asymmetric synthesis and catalyst design, areas which have not yet been fully explored.
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5.1
This

Introduction
chapter

details

the

investigation

into

the

synthetic

routes

to

octafluoro[2.2]paracyclophane (OPc) 1. Mono-substituted derivatives of 1 were also prepared
and interpretation of their NMR spectra is discussed in detail. Finally, the Buchwald-Hartwig
amination was used in attempts to couple the OPc framework with a phenyl-oxazoline to
prepare analogous ligands to those reported in Chapter 3.
5.2

Preparation of octafluoro[2.2]paracyclophane

Two synthetic routes to 1 were investigated and these are presented in Scheme 5.1.

Scheme 5.1: Synthetic routes for the preparation of octafluoro[2.2]paracyclophane.
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Synthesis of 1,4-bis-dichloromethylbenzene

Terephthaldehyde 2 was selected as an inexpensive and readily available starting material for
the synthesis of 1. It was intended that the initial step would involve the conversion of 2 to
the geminal dichloride 1,4-bis-dichloromethylbenzene 3. To this end four options were
available, chlorination via chlorine gas (Cl2),1 phosphorus pentachloride (PCl5),2 boron
trichloride (BCl3)3 or thionyl chloride (SOCl2).4 Due to availability and ease of handling, it
was decided to utilise the BCl3 and SOCl2 routes (Scheme 5.2).

Scheme 5.2: The synthesis of 1,4-bis-dichloromethylbenzene.
BCl3 was purchased as a 1M solution in pentane. This was added to a solution of dry hexane
and 2 which was heated at reflux for 4 hours. The product was isolated in 45% yield (98%
reported3) by a standard work-up followed by flash column chromatography. In addition, the
intermediate 4-dichloromethylbenzaldehyde 4 was isolated in a yield of 11%.
In the alternative procedure, SOCl2 was used neat with a catalytic amount of dimethyl
formamide (DMF). After a 3 hour reflux, the reaction mixture was poured onto cold water
and the product was immediately precipitated and collected by filtration. The yield was 70%
(94% reported4) and no further purification was required. Using SOCl2 provided a simpler,
higher yielding procedure and has the additional advantage of being significantly cheaper
than BCl3.
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The reaction involving BCl3 is proposed to proceed via the formation of an alkoxyboron
dichloride and presumably the migration of a second chlorine atom to the carbon centre to
yield the product (Scheme 5.3). The SOCl2 reaction then follows the same pathway differing
only in producing sulphur dioxide (SO2) as a by-product.

Scheme 5.3: The proposed mechanisms for the formation of 1,4-bis-dichloromethyl benzene.
5.2.2

Synthesis of 1,4-bis-difluoromethylbenzene

Two general routes were considered to prepare 1,4-bis-difluoromethylbenzene 5 (Scheme
5.4), a halogen exchange process beginning with 3, or direct fluorination of 2. 5 has been
synthesised by both routes with examples shown of solid phase exchange processes,5,6
exchange processes via phase transfer catalysis5,7 and direct fluorination using various
fluorinating reagents.8–10

Scheme 5.4: The synthesis of 1,4-bis-difluoromethylbenzene.
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Fluoride exchange processes

The halogen exchange process relies on the nucleophilic displacement of chlorine by fluorine
via an SN2 mechanism (Figure 5.1). However, to achieve this, there must be an interaction
between 3 and the fluoride generated from CsF. Solubility is the main issue as 3 is insoluble
in water and the ionic salt CsF is insoluble in most organic solvents. Phase transfer catalysis
offers a solution to this problem by allowing the reaction to be carried out with a mixture of
two immiscible solvents, in this case benzene and water. The reaction is mediated by the use
of a phase transfer catalyst. Such catalysts are usually ammonium salts or phosphonium salts
if strongly basic conditions or very high temperatures are required.11,12 Tetrabutyl ammonium
bromide (TBAB) is a widely used catalyst and was used in this work. The tetrabutyl
ammonium cation forms a complex with the fluoride anion resulting in a neutral species
capable of passing from the aqueous phase into the organic phase, thus delivering the
fluoride. The nucleophilicity of the fluoride anion should also be increased without the
stabilising effect of the hydration shell provided by the aqueous solvent. It was also
envisaged that the carbon centre would be more susceptible to nucleophilic attack due to the
electron withdrawing chlorine atoms. This process is similar to the Finkelstein reaction which
involves the substitution of alkyl chlorides and bromides for iodides and has been further
extended to encompass α-carbonyl, allyl and benzyl halides.13,14
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Figure 5.1: The proposed mechanism for the synthesis of 1,4-bis-difluoromethylbenzene via
phase transfer catalysis.
On performing this procedure in a mixture of benzene and water with temperatures up to 100
°

C, no product was detected by

19

F NMR. The reaction was then attempted in dry DMF in

which CsF has limited solubility. TBAB was again added to aid the delivery of the fluoride
ion and the reaction was carried out for 24 hours at reflux. Again no product was detected.
Finally, the starting material and CsF were mixed together and heated as a solid melt. There
were practical issues with mixing a sealed melt so the reaction could not be stirred which
likely hindered the progress significantly. 19F NMR showed traces of product but no material
was isolated from the mixture.
5.2.2.2

Direct fluorination of terephthaldehyde

The failure of the halogen exchange processes meant considering alternative routes. Direct
fluorination of 2 was the obvious choice because if successful it would remove one step in the
synthetic sequence. Due to the success of BCl3 in yielding 3, boron trifluoride (BF3) seemed a
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logical choice. However when the reaction was carried out no product was formed. This is
likely due to BF3 being a weaker Lewis acid.
The boron trihalides shown in Figure 5.2 are trigonal planar molecules with sp2 hybridisation
where the boron atom has an empty p-orbital, allowing it to act as a Lewis acid. It would be
expected that because of the relative electronegativity of the different halides that BF3 would
yield the most electron deficient boron atom of the boron trihalides and hence be the
strongest Lewis acid. However, the trend in Lewis acidity goes in the opposite direction with
BBr3 being the most acidic. This is because there is an orbital overlap between the empty porbital of boron and the full p-orbitals of the halides. This overlap is most efficient with
fluorine and decreases going down the group. Therefore the boron p-orbital in BF3 actually
has the most electron density of the boron trihalides making it the weakest Lewis acid. On
forming the appropriate adduct this π contribution would be lost as the molecular geometry
switches from trigonal planar to tetrahedral, thus forming the alkoxyboron intermediate
would not be favoured.15

Figure 5.2: The relative Lewis acidity of the boron trihalides.
Diethylaminosulfur trifluoride (DAST) was selected as an alternative fluorinating agent. It is
quite similar in reactivity to SF4 from which it is synthesised but much more easily handled.
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DAST was added to a dry solution of 2 in DCM along with a catalytic amount of ethanol
(EtOH). The reaction was heated at reflux for 16 hours and quenched with water. An aqueous
workup and subsequent flash column chromatography allowed isolation of 5 in a 67% yield
(94% reported9).
The proposed mechanism for this reaction, shown in Scheme 5.5, begins with the generation
of hydrofluoric acid (HF) in the presence of EtOH. This reduces the carbonyl to an alcohol
nucleophile which subsequently attacks the sulfur atom of the DAST reagent. This leads to
regeneration of the initial HF and the formation of an S-O bond which then rearranges with
loss of another fluorine atom to the carbon centre to yield the product and an amino sulfoxide
by product.

Scheme 5.5: The proposed mechanism for the preparation of 1,4-bis-difluoromethyl benzene.
5.2.3

Synthesis of 1,4-bis-chlorodifluoromethylbenzene

Only two methods are presented for the preparation of 1,4-bis-chlorodifluoromethylbenzene
6. The first is chlorination of 5 which can be achieved using either chlorine gas (Cl2) in
tetrachloromethane16 (CCl4) or sulfuryl chloride (SO2Cl2) and a radical initiator (Scheme 5.6).
The latter process is more suitable to carry out on laboratory scale due to the toxicity of

113

Preparation of Asymmetric Ligands Based on Octafluoro[2.2]paracyclophane

Chapter 5

chlorine gas and the difficulty in handling harmful gases. The second method is fluorination
of 1,4-bis-trichloromethylbenzene using anhydrous HF in DCM.6

Scheme 5.6: The synthesis of 1,4-bis-chlorodifluoromethyl benzene.
Initially CCl4 and benzene were selected as possible solvents for the reaction on the basis that
they have no alkyl hydrogen atoms which would compete with the desired transformation.
The radical initiator utililised was azobisisobutyronitrile (AIBN). Benzene was chosen as the
solvent on the basis of availability however the reaction was found to proceed poorly. Even at
extended periods heating at reflux (up to 9 days) and at higher catalyst loadings, no product
was formed by TLC. It was noted that AIBN was soluble in SO2Cl2 so the reaction was run
neat and it was found to proceed much more efficiently. After 5 days heating at reflux the
mixture was diluted with DCM and quenched with slow additions of ice water. The organic
layer was extracted and the solvent removed in vacuo. The resulting oil was purified by flash
column chromatography affording 5 in 20% yield along with the intermediate 1(chlorodifluoromethyl)-4-(difluoromethyl)benzene 7 in 34% yield.
AIBN is thermally decomposed to form two radicals with the elimination of nitrogen gas
(N2). This radical abstracts a chlorine atom from SO2Cl2 which in turn rearranges to form
sulfur dioxide (SO2) and a chlorine radical. This initiates the radical chain reaction. The
chlorine radical abstracts an alkyl hydrogen atom from the starting material generating
hydrogen chloride and a new radical species. This radical then follows the same pathway as
the initiation step which yields the product and regenerates the chlorine radical in the process.
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This process repeats until one of three termination steps occurs. The reaction ends in the
formation of Cl2, the desired product or a diarylfluoroethane type product (Scheme 5.7).

Scheme 5.7: The proposed mechanism for the formation of 1,4-bischlorodifluoromethylbenzene.
5.2.4

Synthesis of 1-(trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene

1-(Trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene 9 can be prepared from 1,4-bistrifluoromethylbenzene 8, and is known to be another precursor to 1 which may be
synthesised via two routes, both of which are defluorinative silylations. The first method is
photo promoted17 while the second utilises magnesium18 (Scheme 5.8). The second method
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was chosen due to a higher reported yield. In addition, the photochemical method is
hampered by formation of polymeric by-products.

Scheme 5.8: The synthesis of 1-(trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene.
The reaction was carried out under anhydrous conditions with the precursor 8 being added to
the mixture dropwise. The reaction is highly exothermic so the precursor was added over 30
minutes. Standard workup and flash column chromatography afforded the product in 32%
yield (48% reported18). The literature indicated that the product was contaminated with a
small amount of side product where an additional fluorine atom has been substituted with
hydrogen (protodesilylation). However none of this by-product was detected by 1H or19F
NMR.
The reaction is proposed to begin with a magnesium promoted defluorination shown in
Scheme 5.9. Normally this would be unlikely due to the strength of the C-F bond
(approximately 550KJ mol-1) but in this case the resulting benzylic anion is stabilised by its
resonance contributors. Nucleophilic attack of this anion on the silicon centre with the loss of
chloride then yields the product.
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Scheme 5.9: The proposed mechanism for the formation of 1-(Trimethylsilyl)difluoromethyl4-trifluoromethylbenzene.
5.2.5

Synthesis of octafluoro[2.2]paracyclophane

For details of the available synthetic routes to octafluoro[2,2]paracyclophane 1 see Section
4.2. The methods selected here were the fluoride catalysed 1,6 elimination reaction beginning
with 918 and the zinc catalysed coupling of 619 (Scheme 5.10).

Scheme 5.10: The synthesis of octafluoro[2,2]paracyclophane.
5.2.5.1

Zinc catalysed homo-coupling

In this procedure 6 was added to a dispersion of zinc in dry DMA. The reported conditions
detail maintaining the reaction at 100°C for 4 hours however in this case no product was
detected. Further modifications were attempted (Table 5.1) but even at reflux and reaction
times of 2 days no product was detected (Entry 1). On the advice of the authors of the
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procedure, it was indicated that the zinc or the zinc washing procedure may have been the
issue. Two different batches of zinc were used with various washing procedure and in each
case no product was isolated.
Table

5.1:

Reaction

conditions

for

the

zinc

catalysed

coupling

of

1,4-bis-

chlorodifluoromethylbenzene.

Entry

Time (h)

Temperature (°C)

Zinc purity

Zinc washing

Yield

1

4, 24, 48

100, reflux

>99

N/A

----

2

4, 24, 48

100, reflux

>99

2% HCl, H2O, EtOH, Et2O

----

3

4, 24, 48

100, reflux

>99

H2O, EtOH, Me2CO, Et2O

----

4

4, 24, 48

100, reflux

98

N/A

----

5

4, 24, 48

100, reflux

98

2% HCl, H2O, EtOH, Et2O

----

6

4, 24, 48

100, reflux

98

H2O, EtOH, Me2CO, Et2O

----

5.2.5.2

Fluoride catalysed 1,6 elimination

The fluoride catalysed method involved heating 9 at reflux in dry anisole in the presence of
catalytic amounts of fluoride from CsF and Pd2(dba)3. The product was isolated by flash
column chromatography in 18% yield (53% reported). It is proposed that the method suffers
from an unwanted protodesilylation reaction which attributes to the low yield (Scheme 5.11)
and this species 10 was observed by 19F NMR but was not isolated.
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Scheme 5.11: The protodesilylation of 1-(Trimethylsilyl)difluoromethyl-4trifluoromethylbenzene.
The mechanism proposed for this reaction begins with loss of the silicon moiety via the
addition of fluoride (Scheme 5.12). This process is thought to proceed due to the stable F-Si
bond. The resulting benzylic anion loses fluoride from the trifluoromethyl group at the 4
position. This generates the reactive p-xylylene, and homo-coupling yields the product. The
palladium is thought to facilitate this coupling but the exact role it plays in the mechanism is
not clear.

Scheme 5.12: The proposed mechanism for the synthesis of octafluoro[2,2]paracyclophane
via fluoride catalysed 1,6 elimination.
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1 was nitrated using a mixture of nitric acid (HNO3) and sulfuric acid (H2SO4) and the
product 11 was isolated in 26% yield (56% reported)20. Along with 11, the di-nitro product
12 was isolated in 19% yield as a mixture of 3 isomers, pseudo-ortho, pseudo-meta and
pseudo-para. 1 was also retrieved in 22% (Scheme 5.13). The mechanism of this reaction is
discussed in Section 3.2.4.

Scheme 5.13: The synthesis of 4-nitro-octafluoro[2.2]paracyclophane.
5.3.2

Synthesis of 4-amino-octafluoro[2.2]paracyclophane

4-Amino-octafluoro[2,2]paracyclophane 13 was produced by reduction of 11 using a mixture
of HCl and iron (Scheme 5.14)20. The product was isolated by filtration in a yield of 80%
(82% reported) and did not require any further purification. The mechanism of this reaction is
discussed in Section 3.2.5.

Scheme 5.14: The synthesis of 4-amino-octafluoro[2,2]paracyclophane.
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The amino analogue has been selected for discussion because of the clear resolution in the 1H
NMR spectrum (Figure 5.3). The amino protons H4 were assigned at 5.6 ppm based on the
broad peak, chemical shift and integration. The adjacent peak was assigned as H5 based on it
being a doublet with a small coupling constant attributed to long range coupling with H7.
Once H5 was assigned the COSY allowed ready identification of H7 and H8 (Figure 5.4).
The COSY allows assignment of the adjacent ring if one of the four protons is assigned first.
A single proton is shifted significantly downfield with respect to the others at 8.0 ppm and
this was assigned H13 due to its pseudo-geminal position which brings it closest spatially to
the electron withdrawing nitrogen atom. Knowing this the pseudo-ortho, pseudo-meta and
pseudo-para positions can be readily assigned from the COSY.

Figure 5.3: The assigned 1H NMR spectrum of 4-amino-octafluoro[2,2]paracyclophane.
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Figure 5.4: The assigned COSY spectrum of 4-amino-octafluoro[2,2]paracyclophane.
5.3.3

Preparation of oxazoline-octafluoro[2.2]paracyclophane derivatives

The amino derivative 13 was utilised along with the iodo phenyl-oxazoline 14 in the
Buchwald-Hartwig amination. The successful conditions outlined in Chapter 3 were used
(10% Pd and 20% ligand) however no product was detected. A second attempt was made
increasing the reaction time to 7 days and delivering two portions of ligand and catalyst, a
second quantity at 4 days reaction time. Even at these extended reaction times and loadings
still no product was detected.
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Scheme 5.15: The attempted synthesis of the diastereomers of N-(2-(4-isopropyl-4,5dihydrooxazol-2-yl)phenyl)-octafluoro[2.2]paracyclophane-4-amine.
5.4

Conclusions

The synthetic routes to 1 were investigated and it was prepared using a fluoride catalyst 1,6
elimination in 18% yield. The reported zinc catalysed method could not be reproduced even
after extensive attempts using various conditions. 1 was successfully derivativised to prepare
the monosubstituted nitro OPc 11 which was then reduced to give the amino OPc 13.
Attempts to couple 13 to an iodo phenyl-oxazoline 14 using the Buchwald-Hartwig amination
were not successful.
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Introduction

Chapter 6

A series of sol-gel formulations were applied as pre-treatments to aluminium panels in an
attempt to improve the adhesion of parylene N surface coatings. These pre-treatments were
characterised by IR and

29

Si NMR spectroscopy. The aluminium panels were subsequently

coated in parylene N and their adhesion promotion was evaluated using the cross hatch
measurement.
6.1.1

Parylene coatings

Parylene is a commonly used industrial term to describe a number of vapour deposited
poly(p-xylylene) polymers. Since their development in the late 1940’s1 these materials have
garnered attention as protective coatings due to their attractive physical and chemical
properties and are widely used by the electronic and medical device industries.2,3 The
conformal coating can be applied at ambient temperatures with tailored thickness, and
specific properties of the coating can be altered by adjusting the chemistry of the precursors
by the addition of various chemical substituents. The precursors used to produce these
coatings are [2.2]paracyclophanes and a variety have been reported (Scheme 6.1).

Scheme 6.1: Examples of different parylene coatings.
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The development by Gorham4 of a deposition process in 1966 ultimately led to the
widespread industrial use of these coatings. The precursors are pyrolysed at temperatures of
approximately 650 °C in a vacuum chamber resulting in the formation of the reactive pxylylene monomers which are deposited and begin chain growth polymerisation on the
substrate (Scheme 6.2). Typical chain lengths are of the order of 2000-4000 units. This is
considered to be a green process as no initiators or terminators are used and the process
produces no by-products. As a result, the coatings are free of contaminants and chemically
pure.

Scheme 6.2: The vapour deposition process for parylene coatings.
However, some substrates can prove more difficult than others to properly coat in parylene
due to the difference in surface adhesion of the coating. A practical example is shown in
Figure 6.1. This is a medical device wire composed of a nickel-chromium alloy. Thermal
treatment has caused the parylene coating to fail and very extensive delamination has
occurred. Only small amounts of the coating remain.
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Figure 6.1: SEM image of a wire coated in parylene C which has heavily delaminated.

A typical metal surface will have a number of free hydroxyl groups present. The
concentration of hydroxyl groups depends on how the metal has been treated, for example
plasma or acid treatment can increase this concentration. The mechanism by which parylene
polymerises is a radical reaction so there will be no chemical bonding occurring between the
metal surface (hydroxyl groups) and the growing polymer, resulting in poor adhesion. To
improve adhesion, adhesion promoters are used and the adhesion promoter of choice for
parylene coatings is 3-methacryloxypropyltrimethoxysilane (MAPTMS). This organosilane
contains two reactive sites, a methoxysilane group that can react with the metal surface and a
methacryloxy group that can be used in radical organic polymerisation. This dual
functionality makes MAPTMS an excellent candidate as an adhesion promoter for parylene
on metal surfaces, the principle of which is shown in Scheme 6.3.5 The standard industrial
approach for the pre-treatment of aluminium 2024 panels to be coated in parylene N is to add
MAPTMS directly into the chamber. This is done by placing an absorbent which has soaked
up MAPTMS in with the panels and when the chamber is placed under vacuum the
MAPTMS is dispersed.
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Scheme 6.3: Parylene adhesion promotion on metal substrates using MAPTMS.

6.1.2

Sol-gels and their use as pre-treatments

The sol-gel method is a frequently used way of applying surface coatings to a material. In this
process the sol (or solution) gradually moves towards the formation of a gel network which
contains both a liquid and solid phase. This process can be used for several applications such
as making coatings, ceramics, fibres, gels and powders as shown in Figure 6.2.

Figure 6.2: Different applications of the sol-gel process.6
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The process begins with the growth of discrete particles from a monomeric material by a
series of hydrolysis and condensation reactions as shown in Figure 6.3. This results in a
colloidal suspension which is an evenly dispersed phase (the particles) within a continuous
phase or dispersion medium (the solvent). These particles continue to grow and link together
to form a polymeric network and the sol may then be applied in conjunction with a curing
treatment to remove the solvent leaving a solid surface coating. The polymer will have a
complex randomly branched structure meaning the final solid coating will be a noncrystalline material.

Figure 6.3: General hydrolysis and condensation reactions of a silicon alkoxide that lead to
the formation of polymer networks from sol-gel precursors.7
The next aspect of the sol-gel process to consider is selecting the appropriate materials.
Invariably these materials are metal or metalloid atoms surrounded by ligands, some of which
must be labile to facilitate polymerisation. The most common compounds used in sol-gel
chemistry are metal alkoxides and metal chlorides particularly of silicon, aluminium, titanium
and zirconium.8 These are readily hydrolysed in water with the reaction being catalysed by
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the addition of acid or base. Specific compounds used depend on the desired application and
properties such as hardness, resistance to chemical erosion or hydrophobicity. To achieve
this, additives may be added to the sol-gel preparation or the monomers themselves can be
chemically modified.
6.2

Sol-gel pre-treatment formulation and coating preparation

To investigate the optimisation of surface adhesion using sol-gel coatings, a series of
formulations were prepared (Table 6.1). These formulations vary two parameters, the
concentration of MAPTMS and the acidity of the solution via the addition of nitric acid
(HNO3) solution.
Table 6.1: Sol-gel pre-treatment formulations.
Sample

MAPTMS (ml)

IPA (ml)

H2O (ml)

HNO3 (ml)

HNO3 (M)

S1

1.25

45

5.0

-

-

S2

2.50

45

5.0

-

-

S3

5.00

45

5.0

-

-

S4

10.00

45

5.0

-

-

S5

1.25

45

4.5

0.5

0.01

S6

2.50

45

4.5

0.5

0.01

S7

5.00

45

4.5

0.5

0.01

S8

10.00

45

4.5

0.5

0.01

S9

1.25

45

4.5

0.5

0.1

S10

2.50

45

4.5

0.5

0.1

S11

5.00

45

4.5

0.5

0.1

S12

10.00

45

4.5

0.5

0.1
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After stirring for 24 hours, the sol-gel formulations were applied to aluminium alloy 2024
panels by a spin coating deposition process. The spin coating process relies on centrifugal
force to coat the substrate and provides high quality uniform coatings. Using higher spin rates
thinner coatings are produced so this method allows control over the coating thickness. The
sol-gels were applied at a speed of 500 rpm for 40 seconds and cured for 1 hour at 100 °C.
Another set of samples were prepared using the same condition but a higher spin rate of 1000
rpm.
Aluminium 2024 has a composition which roughly includes 4.3-4.5% copper, 0.5-0.6%
manganese, 1.3-1.5% magnesium and less than 0.5% of silicon, zinc, nickel, chromium, lead
and bismuth. Immediately prior to spin coating, the panels were treated with the cleaning
process shown in Figure 6.4 to prepare the surface. This process removes any dirt or grease
and activates the surface by formation of reactive hydroxyl groups that will enable the
immobilisation of the hydrolysed and oligomeric MAPTMS species.

Figure 6.4: Cleaning process for coating aluminium alloy 2024-T3 panels.
The sol-gel coated panels were subsequently coated with a layer of parylene N via the vapour
deposition process outlined in Scheme 6.2.
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Si NMR spectroscopy

The 29Si NMR method allows the level of hydrolysis and condensation of silicon containing
species such as MAPTMS to be determined semi-quantitatively. Similar to the

13

C nuclei,

29

Si has a low isotopic abundance, approximately 4.7%. It also has a lower susceptibility to

the technique because of its gyromagnetic ratio which is approximately five times lower than
the hydrogen nuclei. The chemical shift of the silicon nuclei is dependent on the substituents
around it so the various different stages in the sol-gel polymerisation can be identified. The
chemical shifts of the 29Si nuclei, as they relate to hydrolysis and condensation are presented
in Table 6.2.9
Table 6.2: The relevant chemical shifts of the 29Si species in sol-gel formulations.9
Species

Notation

Chemical shift (ppm) ±0.1

RSi(OMe)3

T00

-42.3

RSi(OMe)2OH

T01

-41.4

RSiOMe(OH)2

T02

-40.6

RSi(OH)3

T03

-40.1

RSi(OMe)2-O-Si

T10

-49.9

RSi(OMe)OH-O-Si

T11

-50.5

RSi(OH)2-O-Si

T12

-49.3

RSi(OMe) – (O-Si)2

T20

-59.1

RSiOH-(O-Si)2

T21

-58.5

RSi(OSi)3

T3

-67.4
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The formulations tested using this technique were S4, S8 and S12 as these had the highest
concentration of MAPTMS and would provide the clearest spectra (Figure 6.5).The spectra
were taken 24 hours after preparation of the sol-gel solutions and the chemical shifts are
calibrated to the internal standard tetramethylsilane (TMS) at 0 ppm. S4 was prepared using
no HNO3 and the lack of an acidic environment should lead to little or no hydrolysis and no
condensation. This is what is observed in the

29

Si NMR spectrum with the single peak at -

42.2 ppm indicating only the T00 species. S8 in contrast, prepared with 0.01M HNO3, shows
no T00 but a dominant signal at -40.6 ppm indicating the hydrolysed species T02. This sample
also presents a signal at -49.7 ppm indicating the oligomeric T10 species. The signal at -43.4
ppm was not identified. The final sample S12, prepared with 0.1M HNO3, has its most
significant signal at -49.7 ppm, again indicative of the T10 species. The signal at -59.0 ppm
indicates the more heavily condensed T20 species and the T02 species appears again at -40.7
ppm. This data agrees with the expected trend in that an increase in acidity leads to more
advanced degrees of hydrolysis and then condensation.
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Figure 6.5: 29Si NMR spectra of sol-gel pre-treatment formulations.
6.3.2

Infrared spectroscopy

IR spectra were recorded for selected sol-gels as applied to the aluminium 2024 panels before
the parylene N coating was applied (Figure 6.6). An increase in absorption band intensities in
the 800-1100 cm-1 region is indicative of a thicker coating, as seen most prominently in S12.
This area represents the silicate network and contains several species such as various silanol
stretches (Si-OH, 950 cm-1) and the Si-O-Si stretches (1000-1100 cm-1). This is what is
expected as higher concentrations of acid lead to increased hydrolysis and condensation of
alkoxysilanes, resulting in more condensed, thicker coatings.
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Figure 6.6: IR spectra of applied sol-gel formulations before parylene N deposition.
6.3.3

Adhesion Testing

Adhesion testing is used in industry to determine if a coating will adhere efficiently to a given
substrate. The most common method for adhesion testing is the cross hatch measurement.
This measurement is taken by making 12 equally spaced cuts into the coating, down to the
substrate, in a crosshatch pattern. At this point any detached fragments of the coating are
removed with light brushing and a single piece of pressure sensitive tape is applied across the
incisions. The tape is removed in one rapid motion and can then be discarded. The adhesion
of the coating is then graded from 0B to 5B based on the level of delamination as shown in
Figure 6.7.10
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Figure 6.7: Cross hatch measurement scoring scale.10
As mentioned previously, the standard industrial approach for the pre-treatment of aluminium
2024 panels to be coated in parylene N is to add MAPTMS directly into the chamber. This is
done by placing an absorbent which has soaked up MAPTMS in with the panels and when
the chamber is placed under vacuum the MAPTMS is dispersed. This approach can give
coatings which score 3B using the cross hatch measurement. However there may be
significant batch variation based on the location the absorbent is placed in indicating that the
distribution of MAPTMS is not reliable.
The adhesion results of the pre-treatment formulations shown in Table 6.3 indicate that
thinner sol-gel pre-treatments are better adhesion promoters than their thicker counterparts. In
all cases the adhesion promoters applied at 1000 rpm, which result in thinner coating layers,
perform the same or better than their thicker counterparts deposited at 500 rpm. A general
trend is also observed in increasing the acid concentration. Samples S1-S4 perform better
than S5-S8 which in turn perform better than S9-S12. The concentration of MAPTMS in the
sol affects the adhesion in some cases such as S1-S4 at 500rpm and S9-S12 at 1000rpm.
However in S5-S8 at 500 rpm and S1-S4 at 1000 rpm it shows no apparent effect on the
adhesion, hence no clear conclusion can be drawn about the effect of varying the MAPTMS
concentration. In comparison to the standard industrial method every sample, with the
exception of S12 performed as well or better.
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Table 6.3: The cross hatch test results of the pre-treatment formulations used on aluminium
2024 panels coated with parylene N.

6.4

Sample

Classification (500 rpm)

Classification (1000 rpm)

S1

4B

5B

S2

5B

5B

S3

3B

5B

S4

3B

5B

S5

3B

5B

S6

3B

4B

S7

3B

5B

S8

3B

4B

S9

3B

4B

S10

3B

3B

S11

3B

3B

S12

1B

2B

Conclusion

A series of sol-gel formulations were prepared and applied to aluminium 2024 panels as pretreatments for the application of parylene N coatings. The formulations were designed to
yield successively more hydrolysed and condensed sol-gel systems and this was supported by
the 29Si NMR analysis. The pre-treatments also showed a successive increase in thickness and
this was shown by IR spectroscopy. The adhesion capability of the coatings was assessed by
the cross hatch measurement and the general trend showed that thinner sol-gels coatings were
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better pre-treatments than their thicker counterparts. Of the 24 samples prepared 22 showed
comparable or better adhesion performance in comparison to the industrial benchmark
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The preparation of a range of additives for sol-gel coatings was briefly investigated. The
additives are intended to be used in the production of hydrophobic sol-gel coatings. Two
distinct classes of materials were prepared for this purpose, fluorinated triethoxysilane
precursors and fluorinated mesoporous silicate particles. Following this there was also a brief
investigation into the addition of organic dyes to hybrid sol-gel formulations. These hybrid
sol-gels are prepared with a mixture of silicon and zirconium alkoxides. Molecular
interactions between these materials and a dye molecule can impact the physicochemical
properties of the dye and this was explored here.
7.2

Hydrophobic surfaces and fluorocarbons

Surface hydrophobicity is the property of a surface which makes it water repellent or difficult
to wet. This property has long been recognised as important in self-cleaning technologies and
was initially observed in nature, called the Lotus effect, in reference to the leaves of the Lotus
flower. When water comes into contact with the Lotus leaf surface it remains in a spherical
bead rather than spreading out evenly to wet the surface. This is a measurable property based
on the angle of the water bead to the surface, known as contact angle.1 A perfectly
hydrophobic surface will have a contact angle of 180°, so all surfaces will have contact angle
values between 180° and 0°. This phenomenon can be attributed to a combination of physical
and chemical properties of the surface. In the case of the Lotus leaf, the structure of Papillae,
which are protrusions from the leaf surface, create surface roughness which produces a
hydrophobic effect. This is because the material at the micrometre level is biphasic where it
makes contact with the water, consisting of air which has a contact angle of 180° and the
papillae. The contact angle on this surface can then be described using Cassie’s law which
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describes the effective contact angle of a liquid on a composite surface. A successful use of
this effect is the nanopin film.2 This material is covered with nanoscale cone structures
perpendicular to a borosilicate glass substrate and yields a contact angle of 178°, only 2°
below the maximum possible value for contact angle. Of greater interest here however, are
the chemical properties of surfaces, and again, in the case of the Lotus leaf, the surface is
covered in a waxy substance which is primarily long chain hydrocarbons. Such hydrocarbons
are non-polar molecules and will repel water, thus making it energetically favourable for the
water bead to stay in a spherical shape with the minimal surface contact.
Much work has been done in creating hydrophobic surfaces for different applications. As
such, many publications have reported fabrication methods such as vapour and particle
deposition, plasma treatments and sol-gel methods.3 A common motif in many reports is the
use of hydrophobic fluorocarbons, compounds composed primarily and sometimes
exclusively of carbon and fluorine. The C-F bond is so polar that it possesses a degree of
ionic character and the hold of fluorine on the electrons is so strong that they have a very
limited ability to form the transitory dipoles necessary for Van der Waals forces. In fact,
fluorine has the lowest polarisability of any element. It is this characteristic that accounts for
fluorocarbon’s hydrophobicity.4 A water droplet on a coating surface will adopt the most
favourable energetic arrangement and it is desirable to maintain the maximum amount of
hydrogen bonding and limit the free or hydroxyl groups, keeping the droplet intact. Van der
Waals forces can destabilise this network and interact with the water leading to surface
wetting. Fluorocarbons, both alkyl and aryl, are also very stable compounds due to the
strength of the C-F bond which may be above 500 KJ mol-1.5 This is due to the partial ionic
character of the bond which shortens the bond length and provides favourable coulombic
interactions. Additionally, having geminal C-F bonds adds further stability by increasing the
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carbon’s partial charge and multiple C-F bonds can increase the strength of the molecules
carbon backbone via the inductive effect.
7.3

Preparation of fluorinated sol-gel additives

7.3.1

Synthesis of fluorinated triethoxysilanes

Silylation is a broad term used in organic synthesis to describe the addition of a silicon
containing group to a molecule, usually a substituted silyl group. This type of reaction is most
commonly utilised in protecting group chemistry however it also provides the most
straightforward route to the preparation of sol-gel precursors in the form of alkoxysilanes.6
The aryl silylation shown in Scheme 7.1 was carried out to prepare several derivatives with
varying levels of fluorination. The products were isolated in yields up to 34% via vacuum
distillation and the mono and trifluoro derivatives have not been previously reported. This
purification method was chosen because alkoxy silanes are not generally amenable to
chromatography as they may irreversibly bind to silica.

Scheme 7.1: The synthesis of fluorophenyl triethoxysilanes.
In the case of the perfluoro derivative 1, it was isolated as a mixture with the by-product 2
(Scheme 7.2). Attempts to separate these two compounds were not successful.
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Scheme 7.2: The synthesis of perfluorophenyl triethoxysilane and a disubstituted by-product.
The other approach to aryl silylation is the use of transition metal catalysts, mainly palladium
and rhodium. This has been demonstrated in several reports via the coupling of
triethoxysilane and various aryl halides.7–9 It has been shown to be an effective method with
both activating and deactivating substituents including some fluorinated analogues.10,11
However, no trifluoro or pentafluoro analogues have been synthesised by this method.
7.3.2

Synthesis of fluorinated mesoporous silicates

Mesoporous silicates (MPS) are silica particles that contain pores or cavities. They have a
variety of applications such as catalysis, sensors and molecular filters.12–15 They are prepared
by using a template which the precursor molecules, in this case tetraethyl orthosilicate
(TEOS), condense around (Figure 7.1). The template used here is the surfactant
cetyltrimethylammonium bromide (CTAB), which forms micelles in solution. Once the MPS
have been formed the template is removed and this may be done thermally or chemically.
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Figure 7.1: General preparation process for mesoporous silicates.
In the procedure developed here the MPS are functionalised as they form by the addition of a
fluorinating agent to the reaction mixture. The fluorinating agent used is 1H,1H,2H,2Hperfluorooctyl triethoxysilane 3 (PFOTS) and this is incorporated into the silicate network
(Scheme 7.3). Microwave heating is utilised which rapidly forms the MPS. The solvent is
evaporated and the resulting solid is dried. This solid is then heated at reflux in a mixture of
methanol and HCl to yield the final fluorinated MPS. This is the chemical method of
removing the template. As mentioned previously, the template can also be removed
thermally, by placing the particles in a furnace and heating to approximately 500 °C for
several hours. This option is unsuitable here because it would also remove the fluorocarbon
chains.
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Scheme 7.3: The synthesis of fluorinated mesoporous silicates.
Fluorinated MPS were prepared in quantities up to 50 g. The particles themselves are
relatively uniform in size usually ranging from 400-500 nm as shown in scanning electron
microscope (SEM) images (Figure 7.2).

Figure 7.2: SEM images of fluorinated mesoporous silicates.
Using energy-dispersive X-ray spectroscopy (EDX), an elemental map of the surface can be
acquired. This has been used qualitatively in this case to confirm the presence of fluorine.
The maps also show silicon and oxygen which are the component atoms of the silicate
(Figure 7.3).
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Figure 7.3: Elemental mapping of fluorinated mesoporous silicates using EDX.
7.4

Dye doped hybrid sol-gels

Hybrid sol-gels are prepared from a mixture of silicon and transition metal alkoxide
precursors. Here, hybrid sol-gel materials were prepared from MAPTMS and zirconium (IV)
propoxide (ZPO) along with the incorporation of an organic dye. The dye selected was trypan
blue (TB) and this is commonly used as a biological stain. It is a heavily conjugated azo dye,
and as the name suggests, it has a strong blue colour (Figure 7.4). The prepared hybrid solgels and coatings prepared from them were examined by transmission electron microscopy
(TEM), IR and UV-Vis spectroscopy.

Figure 7.4: The structure of trypan blue dye.
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Coating preparation and formulation

The formulations described in Table 7.1 were used to prepare stable, homogenous hybrid solgels. These formulations differ only in the concentration of methacrylic acid (MAAH). This
material behaves as a bi-dentate ligand and complexes the zirconium centre. This chelation
affects the subsequent hydrolysis and condensation reactions that occur in the sol-gel and
results in significant morphological changes in the final materials. This effect will be
discussed in detail in the following sections.
Table 7.1: Hybrid sol-gel formulations[a].
Formulation

MAPTMS

ZPO[b]

Dye[c]

H2O

0.1M HNO3

MAAH

A

15.00/60

7.07/15

0.15/0.15

1.26/70

0.80/0.08

1.31/15

B

15.00/60

7.07/15

0.15/0.15

1.26/70

0.80/0.08

0.33/4

C

15.00/60

7.07/15

0.15/0.15

1.26/70

0.80/0.08

----

[a] All values are given in the format grams/millimoles (g/mmol). [b] Provided as a 70% wt.
in propanol. [c]1 mol% with respect to zirconium.
The procedure for preparing these hybrid sol-gels is illustrated in Figure 7.5. In one vessel the
ZPO, dye and the MAAH are mixed for 45 minutes. This allows chelation of the zirconium
centre to occur. Concurrently the MAPTMS and HNO3 are mixed in a separate vessel. This is
referred to as pre-hydrolysis and converts the MAPTMS ethoxy groups to hydroxyl groups.
The pre-hydrolysed solution is then slowly added to the chelated solution. After 3 minutes
water is added and an exothermic reaction is observed. After 24 hours stirring the hybrid solgels are ready to be coated onto an appropriate substrate. In this case they were applied to
glass and aluminium substrates by a spin coating process at a rate of 1000 rpm for 40
seconds. The samples were then cured at varying temperatures.
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Figure 7.5: Procedure for the preparation of dye doped hybrid sol-gels.
7.4.2

Structural characterisation of hybrid sol-gels

7.4.2.1

Transmission electron microscopy

Figure 7.6 shows TEM images of the three formulations. A progressive increase in the
particle size is observed as the degree of chelation of the zirconium atom is decreased. For A,
most of the particles are in the nanometre scale (<10 nm). The TEM image of B indicates that
it is relatively homogeneous and dense with a particle size varying from 10 to 200 nm.
However, the particle size of C is in the micron range with an apparent gradual decrease in
the density from the centre to the surface, as observed by the change in the contrast of the
image of the particle. These observations suggest that the formulation of these 3 materials has
a direct impact on the reactivity of the hybrid systems to hydrolysis and condensation
reactions, as well as on the subsequent structure and morphology of the formed particles. This
has been identified in previous studies in catalysing the formation of siloxane bonds and
participating to the formation of the inorganic backbone of the material.16–18
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Figure 7.6: TEM images of hybrid sol-gel formulations A, B and C respectively (Provided by
M. Oubaha).
The only variable here is the concentration of MAAH and hence, the degree of chelation of
the zirconium centre. In A the ligand is added in a stoichiometric amount with respect to
zirconium so only 50% of propoxide groups can undergo hydrolysis and condensation. In B it
is 75% of propoxide groups and in C all propoxide groups are available. So it can be
definitively stated that the availability of the zirconium centre to participate in condensation
reactions significantly impacts the structure of the hybrid sol-gels.
7.4.2.2

Infrared spectroscopy

IR spectroscopy may provide information about the nature of the chemical bonding in the
surface coatings prepared from the formulations. Figure 7.7 shows the spectra of the
formulations applied to aluminium substrates. The absorption bands have been identified
based on the results presented in other studies.19–21 The broad band located at 800–1100 cm-1
is characteristic of the silicate network resulting here mainly from the superimposition of the
Si-OH vibration (950 cm-1), Si-O-Si and Si-O-Zr vibrations (1000–1100 cm-1). The Zr-OH
and Zr-O-C bonds composing the zirconium complex are located in the region 1300–1650
cm-1. The bands located at 1730, 2800–3000 and 3200–3600 cm-1 are due to the C=O
(stretching), C-H (stretching) and residual Si-OH and Zr-OH groups (stretching),
respectively. The intensities of the chemical vibrations due to the zirconium complex located
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at 1300–1650 cm-1 are clearly seen to decrease along with the MAAH concentration. There is
a corresponding increase in intensity at approximately 1100 cm-1, again corresponding to SiO-Zr vibrations.

Figure 7.7: IR spectra of the formulations coated on an aluminium substrate and cured at
100 °C.
7.4.3

Photophysical changes of trypan blue

The UV–Vis absorption spectrum of TB dispersed in isopropanol is shown in Figure 7.8. The
dye exhibits one large band composed of two superimposed bands located in the 400–600 nm
region and a large absorption extending from around 300-350 nm. TB is a symmetrical
molecule that contains unsaturated and conjugated C=C and N=N bonds, in addition to
amino, hydroxyl and sulfonyl groups. The absorption domain above 400 nm can be attributed
to the n→π* electronic transitions of the amino, hydroxyl and sulfonyl groups. The absorption
domain below 400 nm can be attributed to the π→π* electronic transitions of the unsaturated
C=C and N=N bonds.
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Figure 7.8: The UV-vis absorption spectrum of trypan blue dispersed in isopropanol.
When incorporated into the 3 formulations, the λmax of the dye absorption is red shifted in all
cases. The initial λmax of 610 nm is found to be 624, 620 and 617 in formulations A, B and C
respectively (Figure 7.9). The smaller particles in the most heavily condensed networks (A)
provide the greatest red shift and this decreased along with the chelation in B and C.
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Figure 7.9: UV-vis absorption spectra of the formulations coated on glass substrates cured at
100 °C.
What is also observed is a progressive decrease in the absorption intensity with the decrease
in particle size (or the increase in chelation) so that absorption for A is lower than B which is
lower than C. This trend follows the particle size (or the increase in chelation) so suggests
that the more heavily condensed networks do not interact with the dye molecules to as great
an extent. A possible coordination of the dye is shown in Figure 7.10. This would explain the
decrease in the n→π* electronic transitions. It is suggested that this process is happening
almost completely in formulation A hence the weak absorption in that spectral region.

Figure 7.10: The proposed binding of dye molecules and the zirconium network.
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When formulation C is applied to the substrate and cured at different temperatures it affects
both the λmax and absorption intensity of the dye (Figure 7.11). When the curing temperature
is increased from 100 °C to 120 °C the λmax is blue shifted from 617 to 613 nm. On increasing
the curing temperature to 150 °C the λmax is further blue shifted to 588 nm. This curing
temperature also shows a significant increase in absorption in π→π* region of 300-400 nm.
Each successive increase in curing temperature gives reduced absorption in the n→π* region
indicating more coordination of the dye and the zirconium centre. Presently no explanation is
offered for the blue shifting of the λmax between samples.

Figure 7.11: UV-vis absorption spectra of formulation C coated on glass substrates at three
different curing temperatures.
7.5

Conclusion

A range of fluorinated aryl triethoxysilanes were prepared in yields up to 34% for application
in hydrophobic surface coatings. Fluorinated MPS were also prepared for the same
application and these were evaluated to show that they had been successfully fluorinated.
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Finally, the addition of a dye in hybrid silicon-zirconium sol-gels was investigated.
Manipulation of the coating morphology was demonstrated by using varying concentrations
of chelating ligand. This morphology subsequently altered the physicochemical properties of
the dye, both the UV-vis absorption intensity and λmax values.

155

Sol-gel Coating Additives
7.6

Chapter 7

References

(1)

Mittal, K. L. Contact Angle, Wettability and Adhesion; BRILL: Leiden, 2007.

(2)

Hosono, E.; Fujihara, S.; Honma, I.; Zhou, H. J. Am. Chem. Soc. 2005, 127, 13458.

(3)

Latthe, S. S.; Gurav, A. B.; Maruti, C. S.; Vhatkar, R. S. J. Surf. Eng. Mater. Adv.
Technol. 2012, 2, 76.

(4)

Lemal, D. M. J. Org. Chem. 2004, 69, 1.

(5)

http://butane.chem.uiuc.edu/cyerkes/Chem104ACSpring2009/Genchemref/
bondenergies.html (accessed Jun 23, 2016).

(6)

Lebeau, B.; Marichal, C.; Mirjol, A.; Soler-Illia, G.; Buestrich, R.; Popall, M.;
Mazerolles, L.; Sanchez, C. New J. Chem. 2003, 27, 166.

(7)

Murata, M.; Suzuki, K.; Watanabe, S.; Masuda, Y. J. Org. Chem. 1997, 62, 8569.

(8)

Manoso, a. S.; DeShong, P. J. Org. Chem. 2001, 66, 7449.

(9)

Maegawa, Y.; Nagano, T.; Yabuno, T.; Nakagawa, H.; Shimada, T. Tetrahedron 2007,
63, 11467.

(10)

Murata, M.; Ishikura, M.; Nagata, M.; Watanabe, S.; Masuda, Y. Org. Lett. 2002, 4,
1843.

(11)

Murata, M.; Yamasaki, H.; Ueta, T.; Nagata, M.; Ishikura, M.; Watanabe, S.; Masuda,
Y. Tetrahedron 2007, 63, 4087.

(12)

Alothman, Z. Materials (Basel). 2012, 5, 2874.

(13)

Melde, B. J.; Johnson, B. J. Anal. Bioanal. Chem. 2010, 398, 1565.

156

Sol-gel Coating Additives

Chapter 7

(14)

SLowing, I.; Vivero-Escoto, J.; Wu, C.; Lin, V. Adv. Drug Deliv. Rev. 2008, 60, 1278.

(15)

Trewyn, B.; Slowing, I.; Giri, S.; Chen, H.; Lin, V. Acc. Chem. Res. 2007, 40, 846.

(16)

Oubaha, M.; Smaı̈ hi, M.; Etienne, P.; Coudray, P.; Moreau, Y. J. Non. Cryst. Solids
2003, 318 (3), 305.

(17)

Oubaha, M.; Dubois, M.; Murphy, B.; Etienne, P. J. Sol-Gel Sci. Technol. 2006, 38,
111.

(18)

Oubaha, M.; Kavanagh, A.; Gorin, A.; Bickauskaite, G.; Byrne, R.; Farsari, M.;
Winfield, R.; Diamond, D.; McDonagh, C.; Copperwhite, R. J. Mater. Chem. 2012,
22, 10552.

(19)

Elvira, M. R.; Mazo, M. A.; Tamayo, A.; Rubio, F.; Rubio, J. J. Chem. Chem. Eng.
2013, 7, 120.

(20)

Pickup, D. M.; Mountjoy, G.; Wallidge, G. W.; Newport, J.; Smith, M. E. Phys. Chem.
Chem. Phys. 1999, 1, 2527.

(21)

Varma, P. C. R.; Colreavy, J.; Cassidy, J.; Oubaha, M.; Duffy, B.; McDonagh, C.
Prog. Org. Coatings 2009, 66, 406.

157

Conclusions and Future Work
8.0

Chapter 8

Conclusions and Future Work

This chapter summarises the outcomes of this thesis and details suggestions for future work
and further development of certain aspects of the work.
8.1

Preparation of asymmetric ligands based on [2.2]paracyclophane

The aim of the work with regard to [2.2]paracyclophane (Pc) was to prepare novel
asymmetric ligands based on the Pc framework. To begin, the Pc framework was
functionalised and 5 monosubstituted analogues were successfully prepared. Subsequent
functionalisation garnered 4 disubstituted derivatives, two of which have not been previously
reported. Attempts were made at the resolution of two selected monosubstituted derivatives,
namely the amino and bromo analogues. The amino derivative was resolved but the yields
were not satisfactory at 5%. The bromo derivative was successfully resolved using a novel
procedure and proceeded in a moderate yield of 35%. A range of 7 phenyl-oxazoline
compounds were prepared via the Witte-Seeliger reaction, two of which have not been
previously reported. A selection of these analogues were coupled to the Pc framework via the
palladium

catalysed

Buchwald-Hartwig

amination.

Column

chromatography

and

recrystallisation allowed a one-pot synthesis and resolution procedure which garnered two
novel enantiopure ligands. These compounds were characterised and X-Ray crystallography
allowed determination of the absolute configuration of one of the ligands. The yields however
were not satisfactory at <10% so alternative synthetic routes were investigated. This did not
prove successful in the preparation of the desired ligands but did afford another previously
unreported Pc analogue.
Further work should first be aimed at increasing the yields of the final Buchwald-Hartwig
coupling. It is suggested that microwave heating, as shown in Scheme 8.1, may provide
improved yields along with shorter reaction times. Toluene is not an ideal solvent for
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microwave assisted reactions because of its low susceptibility to microwave heating. The
structurally similar trifluoromethylbenzene (or benzotrifluoride, BTF) is more efficiently
heated by this method and has been shown to provide increased yields, as well as
significantly shorter reaction times, in comparison to thermal heating using toluene.1,2
Increased yields when using microwave heating has been demonstrated previously in the
Buchwald-Hartwig coupling of phenyl-oxazolines.3 If successful this may then be extended
to other analogues.

Scheme 8.1: Proposed microwave assisted route for the optimisation of ligand synthesis.
Another approach would be the use of thiophene-oxazoline compounds for coupling. Such
derivatives have been prepared previously and may be more amenable for coupling to the Pc
framework to prepare asymmetric Pc ligands.4 The routes presented in Scheme 8.2 may
afford these ligands.
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Scheme 8.2: Proposed synthetic routes for the preparation of thiophene-oxazoline
[2.2]paracyclophane ligands.
Once a suitable procedure for the preparation of these ligands is established the next course
of action is to model their ability to bind metals. The best way to model this would be to
isolate the ligand-metal complexes and obtain their crystal structures for study. The suggested
metals for this are palladium and zinc. These metals are used in reactions of interest such as
the asymmetric addition of diethyl zinc to aldehydes and asymmetric allylic alkylations.
8.2

Preparation

of

asymmetric

ligands

based

on

octafluoro[2.2]paracyclophane
Two

synthetic

routes

were

investigated

towards

the

preparation

of

octafluoro[2.2]paracyclophane (OPc). The first route was a two-step synthesis beginning with
a silylation followed by a fluoride catalysed 1,6 elimination. This final step allowed isolation
of OPc in 18%. The other synthetic route consisted of three steps beginning with the
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preparation of germinal difluoride from an aldehyde and a subsequent radical chlorination.
The final step was a zinc catalysed homo-coupling which was reported to garner OPc in
yields up to 60%. However, this procedure could not be reproduced here. Different batches of
zinc and several washing procedures for the catalyst were utilised with no success. A recent
patent reports this reaction but with an additional additive included. A large range of
additives were tested and KI proved the most efficacious garnering OPc in 46%.5 This
method may be useful for a higher yielding synthesis of OPc.
The OPc prepared was subsequently nitrated and reduced to the corresponding amine. This
material was utilised in the Buchwald-Hartwig amination along with an iodo phenyloxazoline, however none of the desired product was detected. It is proposed that if a system
for the preparation of the hydrocarbon Pc analogues is optimised that this be extended to the
OPc framework.
8.3

Parylene coating pre-treatment and adhesion promotion

A series of sol-gel formulations were prepared and used as pre-treatments for aluminium
substrates. The sol-gel formulations were characterised by 29Si NMR to show the difference
in the extent of hydrolysis and condensation which had occurred. IR spectroscopy was carried
out on the pre-treated aluminium substrates and a progressive increase in coating thickness
was shown. These substrates were subsequently coated in parylene N and the adhesion of the
parylene was assessed using the cross hatch measurement. In all formulations, with the
exception of one, the parylene coatings showed better adhesion than the industrial
benchmark. Generally it was found that thinner sol-gel coatings were better pre-treatments
than their thicker counterparts. This pre-treatment method should also allow better
reproducibility over a large number of samples. Future investigations in this area should be
aimed at optimising adhesion on other substrates. Parylene coatings have a wide variety of
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applications so effective pre-treatments for different substrates would be industrially
valuable.
8.4

Sol-gel coating additives

Two classes of fluorinated additives were prepared, intended to be used in the preparation of
hydrophobic sol-gel coatings. These were three fluorinated aryl triethoxysilanes, two of
which have not been previously reported, and fluorinated mesoporous silicate particles. The
fluorinated silanes were prepared via a modified Grignard reaction and isolated by vacuum
distillation. The fluorinated particles were prepared using a modified microwave assisted
Stöber process. The particles were characterised with SEM imaging and EDX spectroscopy.
The incorporation of the dye trypan blue into hybrid sol-gel formulations, prepared from
silicon and zirconium precursors, was also briefly investigated. It was shown that the addition
of varying amounts of a chelate could alter the size of particles formed in the sol-gel. These
varied from 10 nm to 1 micron in size as shown in TEM imaging. The organic dye
demonstrated molecular interactions with the zirconium centre and these interactions were
shown to be affected by the particle size. Changes in the UV-Vis absorption spectra in both
the absorption intensity and λmax values were found across the formulations. It is proposed
that smaller particle sizes result in more efficient interaction of the dye species with the
zirconium centre. It was found curing temperatures also impacted the UV-Vis absorption of
the dye, and that higher curing temperatures led to a decrease in absorption. Again, this
implies more efficient interaction of the dye and the zirconium centre. Future work could
examine the use of different metals such as titanium and tantalum and also different organic
dyes. Coloured sol-gel coatings are industrially desirable for simple aesthetics however
coatings with tuneable optical properties may have applications.
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Experimental

9.1

General experimental

1

H NMR (400 MHz), 19F NMR (376 MHz), 13C NMR (100 MHz) and 29Si NMR (79 MHz)

spectra were recorded on a Bruker Avance 400 MHz spectrometer at room temperature in
deuterated solvents using tetramethylsilane as an internal standard. Chemical shifts (δ) are
given in parts per million and coupling constants are given as absolute values in Hertz.
Infrared spectra were recorded on a Perkin Elmer Spotlight 400N FT-IR. UV-vis spectra were
recorded on a Perkin Elmer Lambda 900 UV/VIS/NIR spectrometer. UV-vis spectra were
collected both in the solution phase using plastic cuvettes and in solid phase as coatings on
glass slides (coating procedure described in section 7.4.1). Mass spectra were collected using
a Maldi-Q-TOF premier mass spectrometer. SEM images were obtained on a Hitachi SU-70
field emission scanning electron microscope. X-ray crystal structures were taken using a
Rigaku Saturn-724 instrument. Melting points were determined in open capillary tubes in a
Stuart melting point apparatus and are uncorrected. Thin layer chromatography (TLC) was
carried out on aluminium sheets pre-coated with silica gel 60 F254 (Sigma). Column
chromatography separations were performed using Davisil LC60A (0.035-0.070 mm). All
reagents and solvents were purchased from Sigma-Aldrich and Apollo Scientific and used as
received unless otherwise stated. Oxygen free argon was obtained from BOC gases and was
used as received.
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9.2

Monosubstituted [2.2]paracyclophanes

9.2.1

(rac)-4-Bromo[2.2]paracyclophane

A solution of [2.2]paracyclophane (5.00 g, 24 mmol) and iron powder (0.34 g, 6 mmol) in
DCM (250 ml) was stirred for one hour at room temperature. To this was added bromine
(3.84 g, 24 mmol) and the mixture was heated at reflux for 20 hours. The organic phase was
washed with 10% Na2S2O3 (2 x 100 ml), water (100 ml), dried over MgSO4 and the solvent
removed in vacuo to yield the title compound as a white solid (6.61 g, 96%); mp = 134-136
°C; Rf = 0.55 (8:2 Cy/DCM); 1H NMR (400 MHz, CDCl3): δ = 7.16 (dd, J = 8, 1.6, 1H),
6.44-6.57 (m, 6H), 3.45 (ddd, J = 15.6, 10, 2, 1H), 2.78-3.23 (m, 7H); 13C NMR (100 MHz):
δ = 141.6, 139.6, 139.3, 139.1, 137.3, 135.1, 133.3, 132.9, 132.3, 131.5, 128.7, 127.0, 35.7,
35.5, 34.8, 33.5; IR: 2923, 1586, 1493, 1391, 1035 cm-1 (See Section 3.2.1 and Appendix 13).
9.2.2

(rac)-4-Formyl[2.2]paracyclophane

A solution of [2.2]paracylophane (4.52 g, 22 mmol) in DCM (200 ml) was cooled to 0 °C. To
the solution was added TiCl4 (8.30 g, 44 mmol) followed by dichloromethoxymethane (2.54
g, 22 mmol). The mixture was warmed to room temperature and stirred for 20 hours. Water
(100 ml) was added to the mixture and stirring was continued for 3 hours. The phases were
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then separated and the aqueous phase was washed with DCM (100 ml). The combined
organic phases were dried over MgSO4 and the solvent removed in vacuo. The title
compound was isolated by flash column chromatography as a white solid (3.28 g, 63%);
decomp. = 142-144 °C (151-152 °C)1; Rf = 0.57 (9:1 Cy/EtOAc); 1H NMR (400 MHz,
CDCl3): δ = 9.94 (s, 1H), 7.01 (d, J = 2, 1H), 6.73 (dd, J = 8, 2, 1H), 6.59 (d, J = 8, 1H), 6.56
(dd, J = 8, 2, 1H), 6.50 (dd, J = 8, 2, 1H) 6.43 (dd, J = 8, 2, 1H), 6.37 (dd, J = 8, 2, 1H), 4.074.13 (m, 1H), 2.91-3.30 (m, 7H); 13C NMR (100 MHz): δ = 192.0, 143.3, 140.7, 139.5, 139.4,
138.1, 136.6, 136.4, 136.1, 133.3, 132.9, 132.4, 132.2, 35.3, 35.2, 35.0, 33.7; IR: 2925, 2855,
1676, 1589, 1226, 1143 cm-1 (See Section 3.2.2 and Appendix 4-6).
9.2.3

(rac)-4-Hydroxy[2.2]paracyclophane

To a solution of 4-formyl[2.2]paracyclophane (1.00 g, 4.2 mmol) in MeOH/DCM (40 ml)
was added conc. H2SO4 (0.10 g, 1 mmol) and 30% H2O2 (0.67 g, 6 mmol). This mixture was
stirred at room temperature for 20 hours. The solvent was evaporated and the residue
dissolved in DCM (50 ml) and washed with water (50 ml). The aqueous phase was washed
again with DCM (50 ml) and the combined organic phases were dried over MgSO4. The
solvent was removed in vacuo and the title compound was isolated by flash column
chromatography as an orange solid (0.52 g, 55%); decomp. = 224-227 °C (lit. 229-232 °C)2;
Rf = 0.37 (9:1 Cy/EtOAc); 1H NMR (400 MHz, CDCl3): δ = 7.00 (dd, J = 8, 2, 1H), 6.55 (dd,
J = 8, 2, 1H), 6.44 (dd, J = 8, 2, 1H), 6.37-6.40 (m, 2H), 6.25 (dd, J = 8, 2, 1H), 5.54 (d, J =
2, 1H), 4.42 (s, 1H), 3.29-3.36 (m, 1H), 2.86-3.11 (m, 6H), 2.61-2.69 (m, 1H); 13C NMR (100
MHz): δ = 153.7, 142.0, 139.6, 138.8, 135.5, 133.6, 132.8, 131.9, 127.9, 125.4, 125.0, 122.6,
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35.3, 34.8, 33.8, 31.1; IR: 3416, 2921, 2849, 1566, 1493, 1416, 1087 cm-1 (See Section 3.2.3
and Appendix 7-9).
9.2.4

(rac)-4-Nitro[2.2]paracyclophane

A mixture of [2.2]paracyclophane (20.00 g, 96 mmol) in AcOH (300 ml) was heated to 90
°C. The solution was allowed to cool to 70 °C and fuming HNO3 (30 ml, 720 mmol) was
carefully added in one portion. The mixture was stirred for approximately 45 seconds and
immediately poured onto ice. The aqueous phase was extracted with DCM (3 x 150 ml). The
combined organic phases were washed with 1M NaOH (3 x 250 ml), dried over MgSO4 and
the solvent was removed in vacuo and the title compound was isolated by flash column
chromatography as a pale yellow solid (6.56 g, 27 %); mp = 154-155 °C (156-157 °C)3; Rf =
0.30 (7:3 Cy/DCM); 1H NMR (400 MHz, CDCl3): δ = 7.22 (s, 1H), 6.79 (d, J = 8, 1H), 6.546.63 (m, 4H), 6.48 (d, J = 8, 1H), 4.00-4.06 (m, 1H), 3.03-3.25 (m, 6H), 2.85-2.94 (m, 1H);
13

C NMR (100 MHz): δ = 142.1, 139.8, 139.3, 137.8, 137.4, 136.5, 133.2, 133.1, 132.4,

130.0, 129.6, 36.0, 35.0, 34.8, 34.5; IR: 2923, 1735, 1513, 1331 cm-1 (See Section 3.2.4 and
Appendix 10-12).
9.2.5

(rac)-4-Amino[2.2]paracyclophane
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A solution of 4-nitro[2.2]paracylophane (3.00 g, 11.8 mmol) in H2O/EtOH (150 ml) was
stirred for 30 minutes followed by the addition of iron powder (1.80 g, 32 mmol). The
mixture was heated to reflux and conc. HCl (20 ml) was added over 5 minutes. The
temperature was maintained for 1 hour after which time the mixture was poured onto ice and
1M NaOH (300 ml). The mixture was extracted with DCM (3 x 40 ml), dried over MgSO4
and the solvent removed in vacuo to yield the title compound as a yellow solid (2.19 g, 83%);
decomp. = 227-230 °C (lit. 239-242 °C)3; Rf = 0.43 (8:2 Cy/EtOAc); 1H NMR (400 MHz,
CDCl3): δ = 7.16 (dd, J = 8, 2, 1H), 6.58 (dd, J = 8, 2, 1H), 6.38 (dd, J = 8, 2, 2H), 6.26 (d, J
= 8, 1H), 6.12 (dd, J = 8, 2, 1H), 5.39 (d, J = 2, 1H), 3.57 (s, 2H), 2.91-3.16 (m, 6H), 2.782.86 (m, 1H), 2.60-2.71 (m, 1H); 13C NMR (100 MHz): δ = 144.8, 141.1, 139.0, 138.9, 135.3,
133.5, 132.4, 131.5, 126.8, 124.6, 123.0, 122.3, 35.4, 35.0, 33.0, 32.3; IR: 3463, 3382, 2920,
2849, 1735, 1611, 1498, 1425 cm-1 (See Section 3.2.5 and Appendix 13-15).
9.2.6

(RP)-4-Amino[2.2]paracyclophane

To a stirred solution of 4-amino[2.2]paracyclophane (2.50 g, 11.2 mmol) in EtOAc (80 ml)
was added (1S)-(+)-10-camphorsulfonic acid (2.50 g, 11 mmol), and the mixture was kept at
0 °C for 4 days. After filtration, the resulting solid was poured into fresh ethyl acetate (35 ml)
and stirred for 3 days at room temperature. The last treatment was then repeated. The salt was
filtered and treated with 0.1 M NaOH to give (RP)-4-amino[2.2]paracyclophane (0.12 g, 5%).
NMR data was in agreement with that collected for the racemate (See Section 3.4.1 and
Appendix 22).
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4-(4-Tolylsulfinyl)-[2.2]paracyclophane

n-BuLi (2.5 M in hexanes, 13.3 ml, 33.25 mmol) was added dropwise to a solution of 4bromo[2.2]paracyclophane (9.08 g, 31.6 mmol) in dry THF (175 ml) at -78 °C under argon.
The resulting solution was stirred for 2 hours and then a solution of (1R,2S,5R)-(-)menthyl(S)-p-toluenesulfinate (9.80 g) in dry THF (175 ml) was added, maintaining a
temperature of -78 °C. The solution was slowly warmed to room temperature over 24 hours.
Saturated NH4Cl (150 ml) was added to the solution and the organic phase was extracted. The
aqueous phase was further extracted with Et2O (3 x 150 ml) and the combined organic phases
dried over Mg2SO4. The solvent was removed in vacuo and the resulting residue purified by
flash column chromatography (19:1 petrol/EtOAc) to give the title compounds (See Section
3.4.2).
(SPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane: white solid (3.00 g, 26%); mp = 153-158 °C
(lit. 148-150 °C)1; Rf 0.20 (9:1 petrol/EtOAc); 1H NMR (400 MHz, CDCl3): δ = 7.36 (d, J =
8, 2H), 7.15 (d, J = 8, 2H), 7.11 (d, J = 2, 1H), 6.96 (d, J = 7.6, 1H), 6.59-6.62 (m, 2H), 6.516.52 (m, 2H), 6.43 (d, J = 8, 1H), 3.47-3.53 (m, 1H), 3.33 (ddd, J = 5.2, 10, 13.2, 1H), 3.033.20 (m, 5H), 2.86 (ddd, J = 5.2, 10.4, 13.6, 1H), 2.29 (s, 3H);

13

C NMR (100 MHz): δ =

144.4, 142.2, 141.9, 141.3, 139.6, 139.0, 136.6, 135.8, 135.4, 133.1, 133.0, 131.5, 129.9,
127.8, 125.7, 35.3, 35.2, 34.7, 32.9, 21.4; IR: 2924, 2848, 1594, 1081, 1059, 1028, 909, 808,
719 cm-1 (See Appendix 16-18).
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(RPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane: white solid (2.88 g, 25%); mp = 149-145 °C
(lit. 175-177 °C)1; Rf 0.30 (9:1 petrol/EtOAc); 1H NMR (400 MHz, CDCl3): δ = 7.39 (d, J =
8.4, 2H), 7.25 (d, J = 8, 2H), 6.79 (d, J = 8, 1H), 6.52-6.59 (m, 4H), 6.46 (d, J = 8.4, 1H),
6.38 (d, J = 8.4, 1H), 3.81-3.88 (m, 1H), 3.36 (ddd, J = 4.8, 10.4, 12.8, 1H), 2.92-3.20 (m,
5H), 2.79 (ddd, J = 5.2, 10.8, 13.2, 1H), 2.38 (s, 3H); 13C NMR (100 MHz): δ = 142.0, 141.3,
141.1, 140.8, 140.7, 140.0, 139.1, 137.6, 136.6, 133.2, 132.7, 132.6, 132.5, 132.4, 129.6,
125.2, 35.5, 35.2, 34.9, 32.9, 21.4; IR: 2924, 2853, 1585, 1079, 1036, 817, 718 cm-1 (See
Appendix 19-21).
9.2.8

(SP)-4-Bromo[2.2]paracyclophane

t-BuLi (1.7 M in pentane, 9 ml, 15.3 mmol) was added dropwise to a solution of (SPS)- 4-(4Tolylsulfinyl)-[2.2]paracyclophane (1.05 g, 3.0 mmol) in dry THF (30 ml) at -78 °C. The
solution was stirred for 10 minutes followed by the addition of bromobenzene (4.49 g, 28.6
mmol). The solution was slowly returned to room temperature and stirred for 2 days.
Saturated NH4Cl (50 ml) was added to the solution and the organic phase was extracted. The
aqueous phase was further extracted with Et2O (3 x 50 ml) and the combined organic phases
dried over Mg2SO4. The solvent was removed in vacuo and the resulting residue purified by
flash column chromatography (Cy) to give the title compound as a white solid (0.30 g, 35%).
NMR data was in agreement with that collected for the racemate (See Section 3.4.2 and
Appendix 23).
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9.3

Disubstituted [2.2]paracyclophanes

9.3.1

(rac)-4-Bromo-13-nitro[2.2]paracyclophane

A solution of 4-nitro[2.2]paracylophane (1.00 g, 3.9 mmol), iron powder (0.02 g, 0.4 mmol)
and bromine (0.63g, 4.0 mmol) in DCM (50 ml) was heated at reflux for 20 hours. The
mixture was cooled to room temperature and washed with 10% Na2S2O3 (2 x 50 ml). The
organic phase was dried over MgSO4 and the solvent removed in vacuo. The title compound
was isolated by flash column chromatography as a pale yellow solid (0.36 g, 28%); Rf = 0.27
(8:2 Cy:DCM); 1H NMR (400 MHz, CDCl3): δ = 7.58 (d, J = 2, 1H), 6.77 (dd, J = 7.6, 2,
1H), 6.71 (d, J = 1.2, 1H), 6.65-6.58 (m, 3H), 4.35-4.42 (m, 1H), 3.63-3.70 (m, 1H), 2.993.21 (m, 6H);

13

C NMR (100 MHz): δ = 141.1, 138.8, 138.0, 137.7, 136.5, 136.2, 134.8,

131.5, 128.0, 127.4, 35.4, 34.7, 34.4, 32.7 (See Section 3.3.1 and Appendix 24-25).
9.3.2

(rac)-4-Bromo-13-amino[2.2]paracyclophane

A solution of 4-bromo-13-nitro[2.2]paracylophane (1.00 g, 3.0 mmol) in water/EtOH (50 ml)
was stirred for 30 minutes followed by the addition of iron powder (1.80 g, 32 mmol). The
mixture was heated to reflux and conc. HCl (7 ml) was added dropwise over 10 minutes. The
temperature was maintained for 4 hours at which time the mixture was poured onto ice and
sat. NaHCO3 (50 ml). The mixture was extracted with DCM (3 x 40 ml), dried over MgSO4
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and the solvent removed in vacuo. The title compound was isolated by flash column
chromatography as an off white solid (0.62 g, 68%); Rf = 0.46 (8:2 Cy/EtOAc); 1H NMR
(400 MHz, CDCl3): δ = 6.83 (d, J = 1.6, 1H), 6.42-6.49 (m, 2H), 6.38 (d, J = 8, 1H), 6.11 (dd,
J = 7.6, 1.6, 1H), 5.69 (d, J = 1.6, 1H), 3.66-3.73 (m, 3H), 3.33 (ddd, J = 14.4, 10, 2.4, 1H),
2.83-3.15 (m, 6H); 13C NMR (100 MHz): δ = 147.0, 141.0, 140.6, 138.1, 135.4, 135.3, 135.2,
132..7, 123..4, 123.1, 122.4, 121.0, 34.9, 34.7, 33.1, 31.5; IR: 3480, 3394, 2921, 2850, 1738,
1611, 1422 cm-1 (See Section 3.3.2 and Appendix 26-28).
9.3.3

(rac)-4-Nitro-13-formyl[2.2]paracyclophane

A solution of 4-nitro[2.2]paracyclophane (2.73 g, 10.8 mmol) in DCM (100 ml) was cooled
to 0 °C. To this solution was added TiCl4 (4.17 g, 22 mmol) and dichloromethoxymethane
(1.38 g, 11.2 mmol) and the mixture was warmed to room temperature. After 20 hours
stirring, water (100 ml) was added and stirring was continued for an additional 2 hours. The
organic layer was extracted, dried over MgSO4 and the solvent removed in vacuo. The title
compound was isolated by flash column chromatography as a pale yellow solid (0.55 g,
18%); Rf = 0.38 (9:1 DCM:Cy); 1H NMR (400 MHz, CDCl3): δ = 9.94 (s, 1H, CHO), 7.15 (d,
J = 2, 1H, Ar-CH), 7.10 (d, J = 2, 1H, Ar-CH), 6.83 (dd, J = 7.6, 1.6, 1H, Ar-CH), 6.78 (dd, J
= 7.6, 2, 1H, Ar-CH), 6.74 (d, J = 7.6, 1H, Ar-CH), 6.67 (d, J = 8, 1H, Ar-CH), 4.15-4.23 (m,
1H, CH2), 3.98-4.06 (m, 1H, CH2), 3.05-3.24 (m, 6H, CH2); 13C NMR (100 MHz): δ = 190.4
(CHO), 149.5 (Ar-C), 142.6 (Ar-C), 141.9 (Ar-C), 140.1 (Ar-C), 137.9 (Ar-C), 137.5 (Ar-C),
137.4 (Ar-C), 136.2 (Ar-C), 136.1 (Ar-C), 135.6 (Ar-C), 134.7 (Ar-C), 128.2 (Ar-C), 34.5
(CH2), 34.2 (CH2), 31.7 (CH2) (See Section 3.3.3 and Appendix 29-30).
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(rac)-4-Amino-7-formyl[2.2]paracyclophane

A solution of 4-amino[2.2]paracyclophane (0.50 g, 2.2 mmol) in DCM (25 ml) was cooled to
0°C. To this solution was added TiCl4 (0.83 g, 4.4 mmol) and dichloromethoxymethane (0.25
g, 2.2 mmol) and the mixture was warmed to room temperature. After 20 hours stirring, water
(25 ml) was added and stirring was continued for an additional 2 hours. The organic layer
was extracted, dried over MgSO4 and the solvent removed in vacuo. The title compound was
isolated by flash column chromatography as a yellow solid (0.15 g, 26%); Rf = 0.74 (7:3
EtOAc:Cy); 1H NMR (400 MHz, CDCl3): δ = 9.76 (s, 1H, CHO), 7.11 (dd, J = 8, 2, 1H, ArCH), 6.83 (s, 1H, Ar-CH), 6.51 (dd, J = 8, 2, 1H, Ar-CH), 6.47 (dd, J = 8, 2, 1H, Ar-CH),
6.40 (dd, J = 8, 2, 1H, Ar-CH), 5.40 (s, 1H, Ar-CH), 4.11 (s, 2H, NH2), 3.97-4.03 (m, 1H,
CH2), 2.97-3.23 (m, 5H, CH2), 2.61-2.77 (m, 2H, CH2);

13

C NMR (100 MHz): δ = 189.9

(CHO), 150.6 (Ar-C), 146.3 (Ar-C), 140.3 (Ar-C), 138.9 (Ar-C), 138.7 (Ar-C), 132.5 (Ar-C),
132.2 (Ar-C), 131.3 (Ar-C), 128.3 (Ar-C), 127.3 (Ar-C), 123.3 (Ar-C), 35.3 (CH2), 33.2
(CH2), 32.6 (CH2), 31.8 (CH2) (See Section 3.3.4 and Appendix 31-32).
9.4

General procedure for the preparation of substituted aryl-oxazolines

The appropriate aryl nitrile (13 mmol) and the appropriate amino alcohol (11 mmol) were
dissolved in dry chlorobenzene (20 ml) under an atmosphere of argon. The solution was
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stirred for 20 minutes at 60 °C followed by the addition of ZnCl2 (1 M solution in Et2O, 4
ml). The solution was heated to 145 °C for 4 days, cooled and the solvent evaporated, with
the title compounds being isolated by flash column chromatography (See section 3.5).
9.4.1

2-(4,5-Dihydrooxazol-2-yl)aniline

Flash column solvent system (19:1 petrol/EtOAc); yellow solid (0.43 g, 24%); mp = 53-55
°C; Rf = 0.39 (9:1 petrol/EtOAc); 1H NMR (400 MHz, CDCl3): δ = 7.69 (dd, J = 8, 1.6, 1H),
7.19 (ddd, J = 8, 7.2, 1.6, 1H), 6.69 (dd, J = 8, 7.2, 1.2, 1H), 6.05 (s, 2H), 4.29-4.34 (m, 2H),
4.07-4.12 (m, 2H); 13C NMR (100 MHz): δ = 164.9, 148.5, 132.0, 129.6, 116.1, 115.7, 109.2,
65.8, 55.0; IR: 3416, 3298, 2926, 2880, 1627, 1251, 1049, 943 cm-1 (See Appendix 33-35).
9.4.2

(S)-2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)aniline

Flash column solvent system (19:1 petrol/EtOAc); yellow solid (1.84 g, 82%); mp = 66-68
°C (lit. 67-69 °C)4; Rf = 0.50 (9:1 petrol/EtOAc); 1H NMR (400 MHz, CDCl3): δ = 7.68 (dd,
J = 8, 1.6, 1H), 7.19 (ddd, J = 8.4, 7.2, 1.6, 1H), 6.68 (dd, J = 8, 0.8, 1H), 6.64 (ddd, 8, 7.2,
0.8, 1H), 6.13 (s, 2H), 4.31 (dd, J = 9.6, 8, 1H) 4.07-4.13 (m, 1H), 3.99 (app. t, J = 8, 1H),
1.72-1.83 (m, 1H), 1.02 (d, J = 6.8, 3H), 0.93 (d, J = 6.8, 3H);

13

C NMR (100 MHz): δ =

163.52, 148.6, 131.9, 129.6, 116.0, 115.6, 109.2, 72.9, 68.8, 33.2, 19.0, 18.6; IR: 3387, 3252,
2957, 2951, 2879, 1631, 1491, 1254 cm-1 (See Appendix 36-38).
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(S)-2-(2-Bromophenyl)-4-isopropyl-4,5-dihydrooxazole

Flash column solvent system (8:2 DCM/Cy); clear oil (1.24 g, 42%); Rf = 0.22 (8:2
DCM/Cy); 1H NMR (400 MHz, CDCl3): δ = 7.67 (dd, J = 8, 1.6, 1H), 7.63 (d, J = 8, 1H),
7.33 (t, J = 7.6, 1H), 7.26 (dt, J = 7.6, 1.6, 1H), 4.40-4.46 (m, 1H), 4.13-4.19 (m, 2H), 1.851.97 (m, 1H), 1.05 (d, J = 6.8, 3H), 0.98 (d, J = 6.8, 3H);

13

C NMR (100 MHz): δ = 162.9,

133.7, 131.5, 131.3, 130.2, 127.1, 121.8, 73.0, 70.4, 32.7, 18.8, 18.3; IR: 2960, 1655, 1352,
1242, 1094, 1024, 952 cm-1 (See Appendix 39-41).
9.4.4

(S)-2-(2-Iodophenyl)-4-isopropyl-4,5-dihydrooxazole

Flash column solvent system (8:2 DCM/Cy); yellow oil (1.66 g, 48%); Rf = 0.22 (8:2
DCM/Cy); 1H NMR (400 MHz, CDCl3): δ = 7.92 (dd, J = 8, 1.2, 1H, Ar-CH), 7.61 (dd, J =
8, 1.6, 1H, Ar-CH), 7.36 (dd, J = 7.2, 1.2, 1H, Ar-CH), 7.09 (dd, J = 7.6, 1.6, 1H, Ar-CH),
4.41-4.47 (m, 1H, N-CH), 4.11-4.18 (m, 2H, O-CH2), 1.85-1.97 (m, 1H, CH(CH3)2), 1.07 (d,
J = 6.8, 3H, CH3), 0.99 (d, J = 6.8, 3H, CH3); 13C NMR (100 MHz): δ = 163.8 (Ar-C), 140.4
(Ar-C), 133.9 (Ar-C), 131.5 (Ar-C), 130.7 (Ar-C), 127.8 (Ar-C), 94.7 (O-C=N), 73.1 (OCH2), 70.5 (N-CH), 32.8 (CH(CH3)2), 19.0 (CH3), 18.5 (CH3); IR: 2960 (C-H), 1654 (C=N),
1468 (C=C), 1351, 1242, 1013 (C-O) cm-1 (See Appendix 42-44).
9.4.5

(S)-2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)-4,5-dimethoxyaniline
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Flash column solvent system (8:2 Cy/EtOAc); off white solid (1.31 g, 45%); mp = 122-123
°C; Rf = 0.40 (7:3 Cy/EtOAc); 1H NMR (400 MHz, CDCl3): δ = 7.15 (s, 1H, Ar-CH), 6.23 (s,
1H, Ar-CH), 5.95 (s, 2H, Ar-NH2), 4.30 (dd, J = 9.2, 8, 1H, N-CH), 4.05-4.11 (m, 1H, OCH2), 3.98 (app. t, J = 8, 1H, O-CH2), 3.85 (s, 3H, OCH3), 3.82 (s, 3H, OCH3), 1.70-1.82 (m,
1H, CH(CH3)2), 1.01 (d, J = 6.8, 3H, CH3), 0.92 (d, J = 6.8, 3H, CH3); 13C NMR (100 MHz):
δ = 163.3 (Ar-C), 152.7 (Ar-C), 144.5 (Ar-C), 140.4 (Ar-C), 111.7 (Ar-C), 100.6 (Ar-C),
99.2 (O-C=N), 72.9 (O-CH2), 68.7 (N-CH), 56.4 (OCH3), 55.7 (OCH3), 33.3 (CH(CH3)2),
19.0 (CH3), 18.6 (CH3); IR: 3391 (N-H), 2968 (C-H), 1637 (C=N), 1514 (C=C), 1209 (C-N),
1003 (C-O) cm-1 (See Appendix 45-47).
9.4.6

(S)-2-(4-Benzyl-4,5-dihydrooxazol-2-yl)aniline

Flash column solvent system (19:1 petrol/EtOAc); yellow solid (1.61 g, 58%); mp = 55-57
°C (lit. 54-56 °C)4; Rf = 0.59 (9:1 petrol/EtOAc); 1H NMR (400 MHz, CDCl3): δ = 7.67 (dd,
J = 8, 1.6, 1H), 7.17-7.32 (m, 6H), 6.62-6.70 (m, 2H), 6.09 (s, 2H), 4.56-4.64 (m, 1H), 4.27
(app. t, J = 9.2, 1H), 4.02 (dd, J = 8.4, 7.2, 1H), 3.12 (dd, J = 13.6, 6, 1H), 2.76 (dd, J = 13.6,
8, 1H);

13

C NMR (100 MHz): δ = 164.1, 148.7, 138.4, 132.1, 129.6, 129.3, 128.5, 126.5,

116.0, 115.7, 109.0, 70.3, 68.1, 42.3; IR: 3389, 3266, 2906, 1625, 1488, 1453, 1362, 1263
cm-1 (See Appendix 48-50).
9.4.7

(S)-2-(4-(Tert-butyl)-4,5-dihydrooxazol-2-yl)aniline

Flash column solvent system (19:1 petrol/EtOAc); yellow solid (0.95 g, 40%); mp = 63-65
°C (lit. 65-66 °C)4; Rf = 0.59 (9:1 petrol/EtOAc); 1H NMR (400 MHz, CDCl3): δ = 7.67 (dd,
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J = 8, 1.6, 1H), 7.19 (ddd, J = 8, 7.2, 1.6, 1H), 6.70 (dd, J = 8, 1.2, 1H), 6.64 (ddd, 8, 7.2, 1.2,
1H), 6.15 (s, 2H), 4.21-4.27 (m, 1H), 4.07-4.13 (m, 2H), 0.94 (s, 9H); 13C NMR (100 MHz):
δ = 163.5, 148.7, 131.9, 129.6, 115.9, 115.6, 109.2, 76.4, 66.9, 33.9, 25.9; IR: 3426, 3272,
2960, 2863, 1635, 1360, 1256 cm-1 (See Appendix 51-53).
9.5

General procedure for preparation of substituted phenyl–oxazoline[2.2]paracyclophanes

A

Schlenk

tube

was

charged

with

the

appropriate

oxazoline

(1

mmol),

4-

bromo[2.2]paracyclophane (0.345 g, 1.2 mmol), BINAP (0.126 g, 0.2 mmol), Pd(dba)2
(0.092 g, 0.1 mmol) and KOtBu (0.224 g, 2 mmol) under an atmosphere of argon. Freshly
distilled toluene (15 ml) was then added and the mixture was heated at 120 °C for 5 days. The
solvent was removed in vacuo and the product was isolated by flash column chromatography.
The product was further purified by recrystallisation from EtOAc (See Section 3.6).
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(SPS)-N-(2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)phenyl)[2.2]paracyclophane-4-amine

Flash column solvent system (8:2 Cy/DCM); Appears as a white crystalline solid (0.025 g,
6%); Rf = 0.57 (6:4 Cy/DCM); 1H NMR (400 MHz, CDCl3): δ = 10.34 (s, 1H, Ar-NH), 7.81
(dd, J = 8, 1.6, 1H, Ar-CH), 7.20 (dd, J = 8, 2, 1H, Ar-CH), 7.14-7.18 (m, 1H, Ar-CH), 6.87
(dd, J = 8.4, 0.8, 1H, Ar-CH), 6.67-6.71 (m, 1H, Ar-CH), 6.56 (dd, J = 8, 2, 1H, Ar-CH),
6.44-6.52 (m, 4H, Ar-CH), 6.01 (d, J = 1.2, 1H, Ar-CH), 4.46 (dd, J = 9.6, 8,1H, N-CH),
4.29-4.35 (m, 1H, O-CH2), 4.11 (app. t, J = 8, 1H, O-CH2), 2.86-3.11 (m, 7H, CH2), 2.66
(ddd, J = 13.2, 10, 6.8, 1H, CH2), 1.88-2.00 (m, 1H, CH(CH3)2), 1.22 (d, J = 6.8, 3H, CH3),
1.08 (d, J = 6.8, 3H, CH3); 13C NMR (100 MHz): δ = 163.9 (Ar-C), 145.8 (Ar-C), 141.2 (ArC), 139.9 (Ar-C), 139.2 (Ar-C), 139.0 (Ar-C), 135.7 (Ar-C), 135.0 (Ar-C), 133.5 (Ar-C),
132.9 (Ar-C), 132.0 (Ar-C), 131.4 (Ar-C), 130.7 (Ar-C), 129.8 (Ar-C), 128.6 (Ar-C), 128.4
(Ar-C), 116.1 (Ar-C), 112.3 (Ar-C), 108.9 (O-C=N), 73.3 (O-CH2), 69.0 (N-CH), 35.3 (CH2),
34.9 (CH2), 34.3 (CH2), 33.9 (CH2), 33.4 (CH(CH3)2), 19.3 (CH3), 18.9 (CH3); IR: 3232 (NH), 2957 (C-H), 2926 (C-H), 2853 (C-H), 1630 (C=N), 1583 (C=C), 1520, 1450 (C-H), 1276
(C-N), 1050 (C-O), 906, 729 cm-1; HRMS (ES+) calculated for C28H31N2O [M+H]+:
411.2436, found: 411.2433 (See Appendix 54-56 and 106).
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(SPS)-N-(2-(4-Benzyl-4,5-dihydrooxazol-2-yl)phenyl)[2.2]paracyclophane-4-amine

Flash column solvent system (8:2 Cy/DCM); Appears as a white solid (0.032 g, 7%); Rf =
0.47 (6:4 Cy/DCM); 1H NMR (400 MHz, CDCl3): δ = 10.29 (s, 1H, Ar-NH), 7.83 (dd, J = 8,
2, 1H , Ar-CH), 7.34-7.46 (m, 5H, Ar-CH), 7.17-7.21 (m, 1H, Ar-CH), 6.96 (dd, J = 8, 2, 1H,
Ar-CH), 6.91 (dd, J = 8.4, 0.8, 1H, Ar-CH), 6.69-6.73 (m, 1H, Ar-CH), 6.51 (dd, 8, 2, 1H,
Ar-CH), 6.38-6.48 (m, 3H, Ar-CH), 5.93 (dd, J = 8, 2, 1H, Ar-CH), 5.91 (d, J = 1.6, 1H, ArCH), 4.80-4.88 (m, 1H, N-CH), 4.49 (app. t, J = 8.8, 1H, O-CH2), 4.16 (dd, J = 8, 7.2, 1H, OCH2), 2.92-3.14 (m, 8H, CH2), 2.79-2.86 (m, 1H, CH2), 2.61-2.68 (m, 1H, CH2);

13

C NMR

(100 MHz): δ = 164.3, 145.5, 141.1, 139.6, 139.1, 138.8, 138.7, 135.7, 134.0, 133.3, 132.6,
132.1, 131.4, 129.9, 129.8, 129.4, 128.7, 128.2, 126.6, 116.2, 112.5, 108.8, 70.7, 68.4, 43.0,
35.1, 34.8, 34.2, 33.7, 29.7; IR: 3190 (N-H), 3030 (C-H), 2923 (C-H), 2890 (C-H), 2855 (CH), 1636 (C=N), 1593 (C=C), 1527, 1492, 1453 (C-H), 1284 (C-N), 1055 (C-O), 960, 744
cm-1; HRMS (ES+) calculated for C32H31N2O [M+H]+: 459.2436, found: 459.2428 (See
Appendix 57-59).
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(rac)-2-(4-Amino[2.2]paracyclophane)-4,5-dimethoxybenzonitrile

To a Schlenk tube was added 2-amino-4,5-dimethoxybenzonitrile (0.178 g, 1 mmol), 4bromo[2.2]paracyclophane (0.345 g, 1.2 mmol), BINAP (0.063 g, 0.1 mmol), Pd(dba)2
(0.046, 0.05 mmol) and KOtBu (0.224 g, 2 mmol) under an atmosphere of argon. Freshly
distilled toluene (15 ml) was added and the mixture was heated at 120 °C for 2 days. The
resulting mixture was diluted with DCM (50ml) and filtered, followed by aqueous extraction.
The aqueous layer was then extracted with DCM (3 x 25 ml) and the combined organic layers
were dried over MgSO4. The title compound was isolated by flash column chromatography
(8:2 Cy/EtOAc) as a waxy solid (0.12 g, 32%); Rf = 0.66 (6:4 Cy/EtOAc); 1H NMR (400
MHz, CDCl3): δ = 7.15 (dd, J = 2, 8, 1H, Ar-CH), 6.23 (s, 1H, Ar-CH), 6.57 (dd, J = 2, 8,
1H, Ar-CH), 6.43-6.53 (m, 5H, Ar-CH), 6.01 (s, 1H, Ar-NH), 5.92 (d, J = 1.2, 1H, Ar-CH),
3.84 (s, 3H, OCH3), 3.66 (s, 3H, OCH3), 2.90-3.12 (m, 7H, CH2), 2.64-2.74 (m, 1H, CH2);
13

C NMR (100 MHz): δ = 154.3 (Ar-C), 143.7 (Ar-C), 142.6 (Ar-C), 142.0 (Ar-C), 139.3

(Ar-C), 138.9 (Ar-C), 138.3 (Ar-C), 136.2 (Ar-C), 133.6 (Ar-C), 132.9 (Ar-C), 132.8 (Ar-C),
131.3 (Ar-C), 128.8 (Ar-C), 128.0 (Ar-C), 127.4 (Ar-C), 118.5 (Ar-C), 113.6 (C≡N), 98.3
(Ar-C), 88.1 (Ar-C), 56.5 (OCH3), 55.9 (OCH3), 35.2 (CH2), 34.8 (CH2), 33.8 (CH2); IR:
3319 (N-H), 2926 (C-H), 2853 (C-H), 2203 (C≡N), 1584 (C=C), 1499, 1449, 1410, 1256,
1210 (C-O) cm-1; HRMS (ES-) calculated for C25H23N2O2 [M-H]-: 383.1760, found: 383.1771
(See Section 3.7 and Appendix 60-63).
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9.7

Octafluoro[2.2]paracyclophane and precursors

9.7.1

1,4-bis-Dichloromethylbenzene

Procedure A: A mixture of terephthaldehyde (14.4 g, 107 mmol), DMF (1.9 g, 26 mmol) and
SOCl2 (24.5 g, 206 mmol) was heated at 90 °C for 1 hour under an atmosphere of argon. The
same quantities of DMF and SOCl2 were again added to the mixture and the temperature
maintained for an additional 2 hours. The mixture was then poured onto cold water (600 ml)
forming a precipitate. The precipitate was filtered, dissolved in DCM (200 ml) and washed
with water (2 x 100 ml). The organic layer was dried over MgSO4 and the solvent was
removed in vacuo to yield the title compound as a white solid (18.29 g, 70%); mp 91-93 °C
(lit. 92-93 °C)5; Rf = 0.57 (9:1 petrol/EtOAc); 1H NMR (400 MHz, CDCl3): δ = 7.63 (s, 4H),
6.71 (s, 2H);

13

C NMR (100 MHz): δ = 141.8, 126.7, 70.8; IR: 1422, 1310, 1214, 800 cm-1

(See Section 5.2.1 and Apendix 64-66).
Procedure B: Terephthaldehyde (1 g, 7.5 mmol) was dissolved in dry hexane (50 ml) under
an atmosphere of argon and 1M BCl3 in pentane (15 ml, 15mmol) was added. The solution
was heated at reflux for 4 hours and quenched with water (25 ml). The organic layer was
separated and dried over MgSO4. The solvent was removed in vacuo. The crude material was
purified using flash column chromatography and yielded the title compound as a white solid
(0.82 g, 45%).
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1,4-bis-Difluoromethylbenzene

Terephthaldehyde (0.5 g, 3.7 mmol) was dissolved in dry DCM (20 ml) under an atmosphere
of argon. DAST (1.83 g, 11.4 mmol) was added dropwise followed by a catalytic amount of
absolute EtOH. The reaction was heated at reflux for 20 hours, cooled to room temperature
and quenched with water (20 ml). The organic layer was extracted and the aqueous layer was
washed with DCM (20 ml). The combined organic layers were dried over MgSO4 and the
solvent removed in vacuo to give an orange oil which was purified by flash column
chromatography to yield the title compound as a colourless clear oil (0.44 g, 67%); Rf = 0.5
(9:1 petrol/EtOAc); 1H NMR (400 MHz, CDCl3): δ = 7.59 (s, 4H), 6.67 (t, J = 56, 2H);
NMR (376 MHz): δ = -111.7 (d, J = 56, 4F);

13

19

F

C NMR (100 MHz): δ = 136.7 (t, J = 23),

126.0 (t, J = 6), 114.0 (t, J = 238); IR: 1430, 1370, 1220, 1018, 809 cm-1 (See Section 5.2.2
and Appendix 67-70).
9.7.3

1,4-bis-Chlorodifluoromethylbenzene

1,4-bis-Difluoromethylbenzene (3 g, 16.8 mmol) was added to a solution of AIBN (0.2 g, 1.2
mmol) and SO2Cl2 (30 ml) under an atmosphere of argon. This solution was heated at reflux
for 5 days, cooled to room temperature, then added to water (150 ml) and allowed to stir for 1
hour. The mixture was extracted with DCM (3 x 40 ml) and the organic phase dried over
MgSO4 and the solvent removed in vacuo. The crude oil was purified using flash column
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chromatography to yield the title compound as a colourless clear oil (0.83 g, 20%); Rf = 0.65
(petrol); 1H NMR (400 MHz, CDCl3): δ = 7.75 (s, 4H);

19

F NMR (376 MHz): δ = -50.0 (s,

4F); 13C NMR (100 MHz): δ = 139.0 (t, J = 27), 125.6 (t, J = 289), 125.2 (t, J = 5); IR: 1413,
1272, 1053, 912, 822, 730 cm-1 (See Section 5.2.3 and Appendix 71-74).
9.7.4

1-(Trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene

Magnesium turnings (1.73 g, 72 mmol) were added to dry DMF (80 ml) under an atmosphere
of argon. Chlorotrimethylsilane (15.6 g, 144 mmol) was added to the mixture followed by the
dropwise addition of 1,4-bis-trifluoromethylbenzene (7.7 g, 36 mmol) over 1 hour. The
mixture was then allowed stir for an additional 30 minutes. The reaction was quenched with
water (80 ml) and extracted with hexane (3 x 60 ml). The organic phase was dried over
MgSO4 and the solvent removed in vacuo to give a brown oil which was purified by flash
column chromatography to yield the product as a colourless clear oil (3.09 g, 32%); Rf = 0.44
(petrol); 1H NMR (400 MHz, CDCl3): δ = 7.55 (d, J = 8, 2H), 7.33 (d, J = 8, 2H), 0.015 (s,
9H); 19F NMR (376 MHz): δ = -113.2 (s, 2F), -62.8 (s, 3F); 13C NMR (100 MHz): δ = 142.0
(t, J = 21), 131.0 (q, J = 32), 126.3 (q, J = 264), 125.3 (q, J = 4), 125.2 (t, J = 8), 123.9 (t, J =
402), -5.0; IR: 1411, 1323, 1128, 1068, 998, 827 cm-1 (See Section 5.2.4 and Appendix 7578).
9.7.5

1,1,2,2,9,9,10,10-Octafluoro[2,2]paracyclophane
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A mixture of 1-(Trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene (1 g, 3.7 mmol),
CsF (0.060 g, 0.4 mmol) and Pd2(dba)3 (20 mg, 0.02 mmol) in dry anisole (80 ml) was heated
at reflux for 24 hours under an atmosphere of argon. The solvent was removed in vacuo and
the title compound was isolated by flash column chromatography as a white crystalline solid
(0.12 g, 18%); mp 261-263 °C (lit. 261 °C)6; Rf = 0.62 (6:4 Cy/DCM); 1H NMR (400 MHz,
CDCl3): δ = 7.16 (s, 8H); 19F NMR (376 MHz): δ = -118.2 (s, 8F); 13C NMR (100 MHz): δ =
134.9 (t, J = 27), 129.8, 118.6 (t, J = 272); IR: 1401, 1257, 1130, 1086, 923, 823, 712 cm-1
(See Section 5.2.5 and Appendix 79-82).
9.8

Monosubstituted octafluoro[2.2]paracyclophanes

9.8.1

(rac)-4-Nitro-1,1,2,2,9,9,10,10-octafluoro[2,2]paracyclophane

Octafluoro[2,2]paracyclophane (2 g, 5.7 mmol) was added to a solution of 67% HNO3 (22
ml) and H2SO4 (3 ml) and heated at 100 °C for 24 hours. The suspension was cooled to room
temperature and added to ice water (200 ml). The resulting solid was isolated by filtration and
flash column chromatography yielded the title compound as an off-white solid (0.59 g, 26%);
mp 117-119 °C (lit. 119-129 °C)7; Rf = 0.44 (6:4 Cy/DCM); 1H NMR (400 MHz, (CD3)2CO):
δ = 7.70 (m, 4H), 7.54 (m, 2H), 7.33 (d, J = 8.8, 1H); 19F NMR (376 MHz): δ = -111.08 (d, J
= 264, 1F), -113.73 (d, J = 264, 1F), -116.08 (m, 4F), -117.75 (m, 2F); IR: 1537, 1402, 1349,
1241, 1126, 1092 cm-1 (See Section 5.3.1 and Appendix 83-86).
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(rac)-4-Amino-1,1,2,2,9,9,10,10-octafluoro[2,2]paracyclophane

A solution of 4-nitro-octafluoro[2.2]paracylophane (1.00 g, 2.5 mmol) in H2O/EtOH (50 ml)
was stirred for 30 minutes followed by the addition of iron powder (1.40 g, 25 mmol). The
mixture was heated to reflux and conc. HCl (7 ml) was added in one portion. The temperature
was maintained for 8 hours at which time the mixture was poured onto ice and 1M NaOH
(100 ml). The mixture was extracted with DCM (3 x 40 ml), dried over MgSO4 and the
solvent removed in vacuo to yield the title compound as a white solid (0.73 g, 80%); mp 219221 °C (lit. 221-223 °C)7; Rf = 0.28 (6:4 Cy/DCM); 1H NMR (400 MHz, (CD3)2CO): δ =
7.99 (dd, J = 8.0, 1.6, 1H), 7.40 (dd, J = 8.8, 1.6, 1H), 7.19 (d, J = 8.4, 1H), 7.11 (d, J = 8.0,
1H), 6.95 (dd, J = 8.8, 1.2, 1H), 6.54 (dd, J = 8.8, 1.2, 1H), 6.09 (d, J = 1.2, 1H), 5.60 (s, 2H);
19

F NMR (376 MHz): δ = -105.40 (d, J = 252, 1F), -107.90 (d, J = 252, 1F), -111.56 (d, J =

232, 1F), -112.30 (d, J = 240, 1F), -114.34 (d, J = 252, 1F), -115.84 (d, J = 252, 1F), -116.81
(d, J = 256, 1F), -117.82 (d, J = 248, 1F); IR: 3534, 3438, 1629, 1437, 1236, 1082 cm-1 (See
Section 5.3.2 and Appendix 87-90).
9.9

General procedure for the preparation of fluorinated aryl triethoxysilanes

A mixture of magnesium turnings (1.27 g, 52 mmol) and 2 crystals of iodine were placed
under an atmosphere of argon. To this was added TEOS (10.9 g, 52 mmol) followed by the
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appropriate fluorobromobenzene (48 mmol) with stirring. To this solution was added dry
Et2O (30 ml) at 0 °C and an exothermic event is observed. After approximately 20 minutes
the solution was allowed to return to room temperature and was subsequently heated at reflux
for 20 hours. An excess of heptane was added until a precipitation of salts is observed. The
precipitate was removed by filtration and the solvent was removed in vacuo. The resulting oil
is purified by vacuum distillation to yield the title compounds (See Section 7.3.1).
9.9.1

4-Fluorophenyltriethoxysilane

Clear oil (4.22 g, 34 %); 1H NMR (400 MHz, CDCl3): δ = 7.67 (q, J = 6.4, 2H, Ar-CH), 7.06
(t, J = 8.8, 2H, Ar-CH), 3.87 (g, J = 7.2, 6H, OCH2CH3), 1.24 (t, J = 7.2, 9H, OCH2CH3); 19F
NMR (376 MHz): δ = -109.80 (s, 1F); 13C NMR (100 MHz): δ = 164.5 (d, J = 248, Ar-CF),
136.8 (d, J = 8, Ar-CH), 126.7 (d, J = 4, Ar-C-Si), 114.9 (d, J = 20, Ar-CH), 58.6
(OCH2CH3), 18.0 (OCH2CH3) (See Appendix 91-93).
9.9.2

3,4,5-Trifluorophenyltriethoxysilane

Clear oil (4.24 g, 30 %); 1H NMR (400 MHz, CDCl3): δ = 7.16 (t, J = 7.2, 2H, Ar-CH), 3.78
(q, J = 7.2, 6H, OCH2CH3), 1.16 (t, J = 7.2, 9H, OCH2CH3);
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F NMR (376 MHz): δ = -
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135.26 (d, J = 23, 2F, Ar-CF), -158.53 (t, J = 23, 1F, Ar-CF);

13

C NMR (100 MHz): δ =

150.4 (dd, J = 51, 9, (Ar-CF), 140.5 (dd, J = 53, 14, (Ar-CF), 127.4, (Ar-CH), 117.4 (d, J =
14, (Ar-CH), 58.1 (OCH2CH3), 17.1 (OCH2CH3) (See Appendix 94-96).
9.9.3

Perfluorophenyltriethoxysilane

Clear oil (4.28 g, 27 %) yield calculated based on desired product; Isolated as a mixture
which could not be separated. 1H,

19

F and

13

C NMR spectra of the mixture provided in

appendices (See Appendix 97-99).
9.10

Fluorinated mesoporous silicate particles

To a beaker was added EtOH (1000 ml), CTAB (55 g, 0.151 mol), H2O (290 g, 16.1 mol) and
28% ammonium hydroxide solution (50 ml, 14 g, 0.4 mol) with stirring. In a second vessel a
mixture of TEOS (186 g, 0.89 mol) and PFOTES (4.57 g, 9 mmol) was prepared. The silane
solution was added to the EtOH solution in one portion and immediately heated using
microwave (10 min, 100 W). The resulting suspension was left to evaporate at 90 °C for
approximately 24 hours. The resulting solid was added to a solution of MeOH (1250 ml) and
conc. HCl (65 ml) and heated at reflux for approximately 24 hours. The resulting particles
were isolated by filtration and washed with a mixture of methanol (500 ml) and conc. HCl
(25 ml) followed by ethanol (250 ml). The particles were then dried under vacuum at room
temperature (See Section 7.3.2).
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9.11

Unsuccessful procedures

9.11.1

4-Amino-13-formyl[2.2]paracyclophane

A solution of 4-nitro-13-formyl[2.2]paracylophane (0.10 g, 0.36 mmol) in H2O/EtOH (5 ml)
was stirred for 30 minutes followed by the addition of iron powder (0.06 g, 1.1 mmol). The
mixture was heated to reflux and conc. HCl (0.6 ml) was added in one portion. The starting
material was observed to degrade almost immediately (See Section 3.3.4).
9.11.2

1,4-bis-Difluoromethylbenzene by solid phase reaction

1,4-bis-dichloromethylbenzene (2.0 g, 8.2 mmol) and CsF (7.47 g, 49 mmol) were ground in
a mortar and pestle and added to a sealed glass vessel. This was heated without mixing at 180
°C for 8 hours. The resulting mixture was dissolved in DCM (100 ml) and washed with water
(3 x 50 ml). The organic phase was dried over MgSO4 and removed in vacuo. No product
was isolated from the resulting material (See Section 5.2.2).
9.11.3
Procedure

1,4-bis-Difluoromethylbenzene by phase transfer catalysis
A:

To

a

mixture

of

benzene/water

(10

ml)

was

added

1,4-bis-

dichloromethylbenzene (0.25 g, 1 mmol), CsF (0.8 g, 5.3 mmol) and TBAB (0.02 g, 0.06
mmol). This mixture was heated at 100 °C with vigorous stirring, for 24 hours. The organic
phase was extracted, dried over MgSO4 and removed in vacuo. No product was isolated from
the resulting material.
Procedure B: To dry DMF (10 ml) under an atmosphere of argon was added 1,4-bisdichloromethylbenzene (0.25 g, 1 mmol), CsF (0.8 g, 5.3 mmol) and TBAB (0.02 g, 0.06
mmol). The mixture was heated at reflux for 24 hours. The resulting solution was diluted
with water (40ml) and washed with DCM (2 x 25 ml). The organic phase was dried over
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MgSO4 and the solvent removed in vacuo. No product was isolated from the resulting
material (See Section 5.2.2).
9.11.4

1,1,2,2,9,9,10,10-Octafluoro[2.2]paracyclophane by zinc coupling

A mixture of zinc (2.0 g, 30.6 mmol) in dry DMA (20 ml) was prepared under an atmosphere
of argon. To this was added 1,4,-bis-chlorodifluoromethylbenzene (2.0 g, 8.1 mmol) with
stirring. The mixture was heated to 100 °C over 40 minutes and was maintained at this
temperature for 24 hours.

19

F NMR indicated only starting material was present in the

reaction mixture and no traces of product were detected (See Section 5.2.5).
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Appendix 1: 1H NMR of (rac)-4-bromo[2.2]paracyclophane

Appendix 2: 13C NMR of (rac)-4-bromo[2.2]paracyclophane
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Appendix 3: IR of (rac)-4-bromo[2.2]paracyclophane

Appendix 4: 1H NMR of (rac)-4-formyl[2.2]paracyclophane
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Appendix 5: 13C NMR of (rac)-4-formyl[2.2]paracyclophane

Appendix 6: IR of (rac)-4-formyl[2.2]paracyclophane
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Appendix 7: 1H NMR of (rac)-4-hydroxy[2.2]paracyclophane

Appendix 8: 13C NMR of (rac)-4-hydroxy[2.2]paracyclophane
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Appendix 9: IR of (rac)-4-hydroxy[2.2]paracyclophane

Appendix 10: 1H NMR of (rac)-4-nitro[2.2]paracyclophane
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Appendix 11: 13C NMR of (rac)-4-nitro[2.2]paracyclophane

Appendix 12: IR of (rac)-4-nitro[2.2]paracyclophane
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Appendix 13: 1H NMR of (rac)-4-amino[2.2]paracyclophane

Appendix 14: 13C NMR of (rac)-4-amino[2.2]paracyclophane
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Appendix 15: IR of (rac)-4-amino[2.2]paracyclophane

Appendix 16: 1H NMR of (SPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane
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Appendix 17: 13C NMR of (SPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane

Appendix 18: IR of (SPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane
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Appendix 19: 1H NMR of (RPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane

Appendix 20: 13C NMR of (RPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane
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Appendix 21: IR of (RPS)-4-(4-Tolylsulfinyl)-[2.2]paracyclophane

Appendix 22: 1H NMR of (RP)-4-amino[2.2]paracyclophane
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Appendix 23: 1H NMR of (SP)-4-bromo[2.2]paracyclophane

Appendix 24: 1H NMR of (rac)-4-bromo-13-nitro[2.2]paracyclophane
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Appendix 25: 13C NMR of (rac)-4-bromo-13-nitro[2.2]paracyclophane

Appendix 26: 1H NMR of (rac)-4-bromo-13-amino[2.2]paracyclophane
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Appendix 27: 13C NMR of (rac)-4-bromo-13-amino[2.2]paracyclophane

Appendix 28: IR of (rac)-4-bromo-13-amino[2.2]paracyclophane
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Appendix 29: 1H NMR of (rac)-4-nitro-13-formyl[2.2]paracyclophane

Appendix 30: 13C NMR of (rac)-4-nitro-13-formyl[2.2]paracyclophane
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Appendix 31: 1H NMR of (rac)-4-amino-7-formyl[2.2]paracyclophane

Appendix 32: 13C NMR of (rac)-4-amino-7-formyl[2.2]paracyclophane
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Appendix 33: 1H NMR of 2-(4,5-dihydrooxazol-2-yl)aniline

Appendix 34: 13C NMR of 2-(4,5-dihydrooxazol-2-yl)aniline
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Appendix 35: IR 2-(4,5-dihydrooxazol-2-yl)aniline

Appendix 36: 1H NMR of (S)-2-(4-isopropyl-4,5-dihydrooxazol-2-yl)aniline
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Appendix 37: 13C NMR of (S)-2-(4-isopropyl-4,5-dihydrooxazol-2-yl)aniline

Appendix 38: IR of (S)-2-(4-isopropyl-4,5-dihydrooxazol-2-yl)aniline
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Appendix 39: 1H NMR of (S)-2-(2-bromophenyl)-4-isopropyl-4,5-dihydrooxazole

Appendix 40: 13C NMR of (S)-2-(2-bromophenyl)-4-isopropyl-4,5-dihydrooxazole
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Appendix 41: IR of (S)-2-(2-bromophenyl)-4-isopropyl-4,5-dihydrooxazole

Appendix 42: 1H NMR of (S)-2-(2-iodophenyl)-4-isopropyl-4,5-dihydrooxazole
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Appendix 43: 13C NMR of (S)-2-(2-iodophenyl)-4-isopropyl-4,5-dihydrooxazole

Appendix 44: IR of (S)-2-(2-iodophenyl)-4-isopropyl-4,5-dihydrooxazole
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Appendix 45: 1H NMR of (S)-2-(4-isopropyl-4,5-dihydrooxazol-2-yl)-4,5-dimethoxyaniline

Appendix 46: 13C NMR of (S)-2-(4-isopropyl-4,5-dihydrooxazol-2-yl)-4,5-dimethoxyaniline
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Appendix 47: IR of (S)-2-(4-isopropyl-4,5-dihydrooxazol-2-yl)-4,5-dimethoxyaniline

Appendix 48: 1H NMR of (S)-2-(4-benzyl-4,5-dihydrooxazol-2-yl)aniline
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Appendix 49: 13C NMR of (S)-2-(4-benzyl-4,5-dihydrooxazol-2-yl)aniline

Appendix 50: IR of (S)-2-(4-benzyl-4,5-dihydrooxazol-2-yl)aniline
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Appendix 51: 1H NMR of (S)-2-(4-(tert-butyl)-4,5-dihydrooxazol-2-yl)aniline

Appendix 52: 13C NMR of (S)-2-(4-(tert-butyl)-4,5-dihydrooxazol-2-yl)aniline
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Appendix 53: IR of (S)-2-(4-(tert-butyl)-4,5-dihydrooxazol-2-yl)aniline

Appendix 54: 1H NMR of (SPS)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)[2.2]paracyclophane-4-amine
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Appendix 55: 13C NMR of (SPS)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)[2.2]paracyclophane-4-amine

Appendix 56: HRMS of (SPS)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)[2.2]paracyclophane-4-amine
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Appendix 57: 1H NMR of (SPS)-N-(2-(4-benzyl-4,5-dihydrooxazol-2-yl)phenyl)[2.2]paracyclophane-4-amine

Appendix 58: 13C NMR of (SPS)-N-(2-(4-benzyl-4,5-dihydrooxazol-2-yl)phenyl)[2.2]paracyclophane-4-amine
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Appendix 59: HRMS NMR of (SPS)-N-(2-(4-benzyl-4,5-dihydrooxazol-2-yl)phenyl)[2.2]paracyclophane-4-amine

Appendix 60: 1H NMR of (rac)-2-(4-amino[2.2]paracyclophane)-4,5-dimethoxybenzonitrile
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Appendix 61: 13C NMR of (rac)-2-(4-amino[2.2]paracyclophane)-4,5-dimethoxybenzonitrile

Appendix 62: IR of (rac)-2-(4-amino[2.2]paracyclophane)-4,5-dimethoxybenzonitrile
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Appendix 63: HRMS of (rac)-2-(4-amino[2.2]paracyclophane)-4,5-dimethoxybenzonitrile

Appendix 64: 1H NMR of 1,4-bis-dichloromethylbenzene

222

Appendices
Appendix 65: 13C NMR of 1,4-bis-dichloromethylbenzene

Appendix 66: IR of 1,4-bis-dichloromethylbenzene
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Appendix 67: 1H NMR of 1,4-bis-difluoromethylbenzene

Appendix 68: 13C NMR of 1,4-bis-difluoromethylbenzene
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Appendix 69: 19F NMR of 1,4-bis-difluoromethylbenzene

Appendix 70: IR of 1,4-bis-difluoromethylbenzene
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Appendix 71: 1H NMR of 1,4-bis-chlorodifluoromethylbenzene

Appendix 72: 13C NMR of 1,4-bis-chlorodifluoromethylbenzene
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Appendix 73: 19F NMR of 1,4-bis-chlorodifluoromethylbenzene

Appendix 74: IR of 1,4-bis-chlorodifluoromethylbenzene
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Appendix 75: 1H NMR of 1-(trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene

Appendix 76: 13C NMR of 1-(trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene
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Appendix 77: 19F NMR of 1-(trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene

Appendix 78: IR of 1-(trimethylsilyl)difluoromethyl-4-trifluoromethylbenzene
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Appendix 79: 1H NMR of octafluoro[2.2]paracyclophane

Appendix 80: 13C NMR of octafluoro[2.2]paracyclophane
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Appendix 81: 19F NMR of octafluoro[2.2]paracyclophane

Appendix 82: IR of octafluoro[2.2]paracyclophane
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Appendix 83: 1H NMR of (rac)-4-nitro-octafluoro[2.2]paracyclophane

Appendix 84: 13C NMR of (rac)-4-nitro-octafluoro[2.2]paracyclophane
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Appendix 85: 19F NMR of (rac)-4-nitro-octafluoro[2.2]paracyclophane

Appendix 86: IR of (rac)-4-nitro-octafluoro[2.2]paracyclophane
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Appendix 87: 1H NMR of (rac)-4-amino-octafluoro[2.2]paracyclophane

Appendix 88: 13C NMR of (rac)-4-amino-octafluoro[2.2]paracyclophane
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Appendix 89: 19F NMR of (rac)-4-amino-octafluoro[2.2]paracyclophane

Appendix 90: IR of (rac)-4-amino-octafluoro[2.2]paracyclophane
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Appendix 91: 1H NMR of 4-fluorophenyltriethoxysilane

Appendix 92: 13C NMR of 4-fluorophenyltriethoxysilane
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Appendix 93: 19F NMR of 4-fluorophenyltriethoxysilane

Appendix 94: 1H NMR of 3,4,5-trifluorophenyltriethoxysilane
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Appendix 95: 13C NMR of 3,4,5-trifluorophenyltriethoxysilane

Appendix 96: 19F NMR of 3,4,5-trifluorophenyltriethoxysilane
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Appendix 97: 1H NMR of perfluorophenyltriethoxysilane

Appendix 98: 13C NMR of perfluorophenyltriethoxysilane
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Appendix 99: 19F NMR of perfluorophenyltriethoxysilane

Appendix 100: 1H NMR of unidentified dibromo-nitro[2.2]paracyclophane regioisomer (a)
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Appendix 101: 13C NMR of unidentified dibromo-nitro[2.2]paracyclophane regioisomer (a)

Appendix 102: 1H NMR of unidentified dibromo-nitro[2.2]paracyclophane regioisomer (b)
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Appendix 103: 13C NMR of unidentified dibromo-nitro[2.2]paracyclophane regioisomer (b)

Appendix 104: 1H NMR of a mixture of diamino-octafluoro[2.2]paracyclophane isomers
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Appendix 105: 19F NMR of a mixture of diamino-octafluoro[2.2]paracyclophane isomers
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Appendix 106: Crystal data and structure refinement for (SPS)-N-(2-(4-Isopropyl-4,5dihydrooxazol-2-yl)phenyl)-[2.2]paracyclophane-4-amine
Identification code
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system

tcd334
C28H30N2O
410.54
100(2) K
1.54178 Å
Monoclinic

Space group
Unit cell dimensions

P21
a = 9.0508(4) Å
b = 20.3629(8) Å
c = 12.1504(5) Å
2236.62(16) Å3
4
1.219 Mg/m3
0.570 mm-1

Volume
Z
Density (calculated)
Absorption coefficient
F(000)

880

Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 67.679°
Absorption correction
Max. and min. transmission
Refinement method

0.280 x 0.140 x 0.080 mm3
3.642 to 70.008°.
-10≤h≤11, -24≤k≤24, -14≤l≤14
31314
8372 [R(int) = 0.0346]
100.0 %
Semi-empirical from equivalents
0.7533 and 0.6249
Full-matrix least-squares on F2

Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole

8372 / 1 / 571
1.036
R1 = 0.0370, wR2 = 0.0967
R1 = 0.0376, wR2 = 0.0978
0.15(7)
0.241 and -0.195 e.Å-3
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Table 1: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters
(Å2x 103) for TCD334. U(eq) is defined as one third of the trace of the orthogonalized Uij
tensor.
___________________________________________________________________________
x
y
z
U(eq)
___________________________________________________________________________
C(1)
3129(2)
311(1)
907(2)
21(1)
C(2)
3607(2)
702(1)
57(2)
22(1)
C(3)
4620(2)
1207(1)
273(2)
24(1)
C(4)
C(5)
C(6)
C(7)
C(8)
C(9)
C(10)
C(11)

5368(2)
4894(2)
3655(2)
2732(3)
1629(4)
1567(3)
2578(3)
2962(3)

1211(1)
816(1)
412(1)
242(1)
806(2)
1366(1)
1881(1)
2244(1)

1305(2)
2152(2)
1999(2)
2961(2)
3268(3)
2449(2)
2568(2)
1662(2)

27(1)
27(1)
24(1)
31(1)
48(1)
33(1)
33(1)
31(1)

C(12)
C(13)
C(14)
C(15)
C(16)
N(17)
C(18)
C(19)
C(20)

2373(3)
1142(3)
738(3)
3215(3)
4647(3)
1897(2)
1847(2)
3072(2)
3016(3)

2097(1)
1684(1)
1327(1)
2244(1)
1801(1)
-107(1)
-770(1)
-1120(1)
-1792(1)

617(2)
548(2)
1453(2)
-396(2)
-473(2)
664(2)
842(2)
1295(2)
1419(2)

29(1)
31(1)
32(1)
40(1)
31(1)
23(1)
21(1)
24(1)
29(1)

C(21)
C(22)
C(23)
C(24)
O(25)
C(26)
C(27)
N(28)
C(29)

1749(3)
526(3)
540(2)
-822(2)
-2034(2)
-3252(3)
-2560(2)
-981(2)
-2754(3)

-2145(1)
-1808(1)
-1126(1)
-791(1)
-1180(1)
-735(2)
-63(1)
-177(1)
235(1)

1094(2)
679(2)
555(2)
159(2)
22(2)
-220(4)
-348(2)
-30(2)
-1497(2)

31(1)
27(1)
21(1)
22(1)
38(1)
64(1)
29(1)
25(1)
30(1)

C(30)
C(31)
C(32)

-2059(3)
-2128(4)
1743(2)

921(2)
-198(2)
9007(1)

-1494(3)
-2361(2)
5781(2)

51(1)
61(1)
22(1)
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C(33)
C(34)
C(35)
C(36)
C(37)
C(38)
C(39)
C(40)
C(41)

1398(2)
381(3)
-499(3)
-147(3)
1081(3)
1872(3)
3354(3)
3366(3)
2326(3)

8634(1)
8119(1)
8080(1)
8444(1)
8858(1)
8981(1)
8574(2)
7980(1)
7477(1)

4845(2)
4862(2)
5759(2)
6703(2)
6769(2)
7873(2)
8031(2)
7287(2)
7372(2)

24(1)
27(1)
30(1)
29(1)
25(1)
33(1)
43(1)
35(1)
39(1)

C(42)
C(43)
C(44)
C(45)
C(46)
C(47)
N(48)
C(49)

1911(3)
2516(3)
3767(3)
4187(3)
1639(4)
468(3)
2957(2)
2981(2)

7092(1)
7196(1)
7591(1)
7979(1)
7024(2)
7565(1)
9443(1)
10091(1)

6474(2)
5458(2)
5447(2)
6345(2)
4411(3)
4041(2)
5755(2)
6046(2)

38(1)
36(1)
34(1)
33(1)
50(1)
36(1)
24(1)
23(1)

C(50)
C(51)
C(52)
C(53)
C(54)
C(55)
O(56)
C(57)
C(58)

1765(3)
1809(3)
3056(3)
4261(3)
4251(2)
5533(2)
6643(2)
7705(3)
7138(2)

10405(1)
11062(1)
11440(1)
11147(1)
10480(1)
10202(1)
10633(1)
10270(1)
9558(1)

6501(2)
6774(2)
6599(2)
6140(2)
5865(2)
5338(2)
5148(2)
4533(2)
4518(2)

26(1)
30(1)
33(1)
30(1)
24(1)
24(1)
33(1)
32(1)
26(1)

N(59)
C(60)
C(61)
C(62)

5700(2)
6964(3)
8453(3)
6330(3)

9609(1)
9251(1)
9241(2)
8563(1)

5034(2)
3374(2)
2826(2)
3430(2)

25(1)
32(1)
48(1)
40(1)

Table 2: Bond lengths [Å] and angles [°] for TCD334.
___________________________________________________________________________
C(1)-C(2)
1.390(3)
C(3)-C(4)
1.395(3)
C(1)-C(6)
1.403(3)
C(3)-C(16)
1.512(3)
C(1)-N(17)
C(2)-C(3)
C(2)-H(2)

1.421(3)
1.394(3)
0.9500

C(4)-C(5)
C(4)-H(4)
C(5)-C(6)
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C(5)-H(5)
C(6)-C(7)
C(7)-C(8)
C(7)-H(7A)
C(7)-H(7B)
C(8)-C(9)
C(8)-H(8A)
C(8)-H(8B)
C(9)-C(14)

0.9500
1.510(3)
1.579(4)
0.9900
0.9900
1.513(4)
0.9900
0.9900
1.394(4)

C(24)-O(25)
O(25)-C(26)
C(26)-C(27)
C(26)-H(26A)
C(26)-H(26B)
C(27)-N(28)
C(27)-C(29)
C(27)-H(27)
C(29)-C(31)

1.357(3)
1.446(3)
1.515(4)
0.9900
0.9900
1.481(3)
1.525(3)
1.0000
1.503(4)

C(9)-C(10)
C(10)-C(11)
C(10)-H(10)
C(11)-C(12)
C(11)-H(11)
C(12)-C(13)
C(12)-C(15)
C(13)-C(14)

1.395(4)
1.385(4)
0.9500
1.385(4)
0.9500
1.395(3)
1.509(4)
1.383(4)

C(29)-C(30)
C(29)-H(29)
C(30)-H(30A)
C(30)-H(30B)
C(30)-H(30C)
C(31)-H(31A)
C(31)-H(31B)
C(31)-H(31C)

1.531(4)
1.0000
0.9800
0.9800
0.9800
0.9800
0.9800
0.9800

C(13)-H(13)
C(14)-H(14)
C(15)-C(16)
C(15)-H(15A)
C(15)-H(15B)
C(16)-H(16A)
C(16)-H(16B)
N(17)-C(18)
N(17)-H(17)

0.9500
0.9500
1.586(4)
0.9900
0.9900
0.9900
0.9900
1.370(3)
0.90(3)

C(32)-C(33)
C(32)-C(37)
C(32)-N(48)
C(33)-C(34)
C(33)-H(33)
C(34)-C(35)
C(34)-C(47)
C(35)-C(36)
C(35)-H(35)

1.390(3)
1.401(3)
1.413(3)
1.397(3)
0.9500
1.384(4)
1.511(3)
1.389(4)
0.9500

C(18)-C(19)
C(18)-C(23)
C(19)-C(20)
C(19)-H(19)
C(20)-C(21)
C(20)-H(20)
C(21)-C(22)
C(21)-H(21)
C(22)-C(23)

1.407(3)
1.417(3)
1.379(3)
0.9500
1.394(3)
0.9500
1.377(3)
0.9500
1.397(3)

C(36)-C(37)
C(36)-H(36)
C(37)-C(38)
C(38)-C(39)
C(38)-H(38A)
C(38)-H(38B)
C(39)-C(40)
C(39)-H(39A)
C(39)-H(39B)

1.394(3)
0.9500
1.511(3)
1.581(4)
0.9900
0.9900
1.511(4)
0.9900
0.9900

C(22)-H(22)
C(23)-C(24)
C(24)-N(28)

0.9500
1.468(3)
1.279(3)

C(40)-C(45)
C(40)-C(41)
C(41)-C(42)

1.395(4)
1.399(4)
1.381(4)
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C(41)-H(41)
C(42)-C(43)
C(42)-H(42)
C(43)-C(44)
C(43)-C(46)
C(44)-C(45)
C(44)-H(44)
C(45)-H(45)
C(46)-C(47)

0.9500
1.391(4)
0.9500
1.388(4)
1.507(4)
1.385(4)
0.9500
0.9500
1.579(4)

C(61)-H(61A)
C(61)-H(61B)
C(61)-H(61C)
C(62)-H(62A)
C(62)-H(62B)
C(62)-H(62C)
C(2)-C(1)-C(6)
C(2)-C(1)-N(17)

121.0(2)
117.22(19)

C(46)-H(46A)
C(46)-H(46B)
C(47)-H(47A)
C(47)-H(47B)
N(48)-C(49)
N(48)-H(48)
C(49)-C(50)
C(49)-C(54)

0.9900
0.9900
0.9900
0.9900
1.367(3)
0.90(3)
1.409(3)
1.422(3)

C(6)-C(1)-N(17)
C(1)-C(2)-C(3)
C(1)-C(2)-H(2)
C(3)-C(2)-H(2)
C(2)-C(3)-C(4)
C(2)-C(3)-C(16)
C(4)-C(3)-C(16)
C(5)-C(4)-C(3)

120.77(19)
120.6(2)
119.7
119.7
117.3(2)
120.5(2)
120.8(2)
120.5(2)

C(50)-C(51)
C(50)-H(50)
C(51)-C(52)
C(51)-H(51)
C(52)-C(53)
C(52)-H(52)
C(53)-C(54)
C(53)-H(53)
C(54)-C(55)

1.379(3)
0.9500
1.392(4)
0.9500
1.385(4)
0.9500
1.399(3)
0.9500
1.466(3)

C(5)-C(4)-H(4)
C(3)-C(4)-H(4)
C(4)-C(5)-C(6)
C(4)-C(5)-H(5)
C(6)-C(5)-H(5)
C(5)-C(6)-C(1)
C(5)-C(6)-C(7)
C(1)-C(6)-C(7)
C(6)-C(7)-C(8)

119.7
119.7
121.1(2)
119.4
119.4
116.5(2)
120.3(2)
121.5(2)
113.3(2)

C(55)-N(59)
C(55)-O(56)
O(56)-C(57)
C(57)-C(58)
C(57)-H(57A)
C(57)-H(57B)
C(58)-N(59)
C(58)-C(60)
C(58)-H(58)

1.274(3)
1.363(3)
1.449(3)
1.537(3)
0.9900
0.9900
1.476(3)
1.525(3)
1.0000

C(6)-C(7)-H(7A)
C(8)-C(7)-H(7A)
C(6)-C(7)-H(7B)
C(8)-C(7)-H(7B)
H(7A)-C(7)-H(7B)
C(9)-C(8)-C(7)
C(9)-C(8)-H(8A)
C(7)-C(8)-H(8A)
C(9)-C(8)-H(8B)

108.9
108.9
108.9
108.9
107.7
113.3(2)
108.9
108.9
108.9

C(60)-C(62)
C(60)-C(61)
C(60)-H(60)

1.518(4)
1.532(3)
1.0000

C(7)-C(8)-H(8B)
H(8A)-C(8)-H(8B)
C(14)-C(9)-C(10)

108.9
107.7
117.0(2)
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C(14)-C(9)-C(8)
C(10)-C(9)-C(8)
C(11)-C(10)-C(9)
C(11)-C(10)-H(10)
C(9)-C(10)-H(10)
C(10)-C(11)-C(12)
C(10)-C(11)-H(11)
C(12)-C(11)-H(11)
C(11)-C(12)-C(13)

122.0(3)
119.7(3)
120.6(2)
119.7
119.7
120.9(2)
119.6
119.6
117.1(2)

C(19)-C(20)-C(21)
C(19)-C(20)-H(20)
C(21)-C(20)-H(20)
C(22)-C(21)-C(20)
C(22)-C(21)-H(21)
C(20)-C(21)-H(21)
C(21)-C(22)-C(23)
C(21)-C(22)-H(22)
C(23)-C(22)-H(22)

121.0(2)
119.5
119.5
118.9(2)
120.6
120.6
121.5(2)
119.2
119.2

C(11)-C(12)-C(15)
C(13)-C(12)-C(15)
C(14)-C(13)-C(12)
C(14)-C(13)-H(13)
C(12)-C(13)-H(13)
C(13)-C(14)-C(9)
C(13)-C(14)-H(14)
C(9)-C(14)-H(14)

121.2(2)
120.3(2)
120.7(2)
119.6
119.6
120.6(2)
119.7
119.7

C(22)-C(23)-C(18)
C(22)-C(23)-C(24)
C(18)-C(23)-C(24)
N(28)-C(24)-O(25)
N(28)-C(24)-C(23)
O(25)-C(24)-C(23)
C(24)-O(25)-C(26)
O(25)-C(26)-C(27)

119.6(2)
119.01(19)
121.35(19)
117.7(2)
126.75(19)
115.48(19)
105.3(2)
105.8(2)

C(12)-C(15)-C(16)
C(12)-C(15)-H(15A)
C(16)-C(15)-H(15A)
C(12)-C(15)-H(15B)
C(16)-C(15)-H(15B)
H(15A)-C(15)-H(15B)
C(3)-C(16)-C(15)
C(3)-C(16)-H(16A)
C(15)-C(16)-H(16A)

112.5(2)
109.1
109.1
109.1
109.1
107.8
112.45(19)
109.1
109.1

O(25)-C(26)-H(26A)
C(27)-C(26)-H(26A)
O(25)-C(26)-H(26B)
C(27)-C(26)-H(26B)
H(26A)-C(26)-H(26B)
N(28)-C(27)-C(26)
N(28)-C(27)-C(29)
C(26)-C(27)-C(29)
N(28)-C(27)-H(27)

110.6
110.6
110.6
110.6
108.7
103.3(2)
111.58(18)
115.1(2)
108.9

C(3)-C(16)-H(16B)
C(15)-C(16)-H(16B)
H(16A)-C(16)-H(16B)
C(18)-N(17)-C(1)
C(18)-N(17)-H(17)
C(1)-N(17)-H(17)
N(17)-C(18)-C(19)
N(17)-C(18)-C(23)
C(19)-C(18)-C(23)

109.1
109.1
107.8
126.06(18)
115(2)
119(2)
122.0(2)
119.97(19)
118.02(19)

C(26)-C(27)-H(27)
C(29)-C(27)-H(27)
C(24)-N(28)-C(27)
C(31)-C(29)-C(27)
C(31)-C(29)-C(30)
C(27)-C(29)-C(30)
C(31)-C(29)-H(29)
C(27)-C(29)-H(29)
C(30)-C(29)-H(29)

108.9
108.9
107.38(19)
112.0(2)
111.6(3)
109.4(2)
107.9
107.9
107.9

C(20)-C(19)-C(18)
C(20)-C(19)-H(19)
C(18)-C(19)-H(19)

120.8(2)
119.6
119.6

C(29)-C(30)-H(30A)
C(29)-C(30)-H(30B)
H(30A)-C(30)-H(30B)

109.5
109.5
109.5
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C(29)-C(30)-H(30C)
H(30A)-C(30)-H(30C)
H(30B)-C(30)-H(30C)
C(29)-C(31)-H(31A)
C(29)-C(31)-H(31B)
H(31A)-C(31)-H(31B)
C(29)-C(31)-H(31C)
H(31A)-C(31)-H(31C)
H(31B)-C(31)-H(31C)

109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5

H(39A)-C(39)-H(39B)
C(45)-C(40)-C(41)
C(45)-C(40)-C(39)
C(41)-C(40)-C(39)
C(42)-C(41)-C(40)
C(42)-C(41)-H(41)
C(40)-C(41)-H(41)
C(41)-C(42)-C(43)
C(41)-C(42)-H(42)

107.9
116.6(2)
120.8(3)
121.2(3)
121.0(3)
119.5
119.5
120.7(3)
119.6

C(33)-C(32)-C(37)
C(33)-C(32)-N(48)
C(37)-C(32)-N(48)
C(32)-C(33)-C(34)
C(32)-C(33)-H(33)
C(34)-C(33)-H(33)
C(35)-C(34)-C(33)
C(35)-C(34)-C(47)

119.6(2)
117.94(19)
121.4(2)
121.3(2)
119.3
119.3
117.4(2)
121.9(2)

C(43)-C(42)-H(42)
C(44)-C(43)-C(42)
C(44)-C(43)-C(46)
C(42)-C(43)-C(46)
C(45)-C(44)-C(43)
C(45)-C(44)-H(44)
C(43)-C(44)-H(44)
C(44)-C(45)-C(40)

119.6
117.0(2)
121.5(3)
119.9(3)
121.0(2)
119.5
119.5
120.7(2)

C(33)-C(34)-C(47)
C(34)-C(35)-C(36)
C(34)-C(35)-H(35)
C(36)-C(35)-H(35)
C(35)-C(36)-C(37)
C(35)-C(36)-H(36)
C(37)-C(36)-H(36)
C(36)-C(37)-C(32)
C(36)-C(37)-C(38)

119.7(2)
120.1(2)
119.9
119.9
121.3(2)
119.3
119.3
117.1(2)
119.5(2)

C(44)-C(45)-H(45)
C(40)-C(45)-H(45)
C(43)-C(46)-C(47)
C(43)-C(46)-H(46A)
C(47)-C(46)-H(46A)
C(43)-C(46)-H(46B)
C(47)-C(46)-H(46B)
H(46A)-C(46)-H(46B)
C(34)-C(47)-C(46)

119.7
119.7
113.3(2)
108.9
108.9
108.9
108.9
107.7
112.9(2)

C(32)-C(37)-C(38)
C(37)-C(38)-C(39)
C(37)-C(38)-H(38A)
C(39)-C(38)-H(38A)
C(37)-C(38)-H(38B)
C(39)-C(38)-H(38B)
H(38A)-C(38)-H(38B)
C(40)-C(39)-C(38)
C(40)-C(39)-H(39A)

121.4(2)
112.51(19)
109.1
109.1
109.1
109.1
107.8
112.2(2)
109.2

C(34)-C(47)-H(47A)
C(46)-C(47)-H(47A)
C(34)-C(47)-H(47B)
C(46)-C(47)-H(47B)
H(47A)-C(47)-H(47B)
C(49)-N(48)-C(32)
C(49)-N(48)-H(48)
C(32)-N(48)-H(48)
N(48)-C(49)-C(50)

109.0
109.0
109.0
109.0
107.8
127.08(19)
114(2)
117(2)
122.5(2)

C(38)-C(39)-H(39A)
C(40)-C(39)-H(39B)
C(38)-C(39)-H(39B)

109.2
109.2
109.2

N(48)-C(49)-C(54)
C(50)-C(49)-C(54)
C(51)-C(50)-C(49)

120.0(2)
117.5(2)
121.4(2)
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C(51)-C(50)-H(50)
C(49)-C(50)-H(50)
C(50)-C(51)-C(52)
C(50)-C(51)-H(51)
C(52)-C(51)-H(51)
C(53)-C(52)-C(51)
C(53)-C(52)-H(52)
C(51)-C(52)-H(52)
C(52)-C(53)-C(54)

119.3
119.3
121.0(2)
119.5
119.5
118.9(2)
120.6
120.6
121.3(2)

N(59)-C(58)-C(57)
C(60)-C(58)-C(57)
N(59)-C(58)-H(58)
C(60)-C(58)-H(58)
C(57)-C(58)-H(58)
C(55)-N(59)-C(58)
C(62)-C(60)-C(58)
C(62)-C(60)-C(61)
C(58)-C(60)-C(61)

103.27(18)
114.7(2)
109.2
109.2
109.2
108.02(19)
111.1(2)
110.5(2)
110.3(2)

C(52)-C(53)-H(53)
C(54)-C(53)-H(53)
C(53)-C(54)-C(49)
C(53)-C(54)-C(55)
C(49)-C(54)-C(55)
N(59)-C(55)-O(56)
N(59)-C(55)-C(54)
O(56)-C(55)-C(54)

119.4
119.4
120.0(2)
118.9(2)
121.1(2)
117.6(2)
126.9(2)
115.56(19)

C(62)-C(60)-H(60)
C(58)-C(60)-H(60)
C(61)-C(60)-H(60)
C(60)-C(61)-H(61A)
C(60)-C(61)-H(61B)
H(61A)-C(61)-H(61B)
C(60)-C(61)-H(61C)
H(61A)-C(61)-H(61C)

108.3
108.3
108.3
109.5
109.5
109.5
109.5
109.5

C(55)-O(56)-C(57)
O(56)-C(57)-C(58)
O(56)-C(57)-H(57A)
C(58)-C(57)-H(57A)
O(56)-C(57)-H(57B)
C(58)-C(57)-H(57B)
H(57A)-C(57)-H(57B)
N(59)-C(58)-C(60)

105.78(18)
104.95(17)
110.8
110.8
110.8
110.8
108.8
111.24(18)

H(61B)-C(61)-H(61C)
C(60)-C(62)-H(62A)
C(60)-C(62)-H(62B)
H(62A)-C(62)-H(62B)
C(60)-C(62)-H(62C)
H(62A)-C(62)-H(62C)
H(62B)-C(62)-H(62C)

109.5
109.5
109.5
109.5
109.5
109.5
109.5

Table 3: Anisotropic displacement parameters (Å2x 103) for TCD334. The anisotropic
displacement factor exponent takes the form: - 2[ h2 a*2U11 + ... + 2 h k a* b* U12 ]
___________________________________________________________________________
U11
U22
U33
U23
U13
U12
___________________________________________________________________________
C(1)
18(1)
17(1)
28(1)
0(1)
-1(1)
2(1)
C(2)
22(1)
21(1)
24(1)
-2(1)
1(1)
4(1)
C(3)
20(1)
17(1)
35(1)
-2(1)
6(1)
1(1)
C(4)
17(1)
19(1)
44(1)
-6(1)
-1(1)
0(1)
C(5)
C(6)
C(7)

25(1)
26(1)
37(1)

23(1)
19(1)
31(1)

33(1)
28(1)
24(1)

-3(1)
1(1)
3(1)
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-2(1)

5(1)
4(1)
1(1)
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C(8)
C(9)
C(10)
C(11)
C(12)
C(13)
C(14)
C(15)
C(16)

54(2)
31(1)
32(1)
27(1)
30(1)
27(1)
20(1)
45(2)
30(1)

44(2)
33(1)
34(1)
22(1)
19(1)
28(1)
26(1)
28(1)
23(1)

49(2)
37(1)
34(1)
44(1)
40(1)
36(1)
51(2)
47(2)
42(1)

13(1)
1(1)
-11(1)
-6(1)
2(1)
-6(1)
-5(1)
10(1)
3(1)

23(1)
11(1)
0(1)
1(1)
3(1)
-5(1)
5(1)
11(1)
9(1)

12(1)
9(1)
10(1)
4(1)
8(1)
10(1)
4(1)
11(1)
-3(1)

N(17)
C(18)
C(19)
C(20)
C(21)
C(22)
C(23)
C(24)

22(1)
23(1)
23(1)
31(1)
37(1)
32(1)
24(1)
21(1)

20(1)
20(1)
24(1)
23(1)
18(1)
22(1)
23(1)
26(1)

27(1)
18(1)
26(1)
32(1)
37(1)
27(1)
18(1)
19(1)

3(1)
-2(1)
-1(1)
-2(1)
-1(1)
-3(1)
-1(1)
0(1)

-5(1)
3(1)
1(1)
0(1)
2(1)
3(1)
3(1)
2(1)

-2(1)
-1(1)
1(1)
7(1)
0(1)
-5(1)
-2(1)
-5(1)

O(25)
C(26)
C(27)
N(28)
C(29)
C(30)
C(31)
C(32)
C(33)

24(1)
21(1)
18(1)
22(1)
22(1)
36(2)
45(2)
20(1)
26(1)

34(1)
57(2)
37(1)
27(1)
36(1)
42(2)
105(3)
21(1)
22(1)

54(1)
114(3)
32(1)
26(1)
30(1)
76(2)
33(1)
25(1)
23(1)

12(1)
44(2)
3(1)
2(1)
1(1)
26(2)
-22(2)
2(1)
4(1)

-9(1)
-12(2)
2(1)
-1(1)
-2(1)
1(1)
-9(1)
1(1)
0(1)

-8(1)
-7(1)
2(1)
1(1)
6(1)
1(1)
31(2)
2(1)
2(1)

C(34)
C(35)
C(36)
C(37)
C(38)
C(39)
C(40)
C(41)
C(42)

27(1)
21(1)
25(1)
27(1)
43(1)
46(2)
33(1)
39(1)
33(1)

22(1)
22(1)
26(1)
22(1)
34(1)
53(2)
38(1)
38(1)
25(1)

32(1)
48(1)
37(1)
26(1)
21(1)
28(1)
32(1)
40(1)
55(2)

0(1)
7(1)
7(1)
2(1)
0(1)
-4(1)
4(1)
15(1)
7(1)

-9(1)
-3(1)
10(1)
5(1)
6(1)
-10(1)
-10(1)
2(1)
1(1)

3(1)
0(1)
5(1)
6(1)
1(1)
7(1)
10(1)
14(1)
8(1)

C(43)
C(44)
C(45)

37(1)
32(1)
26(1)

22(1)
29(1)
33(1)

49(2)
40(1)
40(1)

-5(1)
-2(1)
2(1)

-3(1)
3(1)
-6(1)

11(1)
10(1)
8(1)
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C(46)
C(47)
N(48)
C(49)
C(50)
C(51)
C(52)
C(53)
C(54)

53(2)
41(1)
24(1)
26(1)
27(1)
31(1)
39(1)
31(1)
26(1)

34(1)
27(1)
22(1)
24(1)
27(1)
28(1)
21(1)
24(1)
25(1)

60(2)
39(1)
26(1)
19(1)
26(1)
30(1)
38(1)
33(1)
21(1)

-19(1)
-6(1)
-3(1)
0(1)
1(1)
-1(1)
-2(1)
2(1)
2(1)

-14(1)
-9(1)
6(1)
0(1)
3(1)
3(1)
1(1)
0(1)
-3(1)

11(1)
-3(1)
-3(1)
0(1)
1(1)
5(1)
2(1)
-3(1)
-1(1)

C(55)
O(56)
C(57)
C(58)
N(59)
C(60)
C(61)
C(62)

24(1)
25(1)
22(1)
21(1)
24(1)
29(1)
44(2)
41(1)

25(1)
26(1)
36(1)
30(1)
26(1)
45(1)
71(2)
42(2)

21(1)
48(1)
38(1)
27(1)
26(1)
24(1)
31(1)
37(1)

5(1)
4(1)
6(1)
6(1)
-1(1)
5(1)
10(1)
-11(1)

-2(1)
7(1)
6(1)
2(1)
4(1)
0(1)
12(1)
-5(1)

-4(1)
-5(1)
0(1)
2(1)
-2(1)
11(1)
20(1)
8(1)

Table 4: Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 10 3)
for TCD334.
___________________________________________________________________________
x
y
z
U(eq)
___________________________________________________________________________
H(2)
3240
624
-677
27
H(4)
6208
1486
1429
32
H(5)
5422
821
2847
33
H(7A)
H(7B)
H(8A)
H(8B)
H(10)
H(11)
H(13)
H(14)
H(15A)

3399
2158
625
1933
3007
3638
576
-113
3510

145
-161
617
980
1983
2599
1647
1053
2712

3611
2781
3314
4005
3276
1758
-129
1396
-386

37
37
58
58
40
37
37
39
48

H(15B)
H(16A)
H(16B)

2557
4728
5533

2171
1653
2068

-1060
-1244
-270

48
37
37
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H(19)
H(20)
H(21)
H(22)
H(26A)
H(26B)
H(27)
H(29)
H(30A)

3949
3853
1729
-348
-3939
-3806
-2984
-3838
-981

-890
-2019
-2610
-2045
-733
-866
245
285
882

1519
1730
1158
471
390
-907
194
-1676
-1400

29
34
37
32
77
77
35
35
77

H(30B)
H(30C)
H(31A)
H(31B)
H(31C)
H(33)
H(35)
H(36)

-2432
-2320
-1083
-2219
-2675
1863
-1346
-756

1179
1141
-286
23
-613
8732
7804
8411

-886
-2195
-2169
-3078
-2400
4180
5730
7316

77
77
92
92
92
28
36
35

H(38A)
H(38B)
H(39A)
H(39B)
H(41)
H(42)
H(44)
H(45)
H(46A)

1207
2101
4202
3479
1899
1204
4343
5044
1118

8863
9455
8861
8430
7398
6752
7595
8247
6603

8465
7944
7873
8808
8059
6550
4814
6319
4520

39
39
51
51
47
45
40
40
60

H(46B)
H(47A)
H(47B)
H(50)
H(51)
H(52)
H(53)
H(57A)
H(57B)

2330
732
-518
897
975
3081
5111
8705
7748

6959
7748
7357
10158
11259
11893
11404
10296
10444

3814
3322
3939
6623
7086
6792
6008
4900
3775

60
43
43
32
35
39
35
38
38

H(58)
H(60)
H(61A)

7822
6261
9195

9281
9528
9025

4993
2913
3316

31
39
72
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H(61B)
H(61C)
H(62A)
H(62B)
H(62C)
H(48)
H(17)

8767
8350
6972
6272
5338
3740(40)
1080(40)

9693
9000
8292
8369
8582
9314(16)
60(16)

2683
2129
3919
2691
3717
5370(30)
310(30)

72
72
60
60
60
40(8)
40(8)

Table 5: Torsion angles [°] for TCD334.
___________________________________________________________________________
C(6)-C(1)-C(2)-C(3)
-0.2(3)
C(11)-C(12)-C(15)-C(16)
67.7(3)
N(17)-C(1)-C(2)-C(3)
168.22(19)
C(13)-C(12)-C(15)-C(16)
-98.1(3)
C(1)-C(2)-C(3)-C(4)
13.8(3)
C(2)-C(3)-C(16)-C(15)
68.3(3)
C(1)-C(2)-C(3)-C(16)
-152.9(2)
C(4)-C(3)-C(16)-C(15)
-98.0(3)
C(2)-C(3)-C(4)-C(5)
-13.4(3)
C(12)-C(15)-C(16)-C(3)
16.9(3)
C(16)-C(3)-C(4)-C(5)
153.3(2)
C(2)-C(1)-N(17)-C(18)
126.5(2)
C(3)-C(4)-C(5)-C(6)
-0.7(3)
C(6)-C(1)-N(17)-C(18)
-65.0(3)
C(4)-C(5)-C(6)-C(1)
C(4)-C(5)-C(6)-C(7)
C(2)-C(1)-C(6)-C(5)
N(17)-C(1)-C(6)-C(5)
C(2)-C(1)-C(6)-C(7)
N(17)-C(1)-C(6)-C(7)
C(5)-C(6)-C(7)-C(8)
C(1)-C(6)-C(7)-C(8)
C(6)-C(7)-C(8)-C(9)

14.1(3)
-151.2(2)
-13.7(3)
178.30(19)
151.5(2)
-16.6(3)
79.4(3)
-85.2(3)
7.7(4)

C(1)-N(17)-C(18)-C(19)
-0.7(3)
C(1)-N(17)-C(18)-C(23) -179.86(19)
N(17)-C(18)-C(19)-C(20) -176.9(2)
C(23)-C(18)-C(19)-C(20)
2.3(3)
C(18)-C(19)-C(20)-C(21)
0.3(4)
C(19)-C(20)-C(21)-C(22)
-2.2(4)
C(20)-C(21)-C(22)-C(23)
1.4(3)
C(21)-C(22)-C(23)-C(18)
1.2(3)
C(21)-C(22)-C(23)-C(24) -177.0(2)

C(7)-C(8)-C(9)-C(14)
C(7)-C(8)-C(9)-C(10)
C(14)-C(9)-C(10)-C(11)
C(8)-C(9)-C(10)-C(11)
C(9)-C(10)-C(11)-C(12)
C(10)-C(11)-C(12)-C(13)
C(10)-C(11)-C(12)-C(15)
C(11)-C(12)-C(13)-C(14)
C(15)-C(12)-C(13)-C(14)

79.9(3)
-86.8(3)
-13.5(3)
153.8(2)
-1.2(3)
14.8(3)
-151.4(2)
-13.7(3)
152.7(2)

N(17)-C(18)-C(23)-C(22) 176.2(2)
C(19)-C(18)-C(23)-C(22)
-3.0(3)
N(17)-C(18)-C(23)-C(24)
-5.6(3)
C(19)-C(18)-C(23)-C(24) 175.16(19)
C(22)-C(23)-C(24)-N(28) -177.7(2)
C(18)-C(23)-C(24)-N(28)
4.1(3)
C(22)-C(23)-C(24)-O(25)
4.8(3)
C(18)-C(23)-C(24)-O(25) -173.43(19)
N(28)-C(24)-O(25)-C(26)
-5.4(3)

C(12)-C(13)-C(14)-C(9)
C(10)-C(9)-C(14)-C(13)
C(8)-C(9)-C(14)-C(13)

-1.0(3)
14.6(3)
-152.5(2)

C(23)-C(24)-O(25)-C(26)
C(24)-O(25)-C(26)-C(27)
O(25)-C(26)-C(27)-N(28)
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172.4(2)
7.1(3)
-6.6(3)
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O(25)-C(26)-C(27)-C(29)
O(25)-C(24)-N(28)-C(27)
C(23)-C(24)-N(28)-C(27)
C(26)-C(27)-N(28)-C(24)
C(29)-C(27)-N(28)-C(24)
N(28)-C(27)-C(29)-C(31)
C(26)-C(27)-C(29)-C(31)
N(28)-C(27)-C(29)-C(30)
C(26)-C(27)-C(29)-C(30)

115.3(3)
1.0(3)
-176.6(2)
3.7(3)
-120.6(2)
59.4(3)
-58.0(3)
-65.0(3)
177.7(2)

C(42)-C(43)-C(46)-C(47)
C(35)-C(34)-C(47)-C(46)
C(33)-C(34)-C(47)-C(46)
C(43)-C(46)-C(47)-C(34)
C(33)-C(32)-N(48)-C(49)
C(37)-C(32)-N(48)-C(49)
C(32)-N(48)-C(49)-C(50)
C(32)-N(48)-C(49)-C(54)
N(48)-C(49)-C(50)-C(51)

80.9(3)
-85.2(3)
83.0(3)
-4.7(4)
130.4(2)
-61.6(3)
4.8(3)
-173.5(2)
-179.1(2)

C(37)-C(32)-C(33)-C(34)
1.1(3)
N(48)-C(32)-C(33)-C(34) 169.36(19)
C(32)-C(33)-C(34)-C(35)
13.5(3)
C(32)-C(33)-C(34)-C(47) -155.2(2)
C(33)-C(34)-C(35)-C(36)
-14.2(3)
C(47)-C(34)-C(35)-C(36)
154.2(2)
C(34)-C(35)-C(36)-C(37)
0.5(3)
C(35)-C(36)-C(37)-C(32)
14.1(3)

C(54)-C(49)-C(50)-C(51)
C(49)-C(50)-C(51)-C(52)
C(50)-C(51)-C(52)-C(53)
C(51)-C(52)-C(53)-C(54)
C(52)-C(53)-C(54)-C(49)
C(52)-C(53)-C(54)-C(55)
N(48)-C(49)-C(54)-C(53)
C(50)-C(49)-C(54)-C(53)

-0.7(3)
0.5(4)
0.3(4)
-0.9(4)
0.7(3)
177.5(2)
178.5(2)
0.1(3)

C(35)-C(36)-C(37)-C(38) -150.2(2)
C(33)-C(32)-C(37)-C(36)
-14.7(3)
N(48)-C(32)-C(37)-C(36) 177.47(19)
C(33)-C(32)-C(37)-C(38)
149.2(2)
N(48)-C(32)-C(37)-C(38)
-18.6(3)
C(36)-C(37)-C(38)-C(39)
102.3(3)
C(32)-C(37)-C(38)-C(39)
-61.3(3)
C(37)-C(38)-C(39)-C(40)
-22.1(3)
C(38)-C(39)-C(40)-C(45)
103.9(3)

N(48)-C(49)-C(54)-C(55)
1.8(3)
C(50)-C(49)-C(54)-C(55) -176.58(19)
C(53)-C(54)-C(55)-N(59) -179.8(2)
C(49)-C(54)-C(55)-N(59)
-3.0(3)
C(53)-C(54)-C(55)-O(56)
-0.7(3)
C(49)-C(54)-C(55)-O(56) 176.08(19)
N(59)-C(55)-O(56)-C(57)
4.7(3)
C(54)-C(55)-O(56)-C(57) -174.46(19)
C(55)-O(56)-C(57)-C(58)
-6.3(2)

C(38)-C(39)-C(40)-C(41)
C(45)-C(40)-C(41)-C(42)
C(39)-C(40)-C(41)-C(42)
C(40)-C(41)-C(42)-C(43)
C(41)-C(42)-C(43)-C(44)
C(41)-C(42)-C(43)-C(46)
C(42)-C(43)-C(44)-C(45)
C(46)-C(43)-C(44)-C(45)
C(43)-C(44)-C(45)-C(40)

-61.9(3)
-13.7(4)
152.6(2)
-0.1(4)
14.1(4)
-151.7(2)
-14.3(3)
151.3(2)
0.4(4)

O(56)-C(57)-C(58)-N(59)
O(56)-C(57)-C(58)-C(60)
O(56)-C(55)-N(59)-C(58)
C(54)-C(55)-N(59)-C(58)
C(60)-C(58)-N(59)-C(55)
C(57)-C(58)-N(59)-C(55)
N(59)-C(58)-C(60)-C(62)
C(57)-C(58)-C(60)-C(62)
N(59)-C(58)-C(60)-C(61)

6.0(2)
127.1(2)
-0.6(3)
178.4(2)
-126.9(2)
-3.5(2)
-60.5(3)
-177.2(2)
176.6(2)

C(41)-C(40)-C(45)-C(44)
C(39)-C(40)-C(45)-C(44)
C(44)-C(43)-C(46)-C(47)

13.6(3)
-152.8(2)
-84.3(3)

C(57)-C(58)-C(60)-C(61)

59.9(3)
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Table 6: Hydrogen bonds for TCD334 [Å and °].
___________________________________________________________________________
D-H...A
d(D-H)
d(H...A)
d(D...A)
<(DHA)
___________________________________________________________________________
N(48)-H(48)...N(59)
0.90(3)
1.94(3)
2.694(3)
140(3)
N(17)-H(17)...N(28)
0.90(3)
1.95(3)
2.702(3)
139(3)
___________________________________________________________________________
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